细胞株Cell Lines 51-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV51
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID ML-DmD23
AC CVCL_Z745
SY ML DmD23; DmD23
DR EFO; EFO_0007113
DR DGRC; 121
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD23-c1
AC CVCL_Z777
DR DGRC; 87
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z745 ! ML-DmD23
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD23-c2
AC CVCL_Z778
DR DGRC; 116
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z745 ! ML-DmD23
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD23-c3
AC CVCL_Z779
DR DGRC; 88
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z745 ! ML-DmD23
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD23-c4
AC CVCL_Z780
SY ML DmD23 c4; DmD23-c4
DR EFO; EFO_0007114
DR DGRC; 89
DR GEO; GSM454534
DR GEO; GSM454535
DR GEO; GSM454536
DR GEO; GSM454537
DR GEO; GSM454538
DR GEO; GSM454539
DR GEO; GSM454540
DR GEO; GSM454541
DR GEO; GSM454542
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z745 ! ML-DmD23
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD23-c5
AC CVCL_Z781
DR DGRC; 117
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z745 ! ML-DmD23
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD23-c6
AC CVCL_Z782
DR DGRC; 118
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z745 ! ML-DmD23
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD25
AC CVCL_Z746
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD25-c2
AC CVCL_Z783
DR DGRC; 119
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z746 ! ML-DmD25
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD3
AC CVCL_Z747
SY ML-DmD 3
RX PubMed=3117765;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD31
AC CVCL_Z748
DR DGRC; 144
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD32
AC CVCL_Z749
SY D32
DR EFO; EFO_0005830
DR DGRC; 145
DR ENCODE; ENCBS773DNL
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD4
AC CVCL_Z750
SY ML-DmD 4
RX PubMed=3117765;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD4-c1
AC CVCL_Z784
SY D4-c1; D4c1
DR EFO; EFO_0005831
DR DGRC; 126
DR ENCODE; ENCBS483XFL
DR GEO; GSM278139
DR GEO; GSM278140
DR GEO; GSM278153
DR GEO; GSM278154
DR GEO; GSM278155
DR GEO; GSM278186
DR GEO; GSM278187
DR GEO; GSM278229
DR GEO; GSM278230
DR GEO; GSM278231
DR GEO; GSM278327
DR GEO; GSM279695
DR GEO; GSM279696
DR GEO; GSM279697
DR GEO; GSM279698
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z750 ! ML-DmD4
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD5
AC CVCL_Z751
SY ML-DmD 5
RX PubMed=3117765;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD6
AC CVCL_Z752
SY ML-DmD 6
RX PubMed=3117765;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD7
AC CVCL_Z753
SY ML-DmD 7
RX PubMed=3117765;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD8
AC CVCL_Z754
SY ML-DmD 8; D8
DR EFO; EFO_0005832
DR DGRC; 92
DR ENCODE; ENCBS024JYY
DR GEO; GSM919264
DR GEO; GSM919265
RX PubMed=3117765;
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML-DmD9
AC CVCL_Z755
SY ML-DmD 9; D9
DR EFO; EFO_0005833
DR DGRC; 85
DR ENCODE; ENCBS281VAA
DR GEO; GSM409515
DR GEO; GSM409516
DR GEO; GSM409517
RX PubMed=3117765;
RX PubMed=21177962;
RX PubMed=24434506;
RX PubMed=24985917;
RX PubMed=25262759;
CC Group: Insect cell line.
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML10
AC CVCL_Y283
RX PubMed=9441775;
RX PubMed=17519898;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C7278; Ovarian papillary cystadenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ML108
AC CVCL_F718
DR IMGT/HLA; 11083
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ML108U
AC CVCL_F719
DR IMGT/HLA; 11084
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ML14
AC CVCL_DI50
RX PubMed=204583;
RX PubMed=6876798;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1395 ! M14
OI CVCL_DI53 ! MF14
SX Male
CA Transformed cell line
//
ID ML1805
AC CVCL_F566
SY Ml1805; ML; TER141; TER272; TER276
DR IMGT/HLA; 11814
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ML2308
AC CVCL_M827
RX PubMed=20713527;
RX PubMed=21335544;
DI NCIt; C27781; Myxoid liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ML3
AC CVCL_Y282
RX PubMed=9441775;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C40032; Ovarian serous cystadenofibroma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ML38
AC CVCL_DG81
RX PubMed=17519898;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C4512; Ovarian mucinous cystadenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ML46
AC CVCL_DG82
RX PubMed=17519898;
RX PubMed=23415752;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C4511; Ovarian serous cystadenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ML5
AC CVCL_D278
SY ML-5
DR BTO; BTO:0004040
RX PubMed=9441775;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C4511; Ovarian serous cystadenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ML8
AC CVCL_Y284
RX PubMed=9441775;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C5226; Borderline ovarian serous tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ML81-18
AC CVCL_Z801
DR DGRC; 25
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML82-19a
AC CVCL_Z802
DR DGRC; 27
CC Group: Insect cell line.
OX NCBI_TaxID=7240; ! Drosophila simulans
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML82-8
AC CVCL_Z866
SY ML 82-08
RX DOI=10.1016/0167-8817(85)90023-9;
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=3141801;
CC Group: Insect cell line.
CC Breed/subspecies: mus201D1.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML83-1b
AC CVCL_Z803
DR DGRC; 31
CC Group: Insect cell line.
OX NCBI_TaxID=7243; ! Drosophila teissieri
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML83-26
AC CVCL_Z804
DR DGRC; 38
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML83-33
AC CVCL_Z805
DR DGRC; 35
CC Group: Insect cell line.
OX NCBI_TaxID=7220; ! Drosophila erecta
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML83-62
AC CVCL_Z806
DR DGRC; 41
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML83-63
AC CVCL_Z807
DR DGRC; 33
WW http://flybase.org/reports/FBtc0000033.html
CC Group: Insect cell line.
OX NCBI_TaxID=46245; ! Drosophila pseudoobscura pseudoobscura
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML83-68
AC CVCL_Z808
DR DGRC; 34
CC Group: Insect cell line.
OX NCBI_TaxID=47315; ! Drosophila auraria
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML84-1
AC CVCL_Z809
DR DGRC; 42
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML84-27b
AC CVCL_Z810
DR DGRC; 45
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML84-29
AC CVCL_Z811
DR DGRC; 44
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML85-5
AC CVCL_Z812
DR DGRC; 32
CC Group: Insect cell line.
OX NCBI_TaxID=7245; ! Drosophila yakuba
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ML89-1
AC CVCL_Z813
DR DGRC; 30
CC Group: Insect cell line.
OX NCBI_TaxID=7238; ! Drosophila sechellia
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID MLA144
AC CVCL_3856
SY MLA 144; MLA-144; UCD-MLA-144
DR CLO; CLO_0007744
DR CLDB; cl3495
DR CLDB; cl3496
DR CLDB; cl3497
DR ATCC; HB-8370
DR ATCC; TIB-201
DR ECACC; 86102901
DR IZSLER; BS TCL 43
DR KCB; KCB 99004YJ
RX PubMed=6975300;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MLA-144
CC Group: Non-human primate cell line.
CC Discontinued: ATCC; HB-8370; true.
CC Discontinued: ATCC; TIB-201; true.
OX NCBI_TaxID=9580; ! Hylobates lar
CA Cancer cell line
//
ID MLC-1-B
AC CVCL_2H97
DR CLO; CLO_0051038
DR RCB; RCB1534
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID MLC-2-4
AC CVCL_2H98
DR CLO; CLO_0051039
DR RCB; RCB1535
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID MLC-6
AC CVCL_2H99
DR CLO; CLO_0051040
DR RCB; RCB1536
RX PubMed=11448014;
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MLC-7
AC CVCL_2I00
DR CLO; CLO_0051041
DR RCB; RCB1537
RX PubMed=11448014;
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MLE-12
AC CVCL_3751
SY MLE 12; MLE12; Murine Lung Epithelial-12
DR BTO; BTO:0002268
DR CLO; CLO_0007746
DR ATCC; CRL-2110
RX PubMed=8248207;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: FVB/N.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID MLE-15
AC CVCL_D581
SY MLE 15; MLE15; Murine Lung Epithelial-15
DR BTO; BTO:0005242
RX PubMed=8248207;
RX PubMed=19263283;
WW https://www.abmgood.com/Immortalized-Mouse-Lung-Epithelial-Cells-(MLE-15)-T0495.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: FVB/N.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MLE-7
AC CVCL_9Y84
SY MLE 7; Murine Lung Epithelial-7
RX PubMed=8248207;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: FVB/N.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MLE/BV
AC CVCL_DC33
SY MLE-BV
RX PubMed=8812265;
CC From: Madhukar B.V.; Indiana University School of Medicine; Indianapolis; USA.
CC Breed/subspecies: C3H/HeN.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MLEL1.1c1
AC CVCL_DC34
RX Patent=US5854010;
RX PubMed=8812265;
CC Biotechnology: Cell line developed for CALUX (Chemically Activated LUciferase eXpression) bioassay. CALUX is used for rapid screening of samples for the presence of dioxin/TCDD-like compounds and AhR agonists/antagonists.
CC Characteristics: Acts through the activation of a luciferase gene under the control of dioxin-response elements (DREs).
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: C3H/HeN.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_DC33 ! MLE/BV
CA Cancer cell line
//
ID MLF
AC CVCL_E778
SY MCF
DR dbMHC; 48973
DR IHW; IHW9091
DR IMGT/HLA; 11641
WW http://bioinformatics.hsanmartino.it/ecbr/cl91.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MLg
AC CVCL_0437
SY Mlg 2908
DR CLO; CLO_0007747
DR MCCL; MCC:0000332
DR CLDB; cl3499
DR ATCC; CCL-206
DR ECACC; 90112707
DR KCLB; 10206
RX PubMed=4364904;
RX PubMed=7065527;
CC Breed/subspecies: ddY.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MLH1
AC CVCL_G669
DR CLO; CLO_0007748
DR ATCC; CRL-1766
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MLH2
AC CVCL_G670
DR CLO; CLO_0007749
DR ATCC; CRL-1779
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MLMA
AC CVCL_1419
DR BioSample; SAMN03470810
DR ChEMBL-Cells; CHEMBL3308826
DR ChEMBL-Targets; CHEMBL2366211
DR Cosmic; 908142
DR Cosmic-CLP; 908142
DR GDSC; 908142
DR GEO; GSM827266
DR GEO; GSM1670117
DR JCRB; JCRB0146
DR JCRB; NIHS0175
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: JCRB; NIHS0175; true.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 8,10
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 10
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MLO-A5
AC CVCL_0P24
SY MLOA5; Murine Long bone Osteocyte-A5
RX PubMed=11547831;
RX PubMed=22130923;
WW https://www.kerafast.com/product/2232/murine-osteocyte-like-cell-line-mlo-a5
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MLO-Y4
AC CVCL_M098
SY MLOY4; Murine Long bone Osteocyte-Y4
DR BTO; BTO:0005489
DR EFO; EFO_0005394
DR GEO; GSM1520095
DR GEO; GSM1520096
DR GEO; GSM1520097
DR GEO; GSM1520098
DR GEO; GSM1520099
DR GEO; GSM1520100
DR GEO; GSM1520101
DR GEO; GSM1520102
DR GEO; GSM1520103
DR GEO; GSM1520104
DR GEO; GSM1520105
DR GEO; GSM1520106
RX PubMed=9421234;
RX PubMed=10084404;
RX PubMed=12412815;
RX PubMed=22130923;
WW https://www.kerafast.com/product/2231/murine-osteocyte-like-cell-line-mlo-y4
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MLP-1
AC CVCL_W533
RX PubMed=4280237;
OX NCBI_TaxID=10029; ! Cricetulus griseus
CA Cancer cell line
//
ID MLTC-1
AC CVCL_3544
SY mLTC-1; Murine Leydig Tumor Cell line-1
DR CLO; CLO_0007750
DR ATCC; CRL-2065
DR CCRID; 3131C0001000800008
RX PubMed=6288740;
RX PubMed=15541572;
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_D789 ! MA-10
OI CVCL_U444 ! MA-12
SX Male
CA Cancer cell line
//
ID MM-031
AC CVCL_IS38
RX PubMed=11943340;
CC Derived from metastatic site: Neck.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM-1
AC CVCL_0C21
DR Cosmic; 2239087
RX PubMed=1311980;
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID MM-194
AC CVCL_IS39
RX PubMed=11943340;
CC Doubling time: 51.5 hours (PubMed=11943340).
CC Derived from metastatic site: Armpit.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM-195
AC CVCL_IS40
RX PubMed=11943340;
CC Doubling time: 86.7 hours (PubMed=11943340).
CC Derived from metastatic site: Scapula.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM-201
AC CVCL_IS41
RX PubMed=11943340;
CC Doubling time: 27.1 hours (PubMed=11943340).
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM-232
AC CVCL_IS42
RX PubMed=11943340;
CC Doubling time: 66.2 hours (PubMed=11943340).
CC Derived from metastatic site: Lower leg.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM-254
AC CVCL_IS43
RX PubMed=11943340;
CC Doubling time: 26.3 hours (PubMed=11943340).
CC Derived from metastatic site: Submandibular lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mm-2K
AC CVCL_V316
RX PubMed=217958;
OX NCBI_TaxID=9888; ! Muntiacus muntjak
SX Male
CA Finite cell line
//
ID MM-358
AC CVCL_IS44
RX PubMed=11943340;
RX PubMed=18698037;
CC Doubling time: 35.4 hours (PubMed=11943340).
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM-39
AC CVCL_IN81
SY MM39
RX PubMed=8879186;
RX PubMed=10101000;
RX PubMed=15463957;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID MM-83
AC CVCL_9712
RX PubMed=11004677;
CC From: Van Valen F.; University of Munster; Germany.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM-A1
AC CVCL_M536
RX PubMed=2072743;
RX PubMed=10936422;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM-AN
AC CVCL_H241
AS CVCL_0438
SY MMAN
DR MCCL; MCC:0000333
RX PubMed=1867326;
RX PubMed=7680081;
RX PubMed=8219757;
WW https://www.abmgood.com/MMAN-Cell-Transfection-Efficiency-details.html
CC Derived from metastatic site: Inguinal lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM-BP
AC CVCL_M540
RX PubMed=1867326;
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM-C1
AC CVCL_M537
RX PubMed=2072743;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM-ImJ/XS
AC CVCL_6E56
RX PubMed=16883582;
CC Transformant: Ad5-SV40.
CC Breed/subspecies: 129S1/SvImJ.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MM-LH
AC CVCL_M541
SY MMLH
RX PubMed=1867326;
CC Derived from metastatic site: Visceral (omental).
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM-M1
AC CVCL_M547
DR Cosmic; 2081398
DR Cosmic; 2302407
RX PubMed=8695815;
RX PubMed=8943038;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM-RU
AC CVCL_H242
SY MMRU
RX PubMed=1867326;
RX PubMed=7680081;
RX PubMed=8219757;
RX PubMed=8277038;
WW https://www.abmgood.com/MMRU-Cell-Transfection-Efficiency-details.html
CC Derived from metastatic site: Cervical lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM-RU-Luc
AC CVCL_J263
DR JCRB; JCRB1378
DR JCRB; NIHS0644
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0644; true.
CC Derived from metastatic site: Cervical lymph node.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 11
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H242 ! MM-RU
SX Male
CA Cancer cell line
//
ID MM-S1
AC CVCL_M538
SY MM_S1
DR Cosmic; 720781
DR Cosmic; 2367271
RX PubMed=2072743;
RX PubMed=10936422;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM-Sv/HP-2
AC CVCL_W633
RX PubMed=17960567;
CC Transformant: Ad5-SV40.
CC Breed/subspecies: 129S9/SvEvH.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MM-Sv/XS
AC CVCL_6E57
RX PubMed=16883582;
CC Transformant: Ad5-SV40.
CC Breed/subspecies: 129S9/SvEvH.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MM-Sv/XS-11
AC CVCL_6E58
RX PubMed=16883582;
CC Transformant: Ad5-SV40.
CC Breed/subspecies: 129S9/SvEvH.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6E57 ! MM-Sv/XS
CA Transformed cell line
//
ID MM-Y1
AC CVCL_M539
RX PubMed=2072743;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM.1
AC CVCL_5801
SY MM-1; MM1
DR BTO; BTO:0005490
DR Cosmic; 2302411
DR Cosmic; 2367262
RX PubMed=2926241;
RX PubMed=8943038;
RX PubMed=10087940;
RX PubMed=10936422;
RX PubMed=12691914;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 72 hours (PubMed=12691914).
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM.1-144
AC CVCL_EI97
SY MM1-144
DR Cosmic; 720780
DR Cosmic; 2391807
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5801 ! MM.1
SX Female
CA Cancer cell line
//
ID MM04
AC CVCL_M191
RX PubMed=23516439;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM05
AC CVCL_M192
RX PubMed=23516439;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mm1
AC CVCL_5557
DR CLO; CLO_0051422
DR IFO; IFO50008
DR RCB; RCB0748
CC Breed/subspecies: SL.
DI NCIt; C21889; Mouse myeloid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2107 ! M1
CA Cancer cell line
//
ID MM1.R
AC CVCL_8794
SY MM.1R; MM1-R; MM-1R; MM1R; MM1.R(L); MM1.RL
DR BTO; BTO:0003929
DR ATCC; CRL-2975
DR Cosmic; 1424219
DR Cosmic; 2081429
DR GEO; GSM1374684
DR IZSLER; BS TCL 235
RX PubMed=12691914;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9,14
ST D13S317: 13
ST D16S539: 12
ST D5S818: 8,12
ST D7S820: 10,11
ST TH01: 7,8
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5801 ! MM.1
SX Female
CA Cancer cell line
//
ID MM1.R(E)
AC CVCL_8793
SY MM1.RE
RX PubMed=12691914;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5801 ! MM.1
SX Female
CA Cancer cell line
//
ID MM1.S
AC CVCL_8792
SY MM.1S; MM1-S; MM-1S; MM1S
DR BTO; BTO:0003933
DR EFO; EFO_0005724
DR ATCC; CRL-2974
DR BioSample; SAMN03471684
DR CCLE; MM1S_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1424218
DR Cosmic; 1483077
DR Cosmic; 1762460
DR Cosmic; 1889512
DR Cosmic; 2081430
DR Cosmic; 2391805
DR Cosmic-CLP; 1659818
DR ENCODE; ENCBS205VYW
DR ENCODE; ENCBS241TLI
DR ENCODE; ENCBS299YQN
DR ENCODE; ENCBS523NFL
DR ENCODE; ENCBS981ZAE
DR GDSC; 1659818
DR GEO; GSM887328
DR GEO; GSM888404
DR GEO; GSM1374685
DR GEO; GSM1666388
DR GEO; GSM1670118
DR IZSLER; BS TCL 237
RX PubMed=12691914;
RX PubMed=16956823;
RX PubMed=21173094;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 80 hours (PubMed=25984343).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,14
ST D13S317: 13
ST D16S539: 12
ST D18S51: 11,16
ST D21S11: 29,30
ST D3S1358: 16,17
ST D5S818: 8,12
ST D7S820: 10,11
ST D8S1179: 14
ST FGA: 20,24
ST Penta D: 2.2,9
ST Penta E: 13,15
ST TH01: 7,8
ST TPOX: 8
ST vWA: 15,17
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5801 ! MM.1
SX Female
CA Cancer cell line
//
ID MM102-TC
AC CVCL_B427
SY MM102
DR TKG; TKG 0165
DR TKG; TKG 0588
CC Breed/subspecies: C3H/He.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM1081
AC CVCL_M193
RX PubMed=23516439;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM12
AC CVCL_M194
RX PubMed=23516439;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM127
AC CVCL_2601
SY MM-127
DR CBA; CBA-1344
DR Cosmic; 873569
DR Cosmic; 889012
DR Cosmic; 928705
DR Cosmic; 2159441
DR ECACC; 10092314
DR GEO; GSM78852
DR GEO; GSM78853
DR GEO; GSM78854
DR GEO; GSM78855
DR GEO; GSM78856
DR GEO; GSM78857
DR GEO; GSM162904
DR GEO; GSM219416
RX PubMed=460945;
RX PubMed=830403;
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=27087056;
CC Problematic cell line: Possibly misidentified. It is not certain that this cell line originate from a metastatic melanoma. Lacks the expression of three protein markers: S100, HMB-45 and Melan-A commonly found in melanoma cell lines (PubMed=27087056).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subcutaneous.
ST Source(s): PubMed=27087056
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 10,13
ST D18S51: 15,20
ST D21S11: 29
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 14,15
ST FGA: 14,15
ST Penta D: 10
ST Penta E: 5,10
ST TH01: 8,9
ST TPOX: 11,12
ST vWA: 16,18
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM13
AC CVCL_M195
RX PubMed=23516439;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM138
AC CVCL_2602
DR CBA; CBA-1345
DR ECACC; 10092321
DR GEO; GSM219445
RX PubMed=460945;
RX PubMed=17363583;
CC Doubling time: ~60 hours (ECACC).
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM14
AC CVCL_L439
RX PubMed=7286393;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID MM14DY
AC CVCL_IS08
SY MM14Dy; MM14dy
RX PubMed=7286393;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L439 ! MM14
SX Male
CA Spontaneously immortalized cell line
//
ID MM14DZ
AC CVCL_IS09
RX PubMed=7286393;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L439 ! MM14
SX Male
CA Spontaneously immortalized cell line
//
ID MM14.Lu
AC CVCL_5802
DR CLO; CLO_0007751
DR ATCC; CRL-6382
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5804 ! MM14.Ov
OI CVCL_S355 ! MM14.Sp
OI CVCL_S356 ! MM14.Thy
SX Female
CA Finite cell line
//
ID MM14.OT
AC CVCL_5803
DR CLO; CLO_0007752
DR ATCC; CRL-6384
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6384; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MM14.Ov
AC CVCL_5804
SY Mm14OV
DR CLO; CLO_0007753
DR ATCC; CRL-6383
RX PubMed=4366196;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5802 ! MM14.Lu
OI CVCL_S355 ! MM14.Sp
OI CVCL_S356 ! MM14.Thy
SX Female
CA Finite cell line
//
ID MM14.Sp
AC CVCL_S355
DR ATCC; CRL-6385
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6385; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5802 ! MM14.Lu
OI CVCL_5804 ! MM14.Ov
OI CVCL_S356 ! MM14.Thy
SX Female
CA Finite cell line
//
ID MM14.Thy
AC CVCL_S356
DR ATCC; CRL-6386
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6386; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5802 ! MM14.Lu
OI CVCL_5804 ! MM14.Ov
OI CVCL_S355 ! MM14.Sp
SX Female
CA Finite cell line
//
ID MM15.OT
AC CVCL_5806
SY MM15OT
DR CLO; CLO_0007755
DR ATCC; CRL-6438
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6438; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MM15.Ov
AC CVCL_S285
SY Mm15OV
DR ATCC; CRL-6387
RX PubMed=4366196;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6387; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5805 ! MM15.Sp/Thy
SX Female
CA Finite cell line
//
ID MM15.Sp/Thy
AC CVCL_5805
DR CLO; CLO_0007754
DR ATCC; CRL-6388
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S285 ! MM15.Ov
SX Female
CA Finite cell line
//
ID MM16
AC CVCL_L789
RX PubMed=21205078;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM16.Mg
AC CVCL_S284
DR ATCC; CRL-6389
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6389; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S283 ! MM16.Sp
OI CVCL_5807 ! MM16.Ov
SX Female
CA Finite cell line
//
ID MM16.Ov
AC CVCL_5807
SY Mm16OV
DR CLO; CLO_0007756
DR ATCC; CRL-6390
RX PubMed=4366196;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6390; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S284 ! MM16.Mg
OI CVCL_S283 ! MM16.Sp
SX Female
CA Finite cell line
//
ID MM16.Sp
AC CVCL_S283
DR ATCC; CRL-6391
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6391; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S284 ! MM16.Mg
OI CVCL_5807 ! MM16.Ov
SX Female
CA Finite cell line
//
ID MM17
AC CVCL_9482
RX PubMed=15067335;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM17.Br
AC CVCL_S282
DR ATCC; CRL-6392
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6392; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S281 ! MM17.Sp/Thy
CA Finite cell line
//
ID MM17.Sp/Thy
AC CVCL_S281
DR ATCC; CRL-6393
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6393; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S282 ! MM17.Br
CA Finite cell line
//
ID MM170
AC CVCL_2603
SY MM 170
DR CBA; CBA-1346
DR Cosmic; 889013
DR Cosmic; 928712
DR ECACC; 10092315
DR GEO; GSM162905
RX PubMed=460945;
RX PubMed=830403;
RX PubMed=6187441;
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17516929;
RX PubMed=23039341;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM19.Ft
AC CVCL_S280
DR ATCC; CRL-6394
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6394; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S279 ! MM19.Ht
OI CVCL_5808 ! MM19.Lu
OI CVCL_S278 ! MM19.Ov
OI CVCL_S277 ! MM19.Sp
SX Female
CA Finite cell line
//
ID MM19.Ht
AC CVCL_S279
DR ATCC; CRL-6395
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6395; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S280 ! MM19.Ft
OI CVCL_5808 ! MM19.Lu
OI CVCL_S278 ! MM19.Ov
OI CVCL_S277 ! MM19.Sp
SX Female
CA Finite cell line
//
ID MM19.Lu
AC CVCL_5808
DR CLO; CLO_0007757
DR ATCC; CRL-6396
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6396; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S280 ! MM19.Ft
OI CVCL_S279 ! MM19.Ht
OI CVCL_S278 ! MM19.Ov
OI CVCL_S277 ! MM19.Sp
SX Female
CA Finite cell line
//
ID MM19.Ov
AC CVCL_S278
DR ATCC; CRL-6397
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6397; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S280 ! MM19.Ft
OI CVCL_S279 ! MM19.Ht
OI CVCL_5808 ! MM19.Lu
OI CVCL_S277 ! MM19.Sp
SX Female
CA Finite cell line
//
ID MM19.Sp
AC CVCL_S277
DR ATCC; CRL-6398
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6398; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S280 ! MM19.Ft
OI CVCL_S279 ! MM19.Ht
OI CVCL_5808 ! MM19.Lu
OI CVCL_S278 ! MM19.Ov
SX Female
CA Finite cell line
//
ID MM2
AC CVCL_B428
DR TKG; TKG 0162
CC Breed/subspecies: C3H/He.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM200
AC CVCL_C836
SY MM 200
DR BTO; BTO:0005717
DR Cosmic; 889014
DR Cosmic; 928753
DR GEO; GSM162935
DR GEO; GSM219446
RX PubMed=460945;
RX PubMed=830403;
RX PubMed=7520026;
RX PubMed=8980186;
RX PubMed=9354451;
RX PubMed=9725211;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=23039341;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM21
AC CVCL_L790
RX PubMed=21205078;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM21.Ut
AC CVCL_S276
DR ATCC; CRL-6399
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6399; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID MM214
AC CVCL_W453
RX PubMed=460945;
RX PubMed=830403;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM22.We
AC CVCL_5809
DR CLO; CLO_0007759
DR ATCC; CRL-6400
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6400; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MM229
AC CVCL_C837
SY MM 229
DR Cosmic; 889015
DR Cosmic; 928699
DR Cosmic; 1211159
DR Cosmic; 1418461
DR GEO; GSM170866
DR GEO; GSM219450
RX PubMed=460945;
RX PubMed=830403;
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=23039341;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM23.We
AC CVCL_5810
DR CLO; CLO_0007760
DR ATCC; CRL-6401
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6401; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MM253
AC CVCL_2604
SY MM 253
DR CBA; CBA-1347
DR Cosmic; 889016
DR Cosmic; 928706
DR ECACC; 11072804
DR GEO; GSM78858
DR GEO; GSM78859
DR GEO; GSM78860
DR GEO; GSM162940
DR GEO; GSM219451
RX PubMed=460945;
RX PubMed=830403;
RX PubMed=6187441;
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM253-12M
AC CVCL_D849
RX PubMed=669848;
RX PubMed=6163526;
CC Selected for resistance to: ChEBI; CHEBI:28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC Derived from metastatic site: Lymph node.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2604 ! MM253
CA Cancer cell line
//
ID MM26
AC CVCL_L791
RX PubMed=21205078;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM266
AC CVCL_DH59
DR GEO; GSM228548
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM27.We
AC CVCL_5811
DR CLO; CLO_0007761
DR ATCC; CRL-6402
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6402; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MM28
AC CVCL_4D15
DR ATCC; CRL-3295
RX PubMed=24994677;
CC Doubling time: 109 hours (PubMed=24994677).
CC Omics: SNP array analysis.
CC Derived from metastatic site: Liver.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 8,11
ST D16S539: 10,12
ST D5S818: 11
ST D7S820: 8,10
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM29.We
AC CVCL_5812
DR CLO; CLO_0007762
DR ATCC; CRL-6403
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6403; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MM2MT
AC CVCL_3545
DR CLO; CLO_0007763
DR ATCC; CRL-6373
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: BALB/cfC3H (BfC3H).
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM2MTC
AC CVCL_3546
DR CLO; CLO_0007764
DR ATCC; CRL-6374
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6374; true.
CC Breed/subspecies: BALB/cfC3H (BfC3H).
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3545 ! MM2MT
SX Female
CA Cancer cell line
//
ID MM2SCT
AC CVCL_3547
DR CLO; CLO_0007765
DR ATCC; CRL-6375
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6375; true.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID Mm2T
AC CVCL_3026
SY Mm-2T
DR JCRB; JCRB0609
RX CelloPub=CLPUB00082;
RX PubMed=7586011;
CC Doubling time: 67.5 hours (CLPUB00082).
CC Discontinued: JCRB; JCRB0609; true.
OX NCBI_TaxID=9888; ! Muntiacus muntjak
SX Male
CA Spontaneously immortalized cell line
//
ID Mm2T.P3
AC CVCL_5481
DR JCRB; JCRB0609.1
DR JCRB; NIHS0358
CC Discontinued: JCRB; NIHS0358; true.
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_3026 ! Mm2T
SX Male
CA Spontaneously immortalized cell line
//
ID Mm2T12.P3
AC CVCL_5482
SY CH3-B12-treated Mm2T
DR JCRB; JCRB0650.1
DR JCRB; NIHS0369
RX PubMed=7586011;
CC Discontinued: JCRB; NIHS0369; true.
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_3026 ! Mm2T
SX Male
CA Spontaneously immortalized cell line
//
ID MM30.Ut
AC CVCL_S272
DR ATCC; CRL-6404
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6404; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID MM31.We
AC CVCL_5813
DR CLO; CLO_0007766
DR ATCC; CRL-6405
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6405; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MM32.Ut
AC CVCL_S273
DR ATCC; CRL-6406
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6406; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID MM329
AC CVCL_C838
SY MM 329
DR Cosmic; 889017
DR Cosmic; 928745
DR GEO; GSM170841
DR GEO; GSM220168
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=23039341;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM33
AC CVCL_4D16
RX PubMed=24994677;
CC Doubling time: 91 hours (PubMed=24994677).
CC Omics: SNP array analysis.
CC Derived from metastatic site: Skin.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM33.Ut
AC CVCL_S274
DR ATCC; CRL-6407
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6407; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID MM339
AC CVCL_GR28
RX PubMed=460945;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM34.We
AC CVCL_5814
DR CLO; CLO_0007767
DR ATCC; CRL-6408
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6408; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MM344
AC CVCL_GR29
RX PubMed=460945;
RX PubMed=6187441;
CC Derived from metastatic site: Not specified.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM35
AC CVCL_L792
RX PubMed=21205078;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM35.Ut
AC CVCL_S275
DR ATCC; CRL-6409
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6409; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID MM369
AC CVCL_C839
SY MM 369
DR Cosmic; 928746
DR Cosmic; 1211157
DR GEO; GSM224861
RX PubMed=9354451;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM36T(A)
AC CVCL_N495
DR ATCC; CRL-6410
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6410; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_N496 ! MM36T(B)
OI CVCL_5815 ! MM36T(C)
OI CVCL_5816 ! MM36.We
SX Female
CA Cancer cell line
//
ID MM36T(B)
AC CVCL_N496
DR ATCC; CRL-6412
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6412; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_N495 ! MM36T(A)
OI CVCL_5815 ! MM36T(C)
OI CVCL_5816 ! MM36.We
SX Female
CA Cancer cell line
//
ID MM36T(C)
AC CVCL_5815
DR CLO; CLO_0007768
DR ATCC; CRL-6411
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6411; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_N495 ! MM36T(A)
OI CVCL_N496 ! MM36T(B)
OI CVCL_5816 ! MM36.We
SX Female
CA Cancer cell line
//
ID MM36.We
AC CVCL_5816
SY MM36We
DR CLO; CLO_0007769
DR ATCC; CRL-6413
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6413; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_N495 ! MM36T(A)
OI CVCL_N496 ! MM36T(B)
OI CVCL_5815 ! MM36T(C)
SX Female
CA Finite cell line
//
ID MM370
AC CVCL_2605
SY MM 370
DR CBA; CBA-1348
DR Cosmic; 889018
DR Cosmic; 928747
DR ECACC; 10092316
DR GEO; GSM162929
DR GEO; GSM226658
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin.
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM37T
AC CVCL_5817
SY MM37.T
DR CLO; CLO_0007770
DR ATCC; CRL-6414
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6414; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM383
AC CVCL_2606
SY MM 383
DR CBA; CBA-1350
DR Cosmic; 889019
DR Cosmic; 928734
DR ECACC; 10092317
DR GEO; GSM170843
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17516929;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM384
AC CVCL_C840
SY MM 384
DR Cosmic; 928741
DR GEO; GSM226659
RX PubMed=9354451;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM386
AC CVCL_2607
SY MM 386
DR CBA; CBA-1349
DR Cosmic; 889020
DR Cosmic; 928736
DR Cosmic; 1418457
DR ECACC; 10092318
DR GEO; GSM162932
DR GEO; GSM226660
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM396
AC CVCL_C841
SY MM 396
DR Cosmic; 928727
DR GEO; GSM226661
RX PubMed=9354451;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM3MG
AC CVCL_5818
DR CLO; CLO_0007771
DR ATCC; CRL-6376
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6376; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID MM4
AC CVCL_S405
SY MM-4
CC From: Stierner U.; Gotenborg; Sweden.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM4.We
AC CVCL_5819
DR CLO; CLO_0007772
DR ATCC; CRL-6377
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6377; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MM40.Ut
AC CVCL_S286
DR ATCC; CRL-6415
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6415; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID MM409
AC CVCL_C842
SY MM 409
DR Cosmic; 928700
DR GEO; GSM226662
RX PubMed=9354451;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM415
AC CVCL_2608
SY MM 415
DR CBA; CBA-1351
DR Cosmic; 889021
DR Cosmic; 928751
DR Cosmic; 2159439
DR ECACC; 10092319
DR GEO; GSM162933
DR GEO; GSM226671
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM418
AC CVCL_C843
SY MM 418
DR ChEMBL-Cells; CHEMBL3307300
DR ChEMBL-Targets; CHEMBL614131
DR Cosmic; 928707
DR GEO; GSM226682
RX PubMed=2798328;
RX PubMed=7520026;
RX PubMed=8980186;
RX PubMed=9354451;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM41.We
AC CVCL_5820
SY MM41We
DR CLO; CLO_0007773
DR ATCC; CRL-6416
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6416; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MM42.Ut
AC CVCL_N494
DR ATCC; CRL-6417
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6417; true.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Finite cell line
//
ID MM426
AC CVCL_2609
SY MM 426
DR CBA; CBA-1352
DR Cosmic; 889022
DR Cosmic; 928740
DR ECACC; 10092320
DR GEO; GSM170848
DR GEO; GSM226718
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM43T
AC CVCL_5821
SY MM43.T
DR CLO; CLO_0007774
DR ATCC; CRL-6418
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6418; true.
CC Breed/subspecies: HRS/J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MM44.Sp
AC CVCL_5822
DR CLO; CLO_0007775
DR ATCC; CRL-6419
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6419; true.
CC Breed/subspecies: Namru.
OX NCBI_TaxID=10090; ! Mus musculus
SX Mixed sex
CA Finite cell line
//
ID MM455
AC CVCL_C835
SY MM 455
DR Cosmic; 706105
DR Cosmic; 888845
DR Cosmic; 889023
DR Cosmic; 928713
DR GEO; GSM78861
DR GEO; GSM78863
DR GEO; GSM78864
DR GEO; GSM162941
RX PubMed=9354451;
RX PubMed=9692547;
RX PubMed=10766161;
RX PubMed=15009714;
RX PubMed=15048078;
RX PubMed=17516929;
CC Omics: Transcriptome analysis.
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM45T.Bl
AC CVCL_5823
DR CLO; CLO_0007776
DR ATCC; CRL-6420
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6420; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5824 ! MM45T.Li
OI CVCL_5825 ! MM45T.Sp
CA Cancer cell line
//
ID MM45T.Li
AC CVCL_5824
DR CLO; CLO_0007777
DR ATCC; CRL-6421
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6421; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5823 ! MM45T.Bl
OI CVCL_5825 ! MM45T.Sp
CA Cancer cell line
//
ID MM45T.Sp
AC CVCL_5825
DR CLO; CLO_0007778
DR ATCC; CRL-6422
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6422; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5823 ! MM45T.Bl
OI CVCL_5824 ! MM45T.Li
CA Cancer cell line
//
ID MM46 [Human mesothelioma]
AC CVCL_L793
RX PubMed=21205078;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM46 [Mouse mammary carcinoma]
AC CVCL_B429
SY SMCXX VI
DR BTO; BTO:0001082
DR ChEMBL-Cells; CHEMBL3307311
DR ChEMBL-Targets; CHEMBL614168
DR RCB; RCB2617
DR TKG; TKG 0163
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Caution: Not from strain C3H/He as originally assigned but from a NIH Swiss strain derivative (DOI 10.4051/ibc.2010.2.4.0014).
CC Discontinued: RCB; RCB2617; true.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM46 CEA1-2
AC CVCL_C515
DR CLO; CLO_0050957
DR RCB; RCB2633
DR TKG; TKG 0597
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Transfected with: HGNC; 1814; CEACAM1.
CC Caution: Not from strain C3H/He as originally assigned but from a NIH Swiss strain derivative (DOI 10.4051/ibc.2010.2.4.0014).
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B429 ! MM46 [Mouse mammary carcinoma]
SX Female
CA Cancer cell line
//
ID MM46-APR-MUC1 cl.1
AC CVCL_C514
SY MM46-APR-MUC1 clone 1
DR CLO; CLO_0050958
DR RCB; RCB2634
DR TKG; TKG 0595
RX DOI=10.4051/ibc.2010.2.4.0014;
CC Transfected with: HGNC; 7508; MUC1.
CC Caution: Not from strain C3H/He as originally assigned but from a NIH Swiss strain derivative (DOI 10.4051/ibc.2010.2.4.0014).
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B429 ! MM46 [Mouse mammary carcinoma]
SX Female
CA Cancer cell line
//
ID MM466
AC CVCL_4449
SY MM 466
DR CBA; CBA-1353
DR Cosmic; 889024
DR Cosmic; 928714
DR Cosmic; 1303047
DR ECACC; 12070507
DR GEO; GSM162936
DR GEO; GSM226721
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM46T
AC CVCL_5826
SY MM46.T
DR CLO; CLO_0007779
DR ATCC; CRL-6423
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6423; true.
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MM47
AC CVCL_B430
SY SMCXX V
CC Breed/subspecies: C3H/He.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM470
AC CVCL_C844
SY MM 470
DR Cosmic; 889025
DR Cosmic; 928697
RX PubMed=9354451;
RX PubMed=15048078;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM472
AC CVCL_C845
SY MM 472
DR Cosmic; 889026
DR Cosmic; 928715
DR GEO; GSM226722
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM473
AC CVCL_4450
SY MM 473
DR CBA; CBA-1354
DR Cosmic; 889027
DR Cosmic; 928743
DR ECACC; 12070508
DR GEO; GSM170835
DR GEO; GSM226723
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM47T
AC CVCL_5827
SY MM47.T
DR CLO; CLO_0007780
DR ATCC; CRL-6424
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6424; true.
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID MM48
AC CVCL_B431
SY SMCXX III
DR TKG; TKG 0164
CC Breed/subspecies: C3H/He.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM485
AC CVCL_2610
SY MM 485
DR CBA; CBA-1355
DR Cosmic; 889028
DR Cosmic; 928728
DR Cosmic; 1206009
DR Cosmic; 2159428
DR ECACC; 11072803
DR GEO; GSM170849
DR GEO; GSM226724
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM488
AC CVCL_C846
SY MM 488
DR Cosmic; 928701
DR GEO; GSM226725
RX PubMed=9354451;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM48T
AC CVCL_5828
SY MM48.T
DR CLO; CLO_0007781
DR ATCC; CRL-6425
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6425; true.
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM49T
AC CVCL_5829
SY MM49.T
DR CLO; CLO_0007782
DR ATCC; CRL-6426
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6426; true.
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM5.1 [Human myeloma]
AC CVCL_6686
RX PubMed=9009094;
RX PubMed=10936422;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MM5%2e1
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM5.1 [Mouse]
AC CVCL_5830
DR CLO; CLO_0007783
DR ATCC; CRL-6380
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6380; true.
CC Breed/subspecies: C3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM5.2
AC CVCL_6687
RX PubMed=9009094;
RX PubMed=10936422;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MM5%2e2
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6686 ! MM5.1 [Human myeloma]
SX Male
CA Cancer cell line
//
ID MM5/C1
AC CVCL_5831
DR CLO; CLO_0007784
DR ATCC; CRL-6444
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6444; true.
CC Breed/subspecies: C3H/Crgl.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5840 ! Mm5MT
SX Female
CA Cancer cell line
//
ID MM51.Sp
AC CVCL_5832
DR CLO; CLO_0007785
DR ATCC; CRL-6427
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6427; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MM52.Sp
AC CVCL_5833
DR CLO; CLO_0007786
DR ATCC; CRL-6428
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6428; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5834 ! MM52.T
CA Finite cell line
//
ID MM52.T
AC CVCL_5834
DR CLO; CLO_0007787
DR ATCC; CRL-6429
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6429; true.
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5833 ! MM52.Sp
CA Cancer cell line
//
ID MM53.Sp
AC CVCL_5835
DR CLO; CLO_0007788
DR ATCC; CRL-6430
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6430; true.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S365 ! MM53.T
CA Finite cell line
//
ID MM53.T
AC CVCL_S365
DR ATCC; CRL-6431
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6431; true.
CC Breed/subspecies: BALB/c.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5835 ! MM53.Sp
CA Cancer cell line
//
ID MM537
AC CVCL_4451
SY MM 537
DR CBA; CBA-1356
DR Cosmic; 889029
DR ECACC; 12070509
DR GEO; GSM162937
DR GEO; GSM226726
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM54.K
AC CVCL_5836
DR CLO; CLO_0007789
DR ATCC; CRL-6433
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: CBA/T6.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5837 ! MM54.Sp/Thy
SX Female
CA Finite cell line
//
ID MM54.Sp/Thy
AC CVCL_5837
DR CLO; CLO_0007790
DR ATCC; CRL-6434
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6434; true.
CC Breed/subspecies: CBA/T6.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5836 ! MM54.K
SX Female
CA Finite cell line
//
ID MM540
AC CVCL_C847
SY MM 540
DR Cosmic; 889030
DR Cosmic; 928735
DR Cosmic; 1211149
DR GEO; GSM170867
DR GEO; GSM226727
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=23039341;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM548
AC CVCL_C848
SY MM 548
DR Cosmic; 928729
DR GEO; GSM170978
DR GEO; GSM226728
RX PubMed=9354451;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM55.Ht/Lu
AC CVCL_S357
DR ATCC; CRL-6435
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6435; true.
CC Breed/subspecies: AKR.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5838 ! MM55.K
OI CVCL_5839 ! MM55.Sp/Thy
SX Female
CA Finite cell line
//
ID MM55.K
AC CVCL_5838
DR CLO; CLO_0007791
DR ATCC; CRL-6436
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: AKR.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S357 ! MM55.Ht/Lu
OI CVCL_5839 ! MM55.Sp/Thy
SX Female
CA Finite cell line
//
ID MM55.Sp/Thy
AC CVCL_5839
DR CLO; CLO_0007792
DR ATCC; CRL-6437
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6437; true.
CC Breed/subspecies: AKR.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S357 ! MM55.Ht/Lu
OI CVCL_5838 ! MM55.K
SX Female
CA Finite cell line
//
ID MM56
AC CVCL_L794
RX PubMed=21205078;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM576
AC CVCL_2611
SY MM 576
DR CBA; CBA-1357
DR Cosmic; 928737
DR Cosmic; 929206
DR ECACC; 11072802
DR GEO; GSM170850
RX PubMed=9354451;
RX PubMed=10338330;
RX PubMed=17516929;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID MM595
AC CVCL_4452
SY MM 595
DR Cosmic; 889031
DR Cosmic; 928708
DR Cosmic; 1303048
DR GEO; GSM170596
DR GEO; GSM226729
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1358 but was never distributed.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM598
AC CVCL_C849
SY MM 598
DR Cosmic; 928752
RX PubMed=9354451;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mm5MT
AC CVCL_5840
AS CVCL_3998
SY Mm5mt; MM5MT
DR BTO; BTO:0003299
DR CLO; CLO_0007793
DR CLO; CLO_0007794
DR ATCC; CRL-1637
DR ATCC; CRL-6590
RX PubMed=4346536;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6590; true.
CC Breed/subspecies: C3H/Crgl.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MM5MTC
AC CVCL_3999
DR BTO; BTO:0003300
DR CLO; CLO_0007795
DR ATCC; CRL-6378
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: C3H/Crgl.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5840 ! Mm5MT
SX Female
CA Cancer cell line
//
ID MM5MTM
AC CVCL_4000
DR CLO; CLO_0007796
DR ATCC; CRL-6379
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6379; true.
CC Breed/subspecies: C3H/Crgl.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5840 ! Mm5MT
SX Female
CA Cancer cell line
//
ID MM603
AC CVCL_2612
SY MM 603
DR CBA; CBA-1359
DR Cosmic; 889032
DR Cosmic; 928754
DR ECACC; 11072801
DR GEO; GSM170597
DR GEO; GSM226730
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MM604
AC CVCL_DG38
SY MM 604
DR GEO; GSM226731
RX PubMed=17363583;
RX PubMed=23039341;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM608
AC CVCL_4453
SY MM 608
DR Cosmic; 888869
DR Cosmic; 889033
DR Cosmic; 928716
DR GEO; GSM170857
RX PubMed=9354451;
RX PubMed=15009714;
RX PubMed=15048078;
RX PubMed=17516929;
CC Omics: Transcriptome analysis.
CC Caution: Was briefly displayed in Cell Bank Australia under catalog number CBA-1360 but was never distributed.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM622
AC CVCL_C850
SY MM 622
DR Cosmic; 889034
DR Cosmic; 928730
DR GEO; GSM170858
DR GEO; GSM226857
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
RX PubMed=23039341;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM628
AC CVCL_C851
SY MM 628
DR Cosmic; 928756
DR GEO; GSM226858
RX PubMed=9354451;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM629
AC CVCL_W873
DR Cosmic; 889035
RX PubMed=15048078;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM636
AC CVCL_DH58
DR GEO; GSM226860
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM647
AC CVCL_C852
SY MM 647
DR Cosmic; 928755
DR GEO; GSM226861
RX PubMed=9354451;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM648
AC CVCL_A777
SY MM 648
DR Cosmic; 889036
DR Cosmic; 928702
DR GEO; GSM162942
DR GEO; GSM226862
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM649
AC CVCL_A776
SY MM 649
DR Cosmic; 889037
DR Cosmic; 928742
DR Cosmic; 1303049
DR GEO; GSM162943
DR GEO; GSM226863
RX PubMed=9354451;
RX PubMed=15048078;
RX PubMed=17363583;
RX PubMed=17516929;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM66
AC CVCL_4D17
RX PubMed=24994677;
CC Doubling time: 80 hours (PubMed=24994677).
CC Omics: SNP array analysis.
CC Derived from metastatic site: Liver.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MM7-11.Sp
AC CVCL_5841
DR CLO; CLO_0007797
DR ATCC; CRL-6381
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Transfected with: UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC Discontinued: ATCC; CRL-6381; true.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MM96
AC CVCL_D848
SY MM-96; MM 96
DR Cosmic; 928749
RX PubMed=460945;
RX PubMed=830403;
RX PubMed=2798328;
RX PubMed=6187441;
RX PubMed=6277475;
RX PubMed=7217226;
RX PubMed=7999427;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MM96 1 TgR
AC CVCL_GR30
SY MM961TgR
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D848 ! MM96
SX Female
CA Cancer cell line
//
ID MM96E
AC CVCL_D852
RX PubMed=1422191;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D848 ! MM96
SX Female
CA Cancer cell line
//
ID MM96L
AC CVCL_D853
DR ChEMBL-Cells; CHEMBL3307555
DR ChEMBL-Targets; CHEMBL614170
DR Cosmic; 889038
DR Cosmic; 1028798
DR Cosmic; 2013935
DR GEO; GSM170979
DR GEO; GSM228385
RX PubMed=1422191;
RX PubMed=15048078;
RX PubMed=17516929;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D848 ! MM96
SX Female
CA Cancer cell line
//
ID MMA
AC CVCL_J769
DR CLO; CLO_0007803
DR ATCC; HB-78
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID MMAc
AC CVCL_5951
DR CLO; CLO_0050087
DR BioSample; SAMN03472870
DR RCB; RCB0808
ST Source(s): PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12 (PubMed=25877200)
ST D13S317: 8,12 (RCB)
ST D16S539: 12 (PubMed=25877200)
ST D16S539: 9,12 (RCB)
ST D18S51: 14,19
ST D19S433: 14
ST D21S11: 31.2,32.2
ST D2S1338: 18,24
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 11,12
ST FGA: 21,22
ST Penta D: 12
ST Penta E: 5,16
ST TH01: 9
ST TPOX: 8
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MMAc-SF
AC CVCL_1420
SY MMAC-SF; MMAc.SF
DR CLO; CLO_0050088
DR BioSample; SAMN03481114
DR ChEMBL-Cells; CHEMBL3308270
DR ChEMBL-Targets; CHEMBL2366196
DR Cosmic; 925339
DR Cosmic-CLP; 925339
DR GDSC; 925339
DR GEO; GSM1670119
DR LINCS; 50999
DR RCB; RCB1200
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 11
ST TH01: 9
ST TPOX: 8
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5951 ! MMAc
SX Female
CA Cancer cell line
//
ID MMC-1
AC CVCL_U917
RX PubMed=2578326;
CC Breed/subspecies: CXBI.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MMC-14
AC CVCL_U918
SY MMC 14
RX PubMed=2578326;
CC Breed/subspecies: BALB/c.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MMC-34
AC CVCL_U919
SY MMC 34
RX PubMed=2578326;
CC Breed/subspecies: CXBG.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MMC-8
AC CVCL_U920
RX PubMed=2578326;
CC Breed/subspecies: C57BL/6 x BALB/c.
DI NCIt; C21632; Mouse mast cell neoplasm
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MMC-E
AC CVCL_R870
SY MMC-E, clone 7; MMC-E clone 7
DR ATCC; CRL-1575
RX PubMed=476648;
CC Discontinued: ATCC; CRL-1575; true.
OX NCBI_TaxID=10091; ! Mus musculus castaneus
OI CVCL_R871 ! MMC-F
CA Spontaneously immortalized cell line
//
ID MMC-F
AC CVCL_R871
SY MMC-F, clone B3
DR ATCC; CRL-1577
RX PubMed=476648;
CC Discontinued: ATCC; CRL-1577; true.
OX NCBI_TaxID=10091; ! Mus musculus castaneus
OI CVCL_R870 ! MMC-E
CA Spontaneously immortalized cell line
//
ID MMDD1
AC CVCL_8112
SY MMDD-1
DR BTO; BTO:0003946
RX PubMed=10982805;
WW http://www.ott.nih.gov/erma/mouse-macula-densa-cell-line
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MMF-1
AC CVCL_M828
RX PubMed=7586821;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MMG1
AC CVCL_H198
SY MMG-1
DR CGH-DB; 9284-4
DR Cosmic; 905198
DR Cosmic; 1598056
DR Cosmic; 2144977
RX PubMed=15160996;
RX PubMed=15467732;
RX PubMed=19035443;
RX PubMed=22578220;
CC From: Department of Dermatology; Gifu University; Japan.
CC Omics: Deep exome analysis.
DI NCIt; C4022; Acral lentiginous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MMG2
AC CVCL_S559
RX PubMed=8097520;
CC From: Department of Dermatology; Gifu University; Japan.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MMG3
AC CVCL_H729
SY MMG-3
DR CGH-DB; 9283-4
DR Cosmic; 905197
RX PubMed=15160996;
RX PubMed=15467732;
CC From: Department of Dermatology; Gifu University; Japan.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MMGT1
AC CVCL_9U35
RX PubMed=8034755;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
CC Breed/subspecies: NMRI.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID MMGT12
AC CVCL_9U36
SY MMGT-12
RX PubMed=8034755;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
CC Breed/subspecies: NMRI.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9U35 ! MMGT1
SX Male
CA Transformed cell line
//
ID MMGT16
AC CVCL_9U37
SY MMGT-16
RX PubMed=8034755;
RX PubMed=11162555;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
CC Breed/subspecies: NMRI.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9U35 ! MMGT1
SX Male
CA Transformed cell line
//
ID MMH-D3
AC CVCL_X374
RX PubMed=10457350;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MMH-D3
CC Transfected with: HGNC; 7029; MET.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MMJ-2
AC CVCL_W45O
RX PubMed=8652447;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MML-1 [Human leukemia]
AC CVCL_9Q62
SY MML1
DR Cosmic; 787455
DR Cosmic; 975272
DR Cosmic; 1281330
RX PubMed=7579353;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MML-1 [Human melanoma]
AC CVCL_6004
SY MML1
DR CLS; 300288/p456_MML-1
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,13
ST D16S539: 10,11
ST D18S51: 13,14
ST D21S11: 31
ST D3S1358: 17
ST D5S818: 10,12
ST D7S820: 10,12
ST D8S1179: 13,14
ST FGA: 23
ST Penta D: 14
ST Penta E: 7,11
ST TH01: 6,10
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MMLAL
AC CVCL_U249
RX PubMed=24330858;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MMM [Mouse]
AC CVCL_S557
RX PubMed=16683986;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MMM [Mus molossinus]
AC CVCL_Y453
DR ATCC; CRL-6439
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6439; true.
OX NCBI_TaxID=57486; ! Mus musculus molossinus
SX Sex undetermined
CA Undefined cell line type
//
ID MMMbz
AC CVCL_S558
RX PubMed=16683986;
WW https://www.kerafast.com/product/2283/mmmbz-blasticidinzeocin-resistant-cell-line
CC Doubling time: 16 hours (Kerafast).
CC Selected for resistance to: ChEBI; CHEBI:22905; Blasticidin.
CC Selected for resistance to: ChEBI; CHEBI:75046; Phleomycin D1 (Zeocin).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S557 ! MMM [Mouse]
CA Spontaneously immortalized cell line
//
ID MMNK-1
AC CVCL_M266
SY MMNK1
DR JCRB; JCRB1554
RX PubMed=14966424;
RX PubMed=21871105;
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 11,13
ST D5S818: 11,15
ST D7S820: 8,9
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9131 ! OUMS-21
CA Telomerase immortalized cell line
//
ID MMQ
AC CVCL_2117
DR CLO; CLO_0007804
DR ATCC; CRL-10609
DR CCRID; 3111C0001CCC000081
DR ChEMBL-Cells; CHEMBL3307313
DR ChEMBL-Targets; CHEMBL614171
DR DSMZ; ACC-484
DR KCB; KCB 200845YJ
RX PubMed=2844508;
RX PubMed=15541569;
CC Doubling time: ~48 hours (DSMZ).
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_U363 ! 235-1
CA Cancer cell line
//
ID MMR
AC CVCL_E779
DR IHW; IHW0802
WW http://bioinformatics.hsanmartino.it/ecbr/cl373.html
CC Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID MMSr-1
AC CVCL_5630
RX PubMed=3041621;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_5634 ! Don D-6
SX Male
CA Spontaneously immortalized cell line
//
ID MMT-060562
AC CVCL_4241
SY MMT 060562
DR CLO; CLO_0007806
DR CLDB; cl3505
DR ATCC; CCL-51
DR ATCC; CRL-6337
DR ECACC; 90111911
DR JCRB; JCRB9077
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6337; true.
CC Breed/subspecies: C57BL/6 x Af.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MMTV-cmyc 116br
AC CVCL_S720
SY 116br
DR SKY/M-FISH/CGH; 2859
RX PubMed=10379871;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MMTV-cmyc 67a5
AC CVCL_S721
SY 67a5
DR SKY/M-FISH/CGH; 2857
RX PubMed=10379871;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MMTV-cmyc 66a7
AC CVCL_S722
SY 66a7
DR SKY/M-FISH/CGH; 2858
RX PubMed=10379871;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MMTV-cmyc myc Tg myc3
AC CVCL_S723
SY MMTV-cmyc myc Tg myc 3; myc Tg myc3
DR SKY/M-FISH/CGH; 23
RX PubMed=10379871;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MMTV-cmyc myc Tg p53+/-67a3
AC CVCL_S724
DR SKY/M-FISH/CGH; 2856
RX PubMed=10379871;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MMTV-cmyc myc6
AC CVCL_S725
SY myc 6
DR SKY/M-FISH/CGH; 24
RX PubMed=10379871;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MMTV-cmyc myc7
AC CVCL_S726
SY myc 7
DR SKY/M-FISH/CGH; 25
RX PubMed=10379871;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MMTV-cmyc myc83
AC CVCL_S727
SY myc 83
DR SKY/M-FISH/CGH; 2855
RX PubMed=10379871;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MMU
AC CVCL_E780
DR dbMHC; 48974
DR IHW; IHW9357
DR IMGT/HLA; 11089
WW http://bioinformatics.hsanmartino.it/ecbr/cl357.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID MMU00343IN
AC CVCL_E173
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Transformed cell line
//
ID MMU00344IN
AC CVCL_E174
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Transformed cell line
//
ID MMU00345IN
AC CVCL_E175
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Transformed cell line
//
ID MMU00346IN
AC CVCL_E176
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Transformed cell line
//
ID MMU00347IN
AC CVCL_E177
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Transformed cell line
//
ID MMU00348IN
AC CVCL_E178
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Transformed cell line
//
ID MN-1
AC CVCL_W126
RX DOI=10.1063/1.1291135;
RX PubMed=8718548;
RX PubMed=15677628;
RX PubMed=19154404;
RX PubMed=22246397;
DI NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MN-11
AC CVCL_3752
SY MN-11 [Mutatect]
DR CLO; CLO_0007807
DR ATCC; CRL-2800
DR BCRC; 60560
RX PubMed=7577474;
CC Breed/subspecies: C57BL/10.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4982 ! MC-TGS17-51
SX Male
CA Cancer cell line
//
ID MN-1112
AC CVCL_Z616
SY MN1112
RX PubMed=8598320;
RX PubMed=17374419;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MN-2
AC CVCL_E781
DR dbMHC; 48975
DR IHW; IHW9331
DR IMGT/HLA; 11090
WW http://bioinformatics.hsanmartino.it/ecbr/cl331.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID MN-60
AC CVCL_1421
SY MN 60; MN60
DR CLO; CLO_0007808
DR CLDB; cl3506
DR BioSample; SAMN03473415
DR ChEMBL-Cells; CHEMBL3308532
DR ChEMBL-Targets; CHEMBL2366070
DR Cosmic; 908143
DR Cosmic; 1012093
DR Cosmic-CLP; 908143
DR DSMZ; ACC-138
DR GDSC; 908143
DR GEO; GSM1670120
RX PubMed=6296550;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~48-60 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MN16
AC CVCL_AP63
SY MN 16
RX PubMed=23974965;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: ICR.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MN4-91-6.E2
AC CVCL_L563
DR ECACC; 89062111
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MN9D
AC CVCL_M067
SY MN-9D
DR BTO; BTO:0003945
DR EFO; EFO_0006455
RX PubMed=1913182;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2132 ! N18TG2
CA Hybrid cell line
//
ID MNB10
AC CVCL_IQ92
RX Patent=US7915004;
CC Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 04001.
CC Monoclonal antibody target: UniProtKB; P26022; Human PTX3.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MNNG/HOS Cl #5
AC CVCL_0439
AS CVCL_3952
SY MNNG/HOS; MNNG-HOS; HOS-MNNG; MNNGHOS; MNNG-HOS (Cl#5); MNNG/HOS Clone F-5; MNNG; R-1059-D; TE85; TE-85; HOS-TE85; Hos TE-85; HOS TE 85; HOS TE85; HOS (TE85); HOS(TE85); HOS (TE85, Clone F5); MNNG-HOS (TE 85, clone F-5); HOS-Te85; TE 85.T; TE 85 ClF-5
DR BTO; BTO:0005416
DR CLO; CLO_0003796
DR CLO; CLO_0007813
DR CLO; CLO_0007814
DR EFO; EFO_0002866
DR MCCL; MCC:0000334
DR CLDB; cl1703
DR CLDB; cl1704
DR CLDB; cl1705
DR CLDB; cl3510
DR ATCC; CRL-1547
DR ATCC; CRL-7734
DR ATCC; CRL-7735
DR ChEMBL-Cells; CHEMBL3307282
DR ChEMBL-Targets; CHEMBL614038
DR ChEMBL-Targets; CHEMBL614173
DR CLS; 300289/p447_MNNG-HOS
DR CLS; 300449/p503_HOS_(TE85)
DR Cosmic; 1044084
DR Cosmic; 1074402
DR Cosmic; 1529901
DR Cosmic; 2301584
DR ECACC; 87070201
DR GEO; GSM879219
DR KCLB; 21543
RX PubMed=265298;
RX PubMed=833871;
RX PubMed=2823272;
RX PubMed=7873286;
RX PubMed=12645653;
RX PubMed=19787792;
RX PubMed=21519327;
RX PubMed=28196595;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/human/hMNNG-HOS%28TE85,clonF-5%29.htm
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Selected for resistance to: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Discontinued: ATCC; CRL-7734; true.
CC Discontinued: ATCC; CRL-7735; true.
ST Source(s): ATCC; CLS; ECACC; KCLB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 10,13
ST D18S51: 14
ST D21S11: 31.2
ST D3S1358: 15
ST D5S818: 13
ST D7S820: 11,12
ST D8S1179: 14
ST FGA: 24
ST Penta D: 9,10
ST Penta E: 7,12
ST TH01: 6
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0312 ! HOS
SX Female
CA Cancer cell line
//
ID MNNG/HOS/DXR1000
AC CVCL_9U38
RX PubMed=10854558;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0439 ! MNNG/HOS Cl #5
SX Female
CA Cancer cell line
//
ID MNT-1
AC CVCL_5624
SY MNT1; MNT
DR BTO; BTO:0002946
RX PubMed=1701342;
RX PubMed=1706743;
RX PubMed=11266471;
RX PubMed=12417263;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-545.html
CC Characteristics: Highly pigmented.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5625 ! MNT-3
CA Cancer cell line
//
ID MNT-3
AC CVCL_5625
SY MNT3
RX PubMed=1701342;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5624 ! MNT-1
CA Cancer cell line
//
ID Mo
AC CVCL_1439
SY MO; Mo-T; Mo T; MoT
DR BTO; BTO:0001014
DR CLO; CLO_0007815
DR ATCC; CRL-8066
DR BioSample; SAMN03471131
DR ChEMBL-Cells; CHEMBL3308523
DR ChEMBL-Cells; CHEMBL3308631
DR ChEMBL-Targets; CHEMBL614722
DR ChEMBL-Targets; CHEMBL2366282
DR Cosmic; 683660
DR Cosmic; 908149
DR Cosmic; 1120712
DR Cosmic-CLP; 908149
DR GDSC; 908149
DR GEO; GSM1670121
DR GEO; GSM1670131
RX Patent=US4438032;
RX PubMed=305224;
RX PubMed=6600440;
RX PubMed=6984393;
RX PubMed=6987658;
RX PubMed=27397505;
WW http://scocal.stanford.edu/opinion/moore-v-regents-university-california-31115
WW http://www.bio.davidson.edu/people/kabernd/Indep/carainbow/Cells.htm
WW http://www.wipo.int/wipo_magazine/en/2006/05/article_0008.html
WW http://helatermproject.blogspot.ch/2012/03/john-moore.html
WW https://en.wikipedia.org/wiki/Moore_v._Regents_of_the_University_of_California
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Anecdotal: John Moore, the patient from which this cell line is derived, sued David Golde and the University of California over the patent that they deposited on the Mo cell line. Although his claims of ownership were rejected, his physician was deemed to have breached his fiduciary duty by not informing Moore of the economic and financial interests arising from the derivation of the cell line.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 9,13
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 9,12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2302 ! Mo-B
SX Male
CA Cancer cell line
//
ID MO-A
AC CVCL_0C22
DR Cosmic; 2239089
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mo-B
AC CVCL_2302
SY Mo B; MoB
DR BTO; BTO:0003680
DR CLO; CLO_0007816
DR CLDB; cl3511
DR ATCC; CCL-245
DR BioSample; SAMN03471482
DR ECACC; 90021503
RX PubMed=6316341;
CC Characteristics: HTLV-2 producing cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 90021503; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 9,13
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 9,12
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1439 ! Mo
SX Male
CA Transformed cell line
//
ID MO-LAS
AC CVCL_K236
RX PubMed=23342252;
CC Doubling time: 91 hours (PubMed=23342252).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3205; Lymphangiosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MO-LAS-B
AC CVCL_AS12
DR TKG; TKG 0714
CC Derived from metastatic site: Pleural effusion.
ST Source(s): TKG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C3205; Lymphangiosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_K236 ! MO-LAS
SX Male
CA Cancer cell line
//
ID MO-N-1
AC CVCL_HF80
RX DOI=10.5794/jjoms.43.789;
CC Doubling time: 46.5 hours (DOI=10.5794/jjoms.43.789).
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_HF81 ! MO-N-2
OI CVCL_HF82 ! MO-T
CA Cancer cell line
//
ID MO-N-2
AC CVCL_HF81
RX DOI=10.5794/jjoms.43.789;
CC Doubling time: 36 hours (DOI=10.5794/jjoms.43.789).
CC Derived from metastatic site: Neck lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_HF80 ! MO-N-1
OI CVCL_HF82 ! MO-T
CA Cancer cell line
//
ID MO-T
AC CVCL_HF82
RX DOI=10.5794/jjoms.43.789;
CC Doubling time: 48 hours (DOI=10.5794/jjoms.43.789).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_HF80 ! MO-N-1
OI CVCL_HF81 ! MO-N-2
CA Cancer cell line
//
ID MO1043
AC CVCL_Y383
SY Mo1043
RX PubMed=8412300;
RX PubMed=19358282;
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MO3.13
AC CVCL_D357
SY M03.13
DR PRIDE; PXD000263
RX PubMed=7707048;
RX PubMed=10074188;
RX PubMed=14618099;
RX PubMed=24167090;
WW https://www.cedarlanelabs.com/Products/Detail/CLU301?lob=Cellutions
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Omics: Deep proteome analysis.
ST Source(s): Cellutions
ST Amelogenin: X
ST CSF1PO: 10,11,14
ST D13S317: 12,13
ST D16S539: 10,11,12
ST D18S51: 13,17
ST D19S433: 11,14
ST D21S11: 28,29
ST D2S1338: 22,23
ST D3S1358: 15,17,18
ST D5S818: 10,11,12
ST D7S820: 8,11,12
ST D8S1179: 11,13,15
ST FGA: 20,21
ST Penta D: 11,13
ST Penta E: 7,12
ST TH01: 9.3
ST TPOX: 9
ST vWA: 18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DP30 ! RD.TG6
CA Hybrid cell line
//
ID MO6-G3
AC CVCL_0E51
SY M06-G3; MO6G3
RX PubMed=7554969;
RX PubMed=12640734;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Swiss Webster.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MOA1
AC CVCL_Y204
SY SCLC-MOA1; ACC-LC-49D
RX PubMed=2540905;
RX PubMed=2547517;
RX PubMed=8384671;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7019 ! ACC-LC-49
SX Male
CA Cancer cell line
//
ID MOA2
AC CVCL_Y205
SY SCLC-MOA2
RX PubMed=2540905;
RX PubMed=2547517;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7019 ! ACC-LC-49
SX Male
CA Cancer cell line
//
ID MOA2/CDDP
AC CVCL_Y206
RX PubMed=2547517;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y205 ! MOA2
SX Male
CA Cancer cell line
//
ID MOBS-1
AC CVCL_8442
DR BioSample; SAMN03151984
DR Cosmic; 998752
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0007 ! U-937
SX Male
CA Cancer cell line
//
ID MOCH-1
AC CVCL_5H94
RX PubMed=1377283;
RX PubMed=7745612;
CC Transfected with: RGD; 2561; Erbb2.
CC Transformant: Activated Erbb2/neu.
CC Breed/subspecies: (C57BL/6 x DBA/2) F2.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MOCHA
AC CVCL_0C87
RX PubMed=12791875;
CC Transfected with: HGNC; 1606; CCR5.
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S545 ! MOLT-4/CCR5
SX Male
CA Cancer cell line
//
ID Mocha-HSA
AC CVCL_0D00
RX PubMed=16797414;
DI NCIt; C122783; Canine hemangiosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID MOCL1
AC CVCL_S517
RX PubMed=11587730;
OX NCBI_TaxID=9940; ! Ovis aries
CA Spontaneously immortalized cell line
//
ID MOCL2
AC CVCL_S518
RX PubMed=11587730;
OX NCBI_TaxID=9940; ! Ovis aries
CA Spontaneously immortalized cell line
//
ID MOCL3
AC CVCL_S519
RX PubMed=11587730;
OX NCBI_TaxID=9940; ! Ovis aries
CA Spontaneously immortalized cell line
//
ID MOCL4
AC CVCL_S520
RX PubMed=11587730;
OX NCBI_TaxID=9940; ! Ovis aries
CA Spontaneously immortalized cell line
//
ID MOCL5
AC CVCL_S521
RX PubMed=11587730;
OX NCBI_TaxID=9940; ! Ovis aries
CA Spontaneously immortalized cell line
//
ID MOCL6
AC CVCL_S522
RX PubMed=11587730;
OX NCBI_TaxID=9940; ! Ovis aries
CA Spontaneously immortalized cell line
//
ID MOCL7
AC CVCL_S523
RX PubMed=11587730;
OX NCBI_TaxID=9940; ! Ovis aries
CA Spontaneously immortalized cell line
//
ID MOCL8
AC CVCL_S524
RX PubMed=11587730;
OX NCBI_TaxID=9940; ! Ovis aries
CA Spontaneously immortalized cell line
//
ID MOCP-5
AC CVCL_F699
RX PubMed=9661075;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MOD
AC CVCL_5G87
RX PubMed=2423737;
RX PubMed=24259225;
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MOG-G-CCM
AC CVCL_2613
SY MOGGCCM; GO-G-CCM; G-CCM; CCM
DR CLO; CLO_0007817
DR CLDB; cl3512
DR BioSample; SAMN03470986
DR CCLE; MOGGCCM_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3308456
DR Cosmic; 687450
DR Cosmic; 908144
DR Cosmic; 2367538
DR Cosmic-CLP; 908144
DR ECACC; 86022702
DR GDSC; 908144
DR GEO; GSM827349
DR GEO; GSM1374686
DR GEO; GSM1670122
RX PubMed=3254724;
RX PubMed=6200130;
RX PubMed=7518347;
RX PubMed=7591247;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 17
ST D19S433: 12,14
ST D21S11: 31.2
ST D2S1338: 21
ST D3S1358: 16,18
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 13,15
ST FGA: 20,21
ST Penta D: 9,13
ST Penta E: 10,13
ST TH01: 6
ST TPOX: 11
ST vWA: 14
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MOG-G-IJK
AC CVCL_S831
SY G-IJK; IJK
RX PubMed=3254724;
RX PubMed=6200130;
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MOG-G-UVW
AC CVCL_2614
SY MOG-GUVW; MOGGUVW; GO-G-UVW; G-UVW; UVW
DR CLO; CLO_0007818
DR CLDB; cl3513
DR BioSample; SAMN03470987
DR CCLE; MOGGUVW_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3308137
DR ChEMBL-Targets; CHEMBL1075508
DR Cosmic; 908145
DR Cosmic; 2367539
DR Cosmic-CLP; 908145
DR ECACC; 86022703
DR GDSC; 908145
DR GEO; GSM827433
DR GEO; GSM1374687
DR GEO; GSM1670123
RX PubMed=3254724;
RX PubMed=7518347;
RX PubMed=7591247;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 13
ST D18S51: 14,15
ST D19S433: 14
ST D21S11: 30,30.2
ST D2S1338: 21,24
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 9,12
ST D8S1179: 13,15
ST FGA: 23,24
ST Penta D: 9,13
ST Penta E: 5,7
ST TH01: 6
ST TPOX: 8,9
ST vWA: 15,17
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MOH (TOU II-3)
AC CVCL_2782
SY MOH; TOU II-3
DR CLO; CLO_0007819
DR CLDB; cl3514
DR ECACC; 93093002
RX PubMed=6438434;
WW http://www.imgt.org/IMGTrepertoire/LocusGenes/locus/human/IGH/Hu_IGHcellines.html
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID MOHITO
AC CVCL_K249
SY MOuse Hematopoietic Interleukin-dependent cell line of T-cell Origin
RX PubMed=21193420;
WW https://www.abmgood.com/Immortalized-Mouse-CD4%3Csup%3E+%3C/sup%3E-CD8%3Csup%3E+%3C/sup%3E-T-Cells-(MOHITO)-T0131.html
CC Characteristics: IL2 and IL7 dependent.
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MOLM-1
AC CVCL_2118
SY MOLM1
DR CGH-DB; 9222-4
DR Cosmic; 787504
DR Cosmic; 798670
DR Cosmic; 919133
DR Cosmic; 994172
DR Cosmic; 996324
DR Cosmic; 998756
DR Cosmic; 999776
DR Cosmic; 1037676
DR Cosmic; 2089677
DR Cosmic; 2378087
DR DSMZ; ACC-720
RX PubMed=1782185;
RX PubMed=10695022;
RX PubMed=23955599;
CC Doubling time: ~60-70 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 8
ST D13S317: 8,12
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 8,12
ST vWA: 14,17
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MOLM-10
AC CVCL_7920
SY MOLM10
RX PubMed=7873501;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2122 ! MOLM-6
OI CVCL_7917 ! MOLM-7
OI CVCL_7918 ! MOLM-8
OI CVCL_7919 ! MOLM-9
OI CVCL_7921 ! MOLM-11
OI CVCL_L075 ! MOLM-12
SX Male
CA Cancer cell line
//
ID MOLM-11
AC CVCL_7921
SY MOLM11
DR Cosmic; 999771
RX PubMed=7873501;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2122 ! MOLM-6
OI CVCL_7917 ! MOLM-7
OI CVCL_7918 ! MOLM-8
OI CVCL_7919 ! MOLM-9
OI CVCL_7920 ! MOLM-10
OI CVCL_L075 ! MOLM-12
SX Male
CA Cancer cell line
//
ID MOLM-12
AC CVCL_L075
SY MOLM12
RX PubMed=7873501;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2122 ! MOLM-6
OI CVCL_7917 ! MOLM-7
OI CVCL_7918 ! MOLM-8
OI CVCL_7919 ! MOLM-9
OI CVCL_7920 ! MOLM-10
OI CVCL_7921 ! MOLM-11
SX Male
CA Cancer cell line
//
ID MOLM-13
AC CVCL_2119
SY MOLM13; Molm13; Molm 13
DR BTO; BTO:0004175
DR BioSample; SAMN03473102
DR CCLE; MOLM13_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 787417
DR Cosmic; 975274
DR Cosmic; 996319
DR Cosmic; 998754
DR Cosmic; 999722
DR Cosmic; 999772
DR Cosmic; 1012095
DR Cosmic; 1037671
DR Cosmic; 1078734
DR Cosmic; 1150897
DR Cosmic; 1152711
DR Cosmic; 1187863
DR Cosmic; 1197930
DR Cosmic; 1278778
DR Cosmic; 1281332
DR Cosmic; 1308222
DR Cosmic; 1465952
DR Cosmic; 1741687
DR Cosmic; 1696139
DR Cosmic; 2089664
DR Cosmic; 2131546
DR Cosmic; 2306220
DR Cosmic-CLP; 1330947
DR DSMZ; ACC-554
DR GDSC; 1330947
DR GEO; GSM482509
DR GEO; GSM887329
DR GEO; GSM888405
DR GEO; GSM1374688
DR GEO; GSM1374689
DR GEO; GSM1670124
RX PubMed=9305600;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=23955599;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=60
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 24 hours (PubMed=25984343); ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): COG; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 10,11
ST D18S51: 13,15
ST D19S433: 12,14
ST D21S11: 30,31
ST D2S1338: 23,25
ST D3S1358: 15
ST D5S818: 10,11
ST D7S820: 10,12
ST D8S1179: 13,14
ST FGA: 21,23
ST Penta D: 9,12
ST Penta E: 18,19
ST TH01: 7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7916 ! MOLM-14
SX Male
CA Cancer cell line
//
ID MOLM-13-RES
AC CVCL_D779
DR Cosmic; 1741689
RX PubMed=22354205;
CC Selected for resistance to: ChEBI; CHEBI:90237; Tandutinib (MLN518; CT53518).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2119 ! MOLM-13
SX Male
CA Cancer cell line
//
ID MOLM-13-RES-AC
AC CVCL_D780
DR Cosmic; 1741691
RX PubMed=22354205;
CC Selected for resistance to: ChEBI; CHEBI:90217; Quizartinib (AC220).
CC Selected for resistance to: ChEBI; CHEBI:90237; Tandutinib (MLN518; CT53518).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D779 ! MOLM-13-RES
SX Male
CA Cancer cell line
//
ID MOLM-14
AC CVCL_7916
SY Molm-14; Molm 14; Molm14; MOLM14
DR BTO; BTO:0005720
DR Cosmic; 787418
DR Cosmic; 1150898
DR Cosmic; 1281333
DR DSMZ; ACC-777
DR Lonza; 978
RX PubMed=9305600;
CC Doubling time: ~50 hours (DSMZ).
ST Source(s): COG; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 10,11
ST D18S51: 13,15
ST D19S433: 12,14
ST D21S11: 30,31
ST D2S1338: 23,25
ST D3S1358: 15
ST D5S818: 10,11
ST D7S820: 10,12
ST D8S1179: 13,14
ST FGA: 21,23
ST TH01: 7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2119 ! MOLM-13
SX Male
CA Cancer cell line
//
ID MOLM-16
AC CVCL_2120
SY MOLM16
DR BTO; BTO:0004176
DR EFO; EFO_0006652
DR BioSample; SAMN03473252
DR CCLE; MOLM16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 787457
DR Cosmic; 975275
DR Cosmic; 1012096
DR Cosmic; 1281334
DR Cosmic; 2131560
DR Cosmic; 2306221
DR Cosmic-CLP; 1330948
DR DSMZ; ACC-555
DR GDSC; 1330948
DR GEO; GSM887330
DR GEO; GSM888406
DR GEO; GSM1374690
RX PubMed=12526922;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50-80 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 9
ST D18S51: 15,23
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 10
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 21
ST Penta D: 9
ST Penta E: 13,20
ST TH01: 9
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MOLM-17
AC CVCL_7922
SY MOLM17
DR Cosmic; 975276
DR Cosmic; 1012097
DR Cosmic; 2306222
RX PubMed=15863212;
RX PubMed=16408098;
DI NCIt; C3247; Myelodysplastic syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L076 ! B422
OI CVCL_L077 ! B423
OI CVCL_7923 ! MOLM-18
SX Male
CA Cancer cell line
//
ID MOLM-18
AC CVCL_7923
SY MOLM18
RX PubMed=15863212;
DI NCIt; C3247; Myelodysplastic syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L076 ! B422
OI CVCL_L077 ! B423
OI CVCL_7922 ! MOLM-17
SX Male
CA Cancer cell line
//
ID MOLM-20
AC CVCL_2121
SY MOLM20
DR BioSample; SAMN03473490
DR Cosmic; 1012098
DR DSMZ; ACC-591
RX PubMed=16408098;
CC Doubling time: ~70 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,11
ST D16S539: 13
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 9,11
ST vWA: 17
DI NCIt; C3179; Chronic neutrophilic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_V650 ! CNLBC1
SX Female
CA Cancer cell line
//
ID MOLM-6
AC CVCL_2122
SY MOLM6
DR BTO; BTO:0004177
DR BioSample; SAMN03473502
DR CCLE; MOLM6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CGH-DB; 9210-4
DR Cosmic; 787505
DR Cosmic; 999769
DR DSMZ; ACC-611
DR GEO; GSM887331
DR GEO; GSM888407
RX PubMed=7873501;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~48-72 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 10,11
ST D5S818: 10,12
ST D7S820: 10
ST TH01: 9
ST TPOX: 8
ST vWA: 16
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_7917 ! MOLM-7
OI CVCL_7918 ! MOLM-8
OI CVCL_7919 ! MOLM-9
OI CVCL_7920 ! MOLM-10
OI CVCL_7921 ! MOLM-11
OI CVCL_L075 ! MOLM-12
SX Male
CA Cancer cell line
//
ID MOLM-7
AC CVCL_7917
SY MOLM7
DR Cosmic; 996325
DR Cosmic; 998757
DR Cosmic; 999770
DR Cosmic; 1012094
DR Cosmic; 1037677
DR Cosmic; 2089676
RX PubMed=7873501;
RX PubMed=16408098;
RX PubMed=23955599;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2122 ! MOLM-6
OI CVCL_7918 ! MOLM-8
OI CVCL_7919 ! MOLM-9
OI CVCL_7920 ! MOLM-10
OI CVCL_7921 ! MOLM-11
OI CVCL_L075 ! MOLM-12
SX Male
CA Cancer cell line
//
ID MOLM-8
AC CVCL_7918
SY MOLM8
RX PubMed=7873501;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2122 ! MOLM-6
OI CVCL_7917 ! MOLM-7
OI CVCL_7919 ! MOLM-9
OI CVCL_7920 ! MOLM-10
OI CVCL_7921 ! MOLM-11
OI CVCL_L075 ! MOLM-12
SX Male
CA Cancer cell line
//
ID MOLM-9
AC CVCL_7919
SY MOLM9
RX PubMed=7873501;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2122 ! MOLM-6
OI CVCL_7917 ! MOLM-7
OI CVCL_7918 ! MOLM-8
OI CVCL_7920 ! MOLM-10
OI CVCL_7921 ! MOLM-11
OI CVCL_L075 ! MOLM-12
SX Male
CA Cancer cell line
//
ID MOLP-2
AC CVCL_2123
SY MOLP2
DR EFO; EFO_0006653
DR BioSample; SAMN03472938
DR CCLE; MOLP2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CGH-DB; 9146-4
DR DSMZ; ACC-607
DR GEO; GSM887332
DR GEO; GSM888408
RX PubMed=8148313;
RX PubMed=10936422;
RX PubMed=15215163;
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~4 days (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 8,9
ST D16S539: 9
ST D18S51: 14
ST D21S11: 30
ST D3S1358: 16,17
ST D5S818: 10
ST D7S820: 11,12
ST D8S1179: 13,15
ST FGA: 22
ST Penta D: 9,10
ST Penta E: 11
ST TH01: 9
ST TPOX: 10,11
ST vWA: 16,18
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5764 ! MOLP-3
SX Male
CA Cancer cell line
//
ID MOLP-2/R
AC CVCL_4V88
RX DOI=10.1007/s10330-009-0051-5;
RX PubMed=19756599;
CC Selected for resistance to: ChEBI; CHEBI:28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2123 ! MOLP-2
SX Male
CA Cancer cell line
//
ID MOLP-3
AC CVCL_5764
SY MOLP3
RX PubMed=8148313;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2123 ! MOLP-2
SX Male
CA Cancer cell line
//
ID MOLP-5
AC CVCL_5842
SY MOLP5
DR CGH-DB; 34-1
DR CGH-DB; 9147-4
RX PubMed=10848782;
RX PubMed=10936422;
RX PubMed=15215163;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L601 ! B407
SX Male
CA Cancer cell line
//
ID MOLP-6
AC CVCL_9984
DR CGH-DB; 35-1
DR CGH-DB; 9148-4
RX PubMed=10937346;
RX PubMed=15215163;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9985 ! MOLP-7
CA Cancer cell line
//
ID MOLP-7
AC CVCL_9985
RX PubMed=10937346;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9984 ! MOLP-6
CA Cancer cell line
//
ID MOLP-8
AC CVCL_2124
SY MOLP8
DR EFO; EFO_0006654
DR BioSample; SAMN03472939
DR CCLE; MOLP8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic-CLP; 1330950
DR DSMZ; ACC-569
DR GDSC; 1330950
DR GEO; GSM887333
DR GEO; GSM888409
DR GEO; GSM1374691
DR GEO; GSM1670125
RX PubMed=15203285;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 10,11
ST D18S51: 15,16
ST D21S11: 29,30
ST D3S1358: 12,15
ST D5S818: 11
ST D7S820: 7,8
ST D8S1179: 11,13
ST FGA: 21,25
ST Penta D: 9
ST Penta E: 11
ST TH01: 9
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MOLT-10
AC CVCL_7924
SY Molt-10; MOLT 10; MOLT10
RX PubMed=155647;
DI NCIt; C3168; Childhood acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MOLT-11
AC CVCL_8152
SY Molt-11; MOLT 11
CC Miscellaneous: Cell line has been lost.
DI NCIt; C3168; Childhood acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MOLT-12
AC CVCL_8151
SY Molt-12; MOLT 12
RX PubMed=2784121;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1422 ! MOLT-13
OI CVCL_1423 ! MOLT-14
SX Female
CA Cancer cell line
//
ID MOLT-13
AC CVCL_1422
SY Molt-13; MOLT 13; Molt 13; MOLT13; Molt13
DR BTO; BTO:0004171
DR CLO; CLO_0007820
DR BioSample; SAMN03473543
DR CCLE; MOLT13_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308875
DR ChEMBL-Targets; CHEMBL2366103
DR Cosmic; 908146
DR Cosmic; 933538
DR Cosmic; 1115594
DR Cosmic; 1151786
DR Cosmic; 1281378
DR Cosmic; 1524805
DR Cosmic-CLP; 908146
DR DSMZ; ACC-436
DR GDSC; 908146
DR GEO; GSM887334
DR GEO; GSM888410
DR GEO; GSM1670126
RX PubMed=2784121;
RX PubMed=11021758;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~80-120 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,13 (Cosmic-CLP)
ST CSF1PO: 11,12 (DSMZ)
ST D13S317: 11,12
ST D16S539: 9,11
ST D5S818: 12
ST D7S820: 10,13
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8151 ! MOLT-12
OI CVCL_1423 ! MOLT-14
SX Female
CA Cancer cell line
//
ID MOLT-14
AC CVCL_1423
SY Molt-14; MOLT 14; Molt 14; MOLT14; Molt14
DR BTO; BTO:0004172
DR CLO; CLO_0007821
DR BioSample; SAMN03473544
DR Cosmic; 998729
DR Cosmic; 1037682
DR Cosmic; 1281379
DR Cosmic; 1330490
DR DSMZ; ACC-437
RX PubMed=2784121;
CC Doubling time: ~40-50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 11,12,13
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,13
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 17,18,19
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8151 ! MOLT-12
OI CVCL_1422 ! MOLT-13
SX Female
CA Cancer cell line
//
ID MOLT-15
AC CVCL_8150
SY Molt-15; MOLT 15
DR BioSample; SAMN03151632
DR Cosmic; 913415
DR Cosmic; 1524806
RX PubMed=2784121;
RX PubMed=9933131;
RX PubMed=10508494;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a CTV-1 derivative (PubMed=10508494, PubMed=12592342, PubMed=20143388).
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1150 ! CTV-1
SX Male
CA Cancer cell line
//
ID MOLT-16
AC CVCL_1424
SY Molt-16; MOLT 16; MOLT16; Molt16
DR BTO; BTO:0004173
DR EFO; EFO_0002239
DR CLDB; cl3516
DR BioSample; SAMN03473343
DR CCLE; MOLT16_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308271
DR ChEMBL-Targets; CHEMBL2366362
DR Cosmic; 908147
DR Cosmic; 913425
DR Cosmic; 919155
DR Cosmic; 922678
DR Cosmic; 998725
DR Cosmic; 1115601
DR Cosmic; 1151787
DR Cosmic; 1226859
DR Cosmic; 1281380
DR Cosmic; 1330491
DR Cosmic; 1641382
DR Cosmic; 1760528
DR Cosmic; 2458764
DR Cosmic; 2462862
DR Cosmic-CLP; 908147
DR DSMZ; ACC-29
DR GDSC; 908147
DR GEO; GSM887335
DR GEO; GSM888411
DR GEO; GSM1670127
DR IGRhCellID; MOLT16
DR Lonza; 2
RX PubMed=2784121;
RX PubMed=9408752;
RX PubMed=9933131;
RX PubMed=15843827;
RX PubMed=22460905;
RX PubMed=22675565;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2125 ! MOLT-17
SX Female
CA Cancer cell line
//
ID MOLT-17
AC CVCL_2125
SY Molt-17; MOLT 17; MOLT17
DR BTO; BTO:0004174
DR CLO; CLO_0051012
DR CLDB; cl3517
DR BioSample; SAMN03472051
DR Cosmic; 933539
DR Cosmic; 1118461
DR DSMZ; ACC-36
DR NCBI_Iran; C516
DR RCB; RCB1982
DR RCB; RCB4561
DR TKG; TKG 0385
RX PubMed=2784121;
WW http://cell.brc.riken.jp/en/announcement/molt-17
CC Problematic cell line: Partially contaminated. The RCB/Riken RCB1982 stock was contaminated and was replaced by RCB4561 which originates from DSMZ ACC-36. On the basis of STR profile, the version at TKG (TKG 0385) seems to be identical or closely related to the RCB1962 contaminated stock.
CC Doubling time: ~50 hours (DSMZ).
CC Discontinued: RCB; RCB1982; true.
ST Source(s): DSMZ; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12 (DSMZ)
ST CSF1PO: 9,10,12 (RCB_RCB1982)
ST CSF1PO: 10,12 (TKG)
ST D13S317: 12 (DSMZ)
ST D13S317: 10,11,12 (RCB_RCB1982)
ST D13S317: 10,12 (TKG)
ST D16S539: 9,10 (DSMZ)
ST D16S539: 9,14,15 (RCB_RCB1982
ST D16S539: 9,15 (TKG)
ST D5S818: 11,12 (DSMZ)
ST D5S818: 12,13 (RCB_RCB1982)
ST D5S818: 12 (TKG)
ST D7S820: 12 (DSMZ)
ST D7S820: 11,12,13 (RCB_RCB1982)
ST D7S820: 11 (TKG)
ST TH01: 9,9.3 (DSMZ)
ST TH01: 9 (RCB_RCB1982; TKG)
ST TPOX: 8,11 (DSMZ)
ST TPOX: 8 (RCB_RCB1982; TKG)
ST vWA: 16 (DSMZ)
ST vWA: 17,18,19 (RCB_RCB1982)
ST vWA: 18,19 (TKG)
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1424 ! MOLT-16
SX Female
CA Cancer cell line
//
ID MOLT-3
AC CVCL_0624
SY Molt-3; MOLT 3; Molt 3; MOLT3; Molt3
DR BTO; BTO:0001081
DR CLO; CLO_0007824
DR CLO; CLO_0051008
DR EFO; EFO_0005265
DR CLDB; cl3519
DR CLDB; cl3521
DR CLDB; cl3522
DR CLDB; cl3523
DR ATCC; CRL-1552
DR BCRC; 60106
DR BioSample; SAMN03470846
DR BioSample; SAMN03471394
DR BioSample; SAMN03472164
DR BioSample; SAMN03473404
DR ChEMBL-Cells; CHEMBL3307556
DR ChEMBL-Targets; CHEMBL614176
DR CLS; 300116/p2664_MOLT-3
DR Cosmic; 724815
DR Cosmic; 850193
DR Cosmic; 913410
DR Cosmic; 999756
DR Cosmic; 1191701
DR Cosmic; 1281377
DR Cosmic; 1524845
DR Cosmic; 2301561
DR Cosmic; 2361367
DR DSMZ; ACC-84
DR ECACC; 90021901
DR GEO; GSM236793
DR GEO; GSM236829
DR IGRhCellID; MOLT3
DR IZSLER; BS TCL 44
DR JCRB; JCRB9048
DR NIH-ARP; 12187-387
DR RCB; RCB1164
RX PubMed=327080;
RX PubMed=2846092;
RX PubMed=4547172;
RX PubMed=4567231;
RX PubMed=6600440;
RX PubMed=8547074;
RX PubMed=9738977;
RX PubMed=9933131;
RX PubMed=11986953;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0010&theme=default
CC Doubling time: ~40 hours (DSMZ).
ST Source(s): ATCC; CLS; COG; DSMZ; PubMed=25877200; RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12 (ATCC; COG; DSMZ)
ST CSF1PO: 11,12,13 (CLS; PubMed=25877200; RCB)
ST D13S317: 12,13 (ATCC; CLS; COG; DSMZ; PubMed=25877200)
ST D13S317: 11,12,13 (RCB)
ST D16S539: 11,13,14 (ATCC; PubMed=25877200)
ST D16S539: 11,14,15 (CLS)
ST D16S539: 11,12,14 (COG)
ST D16S539: 11,14 (DSMZ)
ST D16S539: 10,11,13 (RCB)
ST D18S51: 12,13,16,17 (CLS)
ST D18S51: 13,17 (COG)
ST D18S51: 13,17,18 (PubMed=25877200)
ST D19S433: 14,15
ST D21S11: 29,30,31,32 (CLS)
ST D21S11: 29,30 (PubMed=25877200)
ST D2S1338: 23,24
ST D3S1358: 14,15,16,17 (COG)
ST D3S1358: 15,16,17 (CLS; PubMed=25877200)
ST D5S818: 12 (ATCC; PubMed=25877200)
ST D5S818: 12,13 (CLS; DSMZ; RCB)
ST D7S820: 8,10 (ATCC; COG; PubMed=25877200)
ST D7S820: 7,8,9,10 (CLS)
ST D7S820: 7,8,10 (DSMZ)
ST D7S820: 7,8,9 (RCB)
ST D8S1179: 9,13,14,15 (CLS; PubMed=25877200)
ST D8S1179: 9,14,15 (COG)
ST FGA: 19,21,25 (CLS)
ST FGA: 22,24 (COG)
ST FGA: 21,22,23,24 (PubMed=25877200)
ST Penta D: 8,13
ST Penta E: 14,16
ST TH01: 6,8
ST TPOX: 8
ST vWA: 17 (ATCC; COG; PubMed=25877200)
ST vWA: 17,18 (CLS; DSMZ; RCB)
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0013 ! MOLT-4
SX Male
CA Cancer cell line
//
ID MOLT-3/MTX.P-9
AC CVCL_S660
RX PubMed=8608962;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MOLT-3/MTX10000
AC CVCL_S658
SY MOLT-3/MTX10,000
RX PubMed=3856477;
RX PubMed=8608962;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MOLT-3/MTX200
AC CVCL_S659
RX PubMed=3856477;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MOLT-3/MTXt
AC CVCL_S652
RX PubMed=6978176;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MOLT-3/TMQ200
AC CVCL_S653
RX PubMed=2573416;
CC Selected for resistance to: ChEBI; CHEBI:9737; Trimetrexate.
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MOLT-3/TMQ200-CB371730
AC CVCL_S654
RX PubMed=1683871;
CC Selected for resistance to: ChEBI; CHEBI:9737; Trimetrexate.
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S653 ! MOLT-3/TMQ200
SX Male
CA Cancer cell line
//
ID MOLT-3/TMQ200-MTX500
AC CVCL_S657
RX PubMed=7850779;
CC Selected for resistance to: ChEBI; CHEBI:44185; Methotrexate (MTX).
CC Selected for resistance to: ChEBI; CHEBI:9737; Trimetrexate.
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_S653 ! MOLT-3/TMQ200
SX Male
CA Cancer cell line
//
ID MOLT-3/TMQ2500
AC CVCL_S655
RX PubMed=2573416;
CC Selected for resistance to: ChEBI; CHEBI:9737; Trimetrexate.
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MOLT-3/TMQ800
AC CVCL_S656
RX PubMed=2573416;
CC Selected for resistance to: ChEBI; CHEBI:9737; Trimetrexate.
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID Molt-3/Z29
AC CVCL_M774
SY Molt-3/Z-29; MOLT-3 / Z29
DR NIH-ARP; 12185-363
RX PubMed=1653487;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MOLT-3/ZD1694.C
AC CVCL_S661
RX PubMed=8576277;
RX PubMed=8608962;
CC Selected for resistance to: ChEBI; CHEBI:5847; ICI D1694 (Tomudex; ZD1694).
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MOLT-3/ZD1694.P9
AC CVCL_S662
RX PubMed=8608962;
CC Selected for resistance to: ChEBI; CHEBI:5847; ICI D1694 (Tomudex; ZD1694).
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MOLT-4
AC CVCL_0013
SY Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM2219C
DR BTO; BTO:0000873
DR CLO; CLO_0007825
DR CLO; CLO_0032246
DR CLO; CLO_0050992
DR EFO; EFO_0001220
DR MCCL; MCC:0000335
DR CLDB; cl3524
DR CLDB; cl3525
DR CLDB; cl3527
DR CLDB; cl3528
DR CLDB; cl3529
DR CLDB; cl3530
DR CLDB; cl3531
DR CLDB; cl3532
DR CLDB; cl4976
DR CLDB; cl5233
DR ATCC; CRL-1582
DR BCRC; 60060
DR BCRJ; 0176
DR BioSample; SAMN03470847
DR BioSample; SAMN03471400
DR BioSample; SAMN03472410
DR BioSample; SAMN03473319
DR CCLE; MOLT4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3111C0001CCC000043
DR CCRID; 3131C0001000700037
DR CCRID; 3131C0001001200018
DR CCRID; 3142C0001000000079
DR ChEMBL-Cells; CHEMBL3307557
DR ChEMBL-Targets; CHEMBL614177
DR CLS; 300115/p664_MOLT-4
DR Coriell; GM02219
DR Cosmic; 716176
DR Cosmic; 721716
DR Cosmic; 801730
DR Cosmic; 850194
DR Cosmic; 875865
DR Cosmic; 897451
DR Cosmic; 905958
DR Cosmic; 913409
DR Cosmic; 919154
DR Cosmic; 922677
DR Cosmic; 932766
DR Cosmic; 933547
DR Cosmic; 974249
DR Cosmic; 991545
DR Cosmic; 999763
DR Cosmic; 1012099
DR Cosmic; 1019314
DR Cosmic; 1044254
DR Cosmic; 1070704
DR Cosmic; 1071877
DR Cosmic; 1082518
DR Cosmic; 1092615
DR Cosmic; 1115596
DR Cosmic; 1118467
DR Cosmic; 1127263
DR Cosmic; 1130237
DR Cosmic; 1151788
DR Cosmic; 1175131
DR Cosmic; 1175857
DR Cosmic; 1176596
DR Cosmic; 1226858
DR Cosmic; 1305339
DR Cosmic; 1312325
DR Cosmic; 1330500
DR Cosmic; 1483362
DR Cosmic; 1509200
DR Cosmic; 1524808
DR Cosmic; 1639636
DR Cosmic; 1664513
DR Cosmic; 1811158
DR Cosmic; 1998457
DR Cosmic; 2039521
DR Cosmic; 2165720
DR Cosmic; 2361368
DR Cosmic-CLP; 905958
DR dbMHC; 48976
DR DSMZ; ACC-362
DR ECACC; 85011413
DR ECACC; 94022544
DR GDSC; 905958
DR GEO; GSM50196
DR GEO; GSM50912
DR GEO; GSM236794
DR GEO; GSM236830
DR GEO; GSM750821
DR GEO; GSM799348
DR GEO; GSM799411
DR GEO; GSM887336
DR GEO; GSM888412
DR GEO; GSM1181333
DR GEO; GSM1181349
DR GEO; GSM1670128
DR ICLC; HTL99025
DR IFO; IFO50362
DR IGRhCellID; MOLT4
DR IHW; IHW9226
DR IMGT/HLA; 11094
DR IZSLER; BS TCL 85
DR JCRB; JCRB9031
DR KCB; KCB 200940YJ
DR KCLB; 21582
DR NCBI_Iran; C149
DR RCB; RCB0206
DR SKY/M-FISH/CGH; 2741
RX DOI=10.4172/2157-7145.S2-005;
RX PubMed=165156;
RX PubMed=2041050;
RX PubMed=2846092;
RX PubMed=4547172;
RX PubMed=4567231;
RX PubMed=6582512;
RX PubMed=8316623;
RX PubMed=8547074;
RX PubMed=9685479;
RX PubMed=10071127;
RX PubMed=11021758;
RX PubMed=11986953;
RX PubMed=16408098;
RX PubMed=17088437;
RX PubMed=17117183;
RX PubMed=19372543;
RX PubMed=22460905;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24762992;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=31
WW http://www.proteinatlas.org/learn/cellines
WW http://bioinformatics.hsanmartino.it/ecbr/cl226.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-609.html
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0011&theme=default
WW http://tcpaportal.org/mclp/
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 31.56 +- 1.488 hours (PubMed=24762992); 27.9 hours (DTP); ~40 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; COG; Cosmic-CLP; DSMZ; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=19372543; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12,13 (ATCC; COG; Cosmic-CLP; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200)
ST CSF1PO: 11,12 (DSMZ)
ST D13S317: 12,13 (ATCC; CLS; COG; Cosmic-CLP; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200)
ST D13S317: 12,13,14 (DSMZ)
ST D16S539: 11,14 (ATCC; CLS; Cosmic-CLP; DSMZ; DOI=10.4172/2157-7145.S2-005; PubMed=19372543)
ST D16S539: 11,14,15 (COG; JCRB; PubMed=25877200)
ST D18S51: 12,13,17 (CLS)
ST D18S51: 13,16,17 (DOI=10.4172/2157-7145.S2-005)
ST D18S51: 13,17 (PubMed=19372543; PubMed=25877200)
ST D19S433: 14,15 (DOI=10.4172/2157-7145.S2-005; PubMed=25877200)
ST D19S433: 14,15,16 (PubMed=19372543)
ST D21S11: 27,28,29,30,31 (COG; DOI=10.4172/2157-7145.S2-005; PubMed=25877200)
ST D21S11: 28,29,30 (CLS; PubMed=11416159)
ST D21S11: 28,29,30,31 (PubMed=19372543)
ST D2S1338: 23,24
ST D3S1358: 15,16 (CLS)
ST D3S1358: 14,16 (KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200)
ST D5S818: 12 (ATCC; CLS; COG; Cosmic-CLP; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=19372543)
ST D5S818: 11,12 (DSMZ)
ST D5S818: 12,13 (PubMed=25877200)
ST D7S820: 8,10,11 (ATCC; CLS; COG; Cosmic-CLP; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=19372543; PubMed=25877200)
ST D7S820: 8,10 (DSMZ)
ST D8S1179: 9,13,14 (CLS)
ST D8S1179: 9,14 (COG; DOI=10.4172/2157-7145.S2-005; PubMed=19372543)
ST D8S1179: 9,14,15 (PubMed=11416159)
ST D8S1179: 9,13,14,15 (PubMed=25877200)
ST FGA: 22,24 (CLS)
ST FGA: 22,23,24,25 (COG; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=19372543)
ST FGA: 22,25 (PubMed=11416159)
ST FGA: 21,22,23,24,25 (PubMed=25877200)
ST Penta D: 8,12,13 (CLS)
ST Penta D: 8,13 (PubMed=25877200)
ST Penta E: 14,15,16 (CLS)
ST Penta E: 14,16 (PubMed=25877200)
ST TH01: 6,8
ST TPOX: 8
ST vWA: 17,18 (ATCC; CLS; COG; Cosmic-CLP; JCRB; KCLB; DOI=10.4172/2157-7145.S2-005; PubMed=25877200)
ST vWA: 16,17,18 (DSMZ)
ST vWA: 17 (PubMed=11416159)
ST vWA: 17,18,19 (PubMed=19372543)
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MOLT-4 clone 8
AC CVCL_F827
SY Molt-4 Clone 8; Molt-4 clone no.8; MOLT 4 clone 8; Molt 4 clone 8; Molt4 clone 8; Molt4 Clone8; MOLT-4 cl. 8; MOLT-4 cl.8; MOLT-F8; M4Cl8; M4C18; MOLT4/8
DR NIH-ARP; 175-146
RX PubMed=2419583;
WW http://www.nibsc.org/Default.aspx?pageid=597&id=0052&theme=default
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0013 ! MOLT-4
SX Male
CA Cancer cell line
//
ID MOLT-4-luc2
AC CVCL_5J16
SY MOLT4-luc2
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 125057.
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0013 ! MOLT-4
SX Male
CA Cancer cell line
//
ID MOLT-4/ADR
AC CVCL_4Y72
SY Molt-4/ADR; MAR
RX PubMed=25457413;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0013 ! MOLT-4
SX Male
CA Cancer cell line
//
ID MOLT-4/CCR5
AC CVCL_S545
SY MOLT-4 CCR5+
DR NIH-ARP; 4984-447
RX PubMed=10890354;
CC Transfected with: HGNC; 1606; CCR5.
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F827 ! MOLT-4 clone 8
SX Male
CA Cancer cell line
//
ID MOLT-4F
AC CVCL_2792
SY MOLT-4f; Molt-4F; MOLT 4F; Molt/4F; MOLT4F; MOLT4f
DR CLO; CLO_0050994
DR BioSample; SAMN03472036
DR ChEMBL-Cells; CHEMBL3307263
DR ChEMBL-Targets; CHEMBL613515
DR GEO; GSM827231
DR JCRB; JCRB0021
DR RCB; RCB1936
DR TKG; TKG 0229
RX PubMed=3495441;
RX PubMed=6600440;
RX PubMed=9290701;
RX PubMed=9738977;
RX PubMed=20519628;
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12,13
ST D16S539: 11,12,13
ST D5S818: 11,12,13 (RCB)
ST D5S818: 12,13 (TKG)
ST D7S820: 7,8,10 (RCB)
ST D7S820: 7,8,10,11 (TKG)
ST TH01: 6,8
ST TPOX: 8
ST vWA: 17,18,19 (RCB)
ST vWA: 17,18 (TKG)
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0013 ! MOLT-4
SX Male
CA Cancer cell line
//
ID MOLT-4V
AC CVCL_F830
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0013 ! MOLT-4
SX Male
CA Cancer cell line
//
ID MOMA-1
AC CVCL_5G84
RX PubMed=2423737;
CC Caution: Not to be confused with the monoclonal antibody MOMA-1.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID MOMA-2
AC CVCL_5G85
RX PubMed=2423737;
CC Caution: Not to be confused with the monoclonal antibody MOMA-2.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID MON
AC CVCL_M846
DR Cosmic; 802246
RX PubMed=9671307;
RX PubMed=16945155;
DI NCIt; C6586; Extrarenal rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Monca
AC CVCL_0G15
RX PubMed=9738977;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MONO-7
AC CVCL_A654
SY Mono-7; Monosomy 7
DR Cosmic; 697691
DR Cosmic; 975277
DR Cosmic; 1281336
DR Cosmic; 2089646
RX PubMed=11843295;
RX PubMed=23955599;
DI NCIt; C9160; Childhood acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Mono-Mac-1
AC CVCL_1425
SY MONO-MAC-1; Mono Mac 1; Monomac-1; MonoMac1; MONOMAC1; MM1
DR BTO; BTO:0003928
DR CLO; CLO_0007827
DR CLDB; cl3534
DR BioSample; SAMN03473331
DR CCLE; MONOMAC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 787458
DR Cosmic; 1089515
DR DSMZ; ACC-252
DR GEO; GSM482510
DR GEO; GSM887337
DR GEO; GSM888413
DR GEO; GSM1670129
DR Lonza; 715
RX PubMed=3162233;
RX PubMed=9150350;
RX PubMed=11129653;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 40 hours (PubMed=25984343); ~30-50 hours (DSMZ).
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1426 ! Mono-Mac-6
SX Male
CA Cancer cell line
//
ID Mono-Mac-6
AC CVCL_1426
SY MONO-MAC-6; Mono-mac-6; MONO-MAC 6; Mono Mac 6; Mono Mac6; MonoMac 6; MonoMac6; MONOMAC6; MM6
DR BTO; BTO:0002333
DR CLO; CLO_0007828
DR EFO; EFO_0006287
DR CLDB; cl3535
DR CLDB; cl7057
DR BioSample; SAMN03473411
DR CCLE; MONOMAC6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3307312
DR ChEMBL-Cells; CHEMBL3308335
DR ChEMBL-Targets; CHEMBL614169
DR ChEMBL-Targets; CHEMBL2366062
DR Cosmic; 787459
DR Cosmic; 908148
DR Cosmic; 975278
DR Cosmic; 1012100
DR Cosmic; 1089514
DR Cosmic; 1281335
DR Cosmic; 1465950
DR Cosmic; 1524836
DR Cosmic; 2131547
DR Cosmic; 2306198
DR Cosmic; 2392975
DR Cosmic-CLP; 908148
DR DSMZ; ACC-124
DR GDSC; 908148
DR GEO; GSM236795
DR GEO; GSM236831
DR GEO; GSM887338
DR GEO; GSM888414
DR GEO; GSM1374692
DR GEO; GSM1670130
DR ICLC; HTL01015
RX PubMed=3162233;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=Mono%20Mac%206
WW http://www.infarktforschung.de/macrophages_cell_lines.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-121.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 40 hours (PubMed=25984343); ~60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1425 ! Mono-Mac-1
SX Male
CA Cancer cell line
//
ID MOP-6
AC CVCL_Y512
SY MOP6
RX PubMed=6096696;
CC Transformant: Polyoma large T antigen.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID MOP-8
AC CVCL_2617
SY MOP8
DR CLO; CLO_0007829
DR CLDB; cl3536
DR ATCC; CRL-1709
DR ECACC; 92111707
RX PubMed=6096696;
CC Transformant: Polyoma large T antigen.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID MOPC-104E
AC CVCL_4001
SY MOPC 104E; MOPC104E
DR BTO; BTO:0002102
CC Breed/subspecies: BALB/c.
DI NCIt; C21631; Mouse plasmacytoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MOPC-173
AC CVCL_4002
SY MOPC 173
DR BTO; BTO:0002103
DI NCIt; C21631; Mouse plasmacytoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MOPC-21
AC CVCL_T277
SY MOPC 21; MOPC21
RX PubMed=5439579;
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MOPC-315
AC CVCL_2616
SY MOPC 315; MOPC315
DR BTO; BTO:0000581
DR CLO; CLO_0007830
DR CLDB; cl3537
DR ATCC; TIB-23
DR ChEMBL-Cells; CHEMBL3307316
DR ChEMBL-Targets; CHEMBL614178
DR ECACC; 85022106
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MOPC-315
CC Breed/subspecies: BALB/c.
DI NCIt; C21631; Mouse plasmacytoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MOPC-31C
AC CVCL_2615
SY MOPC 31C
DR CLO; CLO_0007831
DR CLO; CLO_0007832
DR CLDB; cl3538
DR ATCC; CCL-130
DR ECACC; 90110707
CC Breed/subspecies: BALB/cJ.
DI NCIt; C21631; Mouse plasmacytoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MOPC-70A
AC CVCL_T766
DR RCB; RCB3007
DR TKG; TKG 0167
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MOR
AC CVCL_2618
SY MOR/P
DR EFO; EFO_0006655
DR BioSample; SAMN03472982
DR ECACC; 84112312
RX PubMed=3034934;
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 9
ST D18S51: 12,20
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9,12
ST D8S1179: 12,13
ST FGA: 22
ST Penta D: 13
ST Penta E: 7,10
ST TH01: 7
ST TPOX: 11
ST vWA: 15
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mor Man
AC CVCL_U788
DR ATCC; CRL-1230
CC Discontinued: ATCC; CRL-1230; true.
DI NCIt; C75486; Menkes disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID MOR/0.2R
AC CVCL_2126
DR CLO; CLO_0007833
DR ECACC; 96042335
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2618 ! MOR
CA Cancer cell line
//
ID MOR/0.4R
AC CVCL_2619
DR CLO; CLO_0007834
DR ECACC; 96042334
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 9
ST D5S818: 12
ST D7S820: 9
ST TH01: 7
ST TPOX: 11
ST vWA: 15
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2618 ! MOR
CA Cancer cell line
//
ID MOR/CPR
AC CVCL_2620
DR CLO; CLO_0007835
DR CCLE; MORCPR_LUNG
DR ECACC; 96042333
DR GEO; GSM887339
DR GEO; GSM888415
RX PubMed=1327513;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 9
ST D5S818: 12
ST D7S820: 9,12
ST TH01: 7
ST TPOX: 11
ST vWA: 15
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2618 ! MOR
CA Cancer cell line
//
ID MOR115.1.13
AC CVCL_J469
SY MOR 115.1.13
DR JCRB; JCRB1342.06
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR124.2.2
AC CVCL_J470
SY MOR 124.2.2
DR JCRB; JCRB1342.07
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR131.5.13
AC CVCL_J471
SY MOR 131.5.13
DR JCRB; JCRB1342.08
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR158.1.3
AC CVCL_J472
SY MOR 158.1.3
DR JCRB; JCRB1342.09
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR180.2.4
AC CVCL_J473
SY MOR 180.2.4
DR JCRB; JCRB1342.11
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR33.2.9
AC CVCL_J474
SY MOR 33.2.9
DR JCRB; JCRB1342.10
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR35.4.12
AC CVCL_J475
SY MOR 35.4.12
DR JCRB; JCRB1342.02
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR39.3.9
AC CVCL_J476
SY MOR 39.3.9
DR JCRB; JCRB1342.03
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR44.4.1
AC CVCL_J477
SY MOR 44.4.1
DR JCRB; JCRB1342.12
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR76.7F.16
AC CVCL_J478
SY MOR 76.7F.16
DR JCRB; JCRB1342.04
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR8.2.1
AC CVCL_J479
SY MOR 8.2.1
DR JCRB; JCRB1342.01
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MOR83.3.10
AC CVCL_J480
SY MOR 83.3.10
DR JCRB; JCRB1342.05
RX PubMed=3211162;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Morris 5123D-TC
AC CVCL_5335
SY Morris 5123D
DR CLO; CLO_0050617
DR RCB; RCB2766
DR TKG; TKG 0131
DR TKG; TKG 0365
CC Breed/subspecies: Buffalo.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID mos-3Y1-10
AC CVCL_H696
DR RCB; RCB0379
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID mos-3Y1-16
AC CVCL_H697
DR RCB; RCB0380
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID MOS-J
AC CVCL_0J56
RX PubMed=12224130;
CC Breed/subspecies: C57BL/6J.
DI NCIt; C24021; Mouse osteosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MOSER
AC CVCL_R731
SY Moser; HCT-Moser
DR Cosmic; 1374636
RX PubMed=3349466;
RX PubMed=6437669;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MOSERSF
AC CVCL_R732
SY MOSERsf
RX PubMed=3162826;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_R731 ! MOSER
CA Cancer cell line
//
ID MOTN-1
AC CVCL_2127
SY MOTN1
DR BioSample; SAMN03473538
DR CCLE; MOTN1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR DSMZ; ACC-559
DR GEO; GSM887340
DR GEO; GSM888416
RX PubMed=12127564;
RX PubMed=14712486;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Characteristics: IL2 dependent.
CC Doubling time: ~30-40 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 9,11
ST D5S818: 10
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 11
ST vWA: 14,19
DI NCIt; C4664; T-cell large granular lymphocyte leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L208 ! PLT-2
SX Female
CA Cancer cell line
//
ID MOU
AC CVCL_E782
SY MANN; MANN2; GM08605
DR CLO; CLO_0010607
DR Coriell; GM08605
DR dbMHC; 48977
DR ECACC; 88052050
DR IHW; IHW9050
DR IMGT/HLA; 11096
DR PRIDE; PXD001205
RX PubMed=8307784;
RX PubMed=25502872;
WW http://bioinformatics.hsanmartino.it/ecbr/cl50.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: HLA class II peptidome analysis by proteomics.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MOV002AN
AC CVCL_F567
SY TER201; TER274; CS00055; EXT-0497
DR IMGT/HLA; 11809
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID MOVAS-1
AC CVCL_0F08
SY Movas-1; MOVAS; Movas
DR BTO; BTO:0005870
DR ATCC; CRL-2797
RX PubMed=10722757;
RX PubMed=21369692;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MOVP-3
AC CVCL_N031
DR ChEMBL-Cells; CHEMBL3307302
DR ChEMBL-Targets; CHEMBL614133
RX PubMed=12623853;
CC Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0624 ! MOLT-3
SX Male
CA Cancer cell line
//
ID MovS2
AC CVCL_U154
SY 2D2
RX PubMed=14671128;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MovS6
AC CVCL_U155
SY 6H5
RX PubMed=14671128;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MovS6-4
AC CVCL_U158
RX Patent=US20110165613;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-3922.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_U155 ! MovS6
CA Transformed cell line
//
ID MP-ASKIN-SA
AC CVCL_7993
RX PubMed=14553943;
DI NCIt; C7542; Askin tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MP-CCS-SY
AC CVCL_0J33
DR Wikidata; Q28726672
RX PubMed=12072203;
CC Doubling time: 36 hours (PubMed=12072203).
CC Derived from metastatic site: Left femoral bone.
DI NCIt; C3745; Clear cell sarcoma of soft tissue
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MP-N-MS
AC CVCL_Y139
DR CGH-DB; 70-1
DR CGH-DB; 9090-4
RX PubMed=10457905;
RX PubMed=11129446;
RX PubMed=12702577;
RX PubMed=23268333;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MP-N-TS
AC CVCL_Y140
DR CGH-DB; 68-1
DR CGH-DB; 9087-4
RX PubMed=11223544;
RX PubMed=12702577;
RX PubMed=23268333;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MP38
AC CVCL_4D11
DR ATCC; CRL-3296
RX PubMed=24994677;
CC Doubling time: 80 hours (PubMed=24994677).
CC Omics: SNP array analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 9
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MP41
AC CVCL_4D12
DR ATCC; CRL-3297
RX PubMed=24994677;
CC Doubling time: 41 hours (PubMed=24994677).
CC Omics: SNP array analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 11,14
ST D16S539: 13
ST D5S818: 10,13
ST D7S820: 8.3,9,9.3,10
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MP46
AC CVCL_4D13
DR ATCC; CRL-3298
RX PubMed=24994677;
CC Doubling time: 110 hours (PubMed=24994677).
CC Omics: SNP array analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MP65
AC CVCL_4D14
DR ATCC; CRL-3299
RX PubMed=24994677;
CC Doubling time: 120 hours (PubMed=24994677).
CC Omics: SNP array analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 11
ST TH01: 9
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID mPAC L20
AC CVCL_2G62
SY mPacL20; mPAC clone L20
DR BCGO; BCGO_0000121
DR EFO; EFO_0006656
DR GEO; GSM1064999
DR GEO; GSM1065000
DR GEO; GSM1065001
RX PubMed=15340143;
CC Transformant: Polyoma middle T antigen.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mPAC L4S2
AC CVCL_2G63
SY mPAC clone L4S2
RX PubMed=15340143;
CC Transformant: Polyoma middle T antigen.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MPanc-96
AC CVCL_7165
SY Mpanc-96; MPanc96; mPanc96; MPANC96
DR ATCC; CRL-2380
DR BioSample; SAMN03151612
DR Cosmic; 913309
DR Cosmic; 1299303
DR Cosmic; 1571780
DR GEO; GSM784704
RX DOI=10.4172/jpb.1000057;
RX PubMed=20143388;
WW http://www.atcc.org/support/faqs/ffd43/MPanc96%20ATCC%20CRL2380-1054.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a AsPC-1 derivative (PubMed=20143388).
CC Omics: Proteome analysis by 2D-DE/MS.
CC Misspelling: 'Mpan96' in Cosmic 1299303.
CC Discontinued: ATCC; CRL-2380; true.
CC Derived from metastatic site: Ascites.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 9,12
ST D16S539: 11
ST D5S818: 12
ST D7S820: 12,13
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 17
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0152 ! AsPC-1
SX Female
CA Cancer cell line
//
ID MPC 862L
AC CVCL_5F72
SY MPC line 862; MPC862L; 862L
RX PubMed=11151443;
RX PubMed=12438155;
CC Breed/subspecies: 129/Sv (Nf1+/Nf1n31) x C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID MPC-1
AC CVCL_AS86
SY Mouse Podocyte Clone-1
RX PubMed=9344605;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MPC-11
AC CVCL_3857
SY MPC 11; MPC11; Merwin Plasma Cell tumor-11
DR BTO; BTO:0001089
DR CLO; CLO_0007854
DR CLDB; cl3555
DR CLDB; cl3556
DR ATCC; CCL-167
DR CCRID; 3111C0001CCC000250
DR ChEMBL-Cells; CHEMBL3307317
DR ChEMBL-Targets; CHEMBL614179
DR ECACC; 91031103
DR IZSLER; BS TCL 45
DR PRIDE; PXD001273
RX PubMed=4189836;
RX PubMed=5102530;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MPC-11
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MPC-11/OUAr
AC CVCL_5429
SY MPC 11 OUAr
DR CLO; CLO_0007853
DR ATCC; TIB-15
DR JCRB; JCRB9106
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3857 ! MPC-11
SX Female
CA Cancer cell line
//
ID MPC-3-10
AC CVCL_4868
RX PubMed=7176035;
WW http://capcelllines.ca/details.asp?id=76
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID MPC-5
AC CVCL_AS87
SY MPC5; Mouse Podocyte Clone-5
DR Ximbio; 152136
RX PubMed=9344605;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MPC-8
AC CVCL_AS88
SY Mouse Podocyte Clone-8
RX PubMed=9344605;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID mPEC
AC CVCL_6E46
SY mouse PEC; mouse Parietal Epithelial Cells
RX PubMed=18596122;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID mPEC1
AC CVCL_IN73
RX PubMed=11121394;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID mPEC1-CF
AC CVCL_IN74
RX PubMed=11121394;
RX PubMed=15463957;
CC Characteristics: Homozygous for the Cftr p.Ser489Ter mutation.
CC Knockout cell: Method=KO mouse; MGI; MGI:88388; Cftr.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x (C57BL/6J x 129)Cftr-/-].
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID Mpf
AC CVCL_3858
DR CLO; CLO_0007855
DR CLDB; cl3557
DR ATCC; CRL-1656
DR ECACC; 90062801
RX PubMed=6185411;
CC Discontinued: ECACC; 90062801; probable.
OX NCBI_TaxID=9669; ! Mustela putorius furo
CA Spontaneously immortalized cell line
//
ID MPH1
AC CVCL_5F96
RX PubMed=23856644;
CC Group: Non-human primate cell line.
CC Group: Haploid karyotype cell line.
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Female
CA Embryonic stem cell
//
ID MPH2
AC CVCL_5F97
RX PubMed=23856644;
CC Group: Non-human primate cell line.
CC Group: Haploid karyotype cell line.
OX NCBI_TaxID=9541; ! Macaca fascicularis
SX Female
CA Embryonic stem cell
//
ID MPI 65-3
AC CVCL_Y639
RX PubMed=11084865;
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MPI-I
AC CVCL_2H57
RX PubMed=9013705;
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MPI-II
AC CVCL_2H58
RX PubMed=9013705;
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MPI-III
AC CVCL_2H59
RX PubMed=9013705;
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MPI-IV
AC CVCL_2H60
RX PubMed=9013705;
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID MPI-V
AC CVCL_2H61
RX PubMed=9013705;
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID MPI-VI
AC CVCL_2H62
SY MPI VI
RX PubMed=9013705;
CC Breed/subspecies: 129S2/SvPas.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Embryonic stem cell
//
ID mpiNSC
AC CVCL_GP99
SY mini-pig Neural Stem Cell line
RX PubMed=27524466;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
CC Breed/subspecies: Miniature pig.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Male
CA Transformed cell line
//
ID mPitA-1
AC CVCL_D464
SY mPitA1
RX PubMed=22132145;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: Cedarlane Cellutions Systems; Catalog number CLU401.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-1/1
AC CVCL_D465
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU413?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D464 ! mPitA-1
SX Female
CA Transformed cell line
//
ID mPitA-1/3
AC CVCL_D466
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU414?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D464 ! mPitA-1
SX Female
CA Transformed cell line
//
ID mPitA-1/4
AC CVCL_D467
WW https://www.cedarlanelabs.com/Products/Detail/CLU424?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D464 ! mPitA-1
SX Female
CA Transformed cell line
//
ID mPitA-1/5
AC CVCL_D468
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU415?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D464 ! mPitA-1
SX Female
CA Transformed cell line
//
ID mPitA-1/6
AC CVCL_D469
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU416?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D464 ! mPitA-1
SX Female
CA Transformed cell line
//
ID mPitA-1/8
AC CVCL_D470
WW https://www.cedarlanelabs.com/Products/Detail/CLU425?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D464 ! mPitA-1
SX Female
CA Transformed cell line
//
ID mPitA-10
AC CVCL_U361
SY mPitA10
RX PubMed=22132145;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-11
AC CVCL_U362
SY mPitA11
RX PubMed=22132145;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-12
AC CVCL_D471
SY mPitA12
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU408?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-12/3
AC CVCL_D472
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU420?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D471 ! mPitA-12
SX Female
CA Transformed cell line
//
ID mPitA-12/4
AC CVCL_D473
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU421?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D471 ! mPitA-12
SX Female
CA Transformed cell line
//
ID mPitA-12/5
AC CVCL_D474
WW https://www.cedarlanelabs.com/Products/Detail/CLU422?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D471 ! mPitA-12
SX Female
CA Transformed cell line
//
ID mPitA-12/6
AC CVCL_D475
WW https://www.cedarlanelabs.com/Products/Detail/CLU423?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D471 ! mPitA-12
SX Female
CA Transformed cell line
//
ID mPitA-13
AC CVCL_U360
SY mPitA13
RX PubMed=22132145;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-14
AC CVCL_D476
SY mPitA14
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU409?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-15
AC CVCL_D477
SY mPitA15
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU410?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-16
AC CVCL_D478
SY mPitA16
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU411?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-17
AC CVCL_U358
SY mPitA17
RX PubMed=22132145;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-18
AC CVCL_U359
SY mPitA18
RX PubMed=22132145;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-19
AC CVCL_D479
SY mPitA19
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU412?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-2
AC CVCL_D480
SY mPitA2
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU402?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-3
AC CVCL_D481
SY mPitA3
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU403?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-3/1
AC CVCL_D482
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU417?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D481 ! mPitA-3
SX Female
CA Transformed cell line
//
ID mPitA-3/2
AC CVCL_D483
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU418?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D481 ! mPitA-3
SX Female
CA Transformed cell line
//
ID mPitA-3/3
AC CVCL_D484
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU419?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_D481 ! mPitA-3
SX Female
CA Transformed cell line
//
ID mPitA-4
AC CVCL_D485
SY mPitA4
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU404?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-5
AC CVCL_D486
SY mPitA5
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU405?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-6
AC CVCL_D487
SY mPitA6
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU406?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-7
AC CVCL_U357
SY mPitA7
RX PubMed=22132145;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-8
AC CVCL_D488
SY mPitA8
RX PubMed=22132145;
WW https://www.cedarlanelabs.com/Products/Detail/CLU407?lob=Cellutions
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-9
AC CVCL_U356
SY mPitA9
RX PubMed=22132145;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID mPitA-POMC/GFP-1
AC CVCL_EP70
RX PubMed=24134870;
WW https://www.cedarlanelabs.com/Products/Detail/CLU504?lob=Cellutions
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID MPK
AC CVCL_3859
SY MiniPig Kidney
DR CLO; CLO_0007856
DR CLDB; cl3558
DR CLDB; cl3559
DR ATCC; CCL-166
DR ECACC; 87032604
DR IZSLER; BS CL 67
RX PubMed=19508353;
CC Breed/subspecies: Miniature pig.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Male
CA Spontaneously immortalized cell line
//
ID mpkCCD
AC CVCL_R771
RX PubMed=9636246;
RX PubMed=11158395;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mpkCCDc14
AC CVCL_F596
DR BTO; BTO:0002657
RX PubMed=10232677;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_R771 ! mpkCCD
CA Transformed cell line
//
ID mpkDCT
AC CVCL_R773
RX PubMed=11158395;
RX PubMed=14625201;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mpkIMCD
AC CVCL_R772
RX PubMed=11158395;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MPM1
AC CVCL_D527
RX PubMed=18383846;
DI NCIt; C45655; Sarcomatoid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MPM2
AC CVCL_D528
RX PubMed=18383846;
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MPM3
AC CVCL_D529
RX PubMed=18383846;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MPN3
AC CVCL_Z590
RX PubMed=15950500;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRNS-1].
CC Breed/subspecies: Minnesota miniature pig.
OX NCBI_TaxID=9823; ! Sus scrofa
CA Transformed cell line
//
ID MPNST-14
AC CVCL_AU21
RX PubMed=19890883;
CC Omics: Transcriptome analysis.
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MPNST-724
AC CVCL_AU20
SY MPNST724
RX PubMed=19890883;
RX PubMed=21084276;
RX PubMed=25878149;
CC Omics: Transcriptome analysis.
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MPNST-90
AC CVCL_J355
RX PubMed=19414372;
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J356 ! MPNST-91
OI CVCL_J357 ! MPNST-92
SX Female
CA Cancer cell line
//
ID MPNST-91
AC CVCL_J356
RX PubMed=19414372;
CC Derived from metastatic site: Right thigh.
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J355 ! MPNST-90
OI CVCL_J357 ! MPNST-92
SX Female
CA Cancer cell line
//
ID MPNST-92
AC CVCL_J357
RX PubMed=19414372;
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_J355 ! MPNST-90
OI CVCL_J356 ! MPNST-91
SX Female
CA Cancer cell line
//
ID MPNST642
AC CVCL_AU19
RX PubMed=21084276;
RX PubMed=25878149;
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MPP 89
AC CVCL_1427
SY MPP-89; MPP89
DR CLO; CLO_0007858
DR CLDB; cl5400
DR CCLE; MPP89_PLEURA
DR ChEMBL-Cells; CHEMBL3308241
DR ChEMBL-Targets; CHEMBL2366357
DR Cosmic; 908150
DR Cosmic; 1995512
DR Cosmic-CLP; 908150
DR GDSC; 908150
DR GEO; GSM887341
DR GEO; GSM888417
DR GEO; GSM1670132
DR ICLC; HTL00012
RX PubMed=10232421;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 8
ST TPOX: 8
ST vWA: 17
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MPRO Cell Line, Clone 2.1
AC CVCL_5430
DR CLO; CLO_0007859
DR ATCC; CRL-11422
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID MPS-KC-iPS 1
AC CVCL_C929
DR ISCR; 1828
RX PubMed=21037085;
CC From: University of Minnesota; USA.
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID MPS-KC-iPS 2
AC CVCL_C930
DR ISCR; 1829
RX PubMed=21037085;
CC From: University of Minnesota; USA.
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C931 ! MPS-MSC-iPS 2
SX Male
CA Induced pluripotent stem cell
//
ID MPS-MSC-iPS 2
AC CVCL_C931
DR ISCR; 1830
RX PubMed=21037085;
CC From: University of Minnesota; USA.
DI NCIt; C61261; Hurler syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C930 ! MPS-KC-iPS 2
SX Male
CA Induced pluripotent stem cell
//
ID MPSC1
AC CVCL_9822
SY MPSC 1
DR Cosmic; 906589
RX PubMed=15753399;
RX PubMed=23415752;
DI NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MPSII-1.3
AC CVCL_IJ23
RX PubMed=27789399;
CC From: BioTalentum, Ltd.
CC Characteristics: Hemizygous for the IDS p.Gln29Ter mutation.
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID MPSII-2.5
AC CVCL_IJ24
RX PubMed=27789398;
CC From: BioTalentum, Ltd.
CC Characteristics: Hemizygous for the IDS p.Gln29Ter mutation.
DI NCIt; C61260; Hunter syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID MPSII-mother.1
AC CVCL_IJ25
RX PubMed=27789401;
CC From: BioTalentum, Ltd.
CC Characteristics: Heterozygous for the IDS p.Gln29Ter mutation.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID MPT-1
AC CVCL_L367
RX PubMed=18086553;
DI NCIt; C129077; Canine mastocytoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID MQ-NCSU
AC CVCL_S483
RX PubMed=2176014;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).
CC Breed/subspecies: DeKalb XL.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Transformed cell line
//
ID MR 10.2
AC CVCL_D672
SY MR10-2
DR BCRJ; 0177
CC Discontinued: BCRJ; 0177; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID MR 12.4
AC CVCL_D673
SY MR12-4
DR BCRJ; 0178
CC Discontinued: BCRJ; 0178; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID MR 9.4
AC CVCL_D674
SY MR9-4
DR BCRJ; 0179
RX PubMed=1714479;
CC Discontinued: BCRJ; 0179; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID MR-87
AC CVCL_A655
DR Cosmic; 787460
DR Cosmic; 975279
DR Cosmic; 999768
RX PubMed=3048438;
DI NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MR-Mel
AC CVCL_7081
DR BTO; BTO:0003790
DR Cosmic; 1109799
RX PubMed=18384130;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MR1
AC CVCL_8964
DR CLO; CLO_0007861
DR ATCC; CRL-2580
DR ATCC; HB-11048
DR CCRID; 3131C0001000600053
RX Patent=US5683693;
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MR1-3
AC CVCL_U180
DR CLO; CLO_0050915
DR BioSample; SAMN03470994
DR Cosmic; 753593
DR RCB; RCB0504
RX PubMed=2372878;
RX PubMed=3608093;
CC Selected for resistance to: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 13.3
ST D16S539: 9,10
ST D18S51: 16
ST D19S433: 13,14
ST D21S11: 27,28
ST D2S1338: 17
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 8
ST D8S1179: 12
ST FGA: 21
ST Penta D: 8,15
ST Penta E: 7,16,17
ST TH01: 7
ST TPOX: 8,12
ST vWA: 15,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U209 ! HeLa S3 mer-
SX Female
CA Cancer cell line
//
ID MR10-1
AC CVCL_U181
DR CLO; CLO_0050917
DR RCB; RCB0507
RX PubMed=2372878;
RX PubMed=3163531;
RX PubMed=3608093;
CC Selected for resistance to: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8
ST TH01: 7
ST TPOX: 8,12
ST vWA: 15,18
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U209 ! HeLa S3 mer-
SX Female
CA Cancer cell line
//
ID MR11
AC CVCL_U182
RX PubMed=2372878;
CC Selected for resistance to: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U209 ! HeLa S3 mer-
SX Female
CA Cancer cell line
//
ID MR6
AC CVCL_U183
DR CLO; CLO_0050916
DR BioSample; SAMN03470988
DR BioSample; SAMN03472275
DR RCB; RCB0505
RX PubMed=2372878;
RX PubMed=3608093;
CC Selected for resistance to: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
ST Source(s): PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 13.3
ST D16S539: 9,10
ST D18S51: 16
ST D19S433: 13,14
ST D21S11: 27,28
ST D2S1338: 17
ST D3S1358: 15,18
ST D5S818: 11,12
ST D7S820: 8
ST D8S1179: 12
ST FGA: 21
ST Penta D: 8
ST Penta E: 7,16,17
ST TH01: 7 (PubMed=25877200)
ST TH01: 7,9.3 (RCB)
ST TPOX: 8,12
ST vWA: 15,18 (PubMed=25877200)
ST vWA: 15,16,18 (RCB)
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U209 ! HeLa S3 mer-
SX Female
CA Cancer cell line
//
ID MR8
AC CVCL_U184
RX PubMed=2372878;
CC Selected for resistance to: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U209 ! HeLa S3 mer-
SX Female
CA Cancer cell line
//
ID MRC-5
AC CVCL_0440
SY MRC5; MRC 5; MRCV; MRC-V; Medical Research Council cell strain-5
DR BTO; BTO:0001590
DR CLO; CLO_0007865
DR CLO; CLO_0050055
DR EFO; EFO_0002835
DR MCCL; MCC:0000336
DR CLDB; cl3563
DR CLDB; cl3564
DR CLDB; cl3566
DR CLDB; cl3567
DR CLDB; cl3568
DR CLDB; cl5168
DR ATCC; CCL-171
DR BCRC; 60023
DR BCRJ; 0180
DR BioSample; SAMN01821580
DR BioSample; SAMN01821702
DR BioSample; SAMN01821735
DR BioSample; SAMN03473183
DR CCRID; 3111C0001CCC000044
DR CCRID; 3111C0002000000002
DR CCRID; 3131C0001000200012
DR CCRID; 3142C0001000000032
DR CCRID; 3153C0001000000002
DR ChEMBL-Cells; CHEMBL3308499
DR ChEMBL-Targets; CHEMBL614181
DR CLS; 300395/NA
DR ECACC; 97112601
DR GEO; GSM248209
DR GEO; GSM248210
DR GEO; GSM579888
DR GEO; GSM579889
DR ICLC; HL95001
DR IFO; IFO50073
DR IZSLER; BS CL 68
DR JCRB; JCRB9008
DR KCB; KCB 89023YJ
DR KCB; KCB 200412YJ
DR KCLB; 10171
DR NCBI_Iran; C125
DR PRIDE; PXD001909
DR RCB; RCB0211
DR RCB; RCB0218
DR Wikidata; Q3273166
RX PubMed=1965304;
RX PubMed=4316953;
RX PubMed=7065527;
RX PubMed=10752125;
RX PubMed=19657000;
RX PubMed=25903999;
WW https://en.wikipedia.org/wiki/MRC-5
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=68
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/mrc5/mrc5cells.html
WW http://en.vircell.com/products/mrc-5-cell-line/
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-380.html
CC Group: Vaccine production cell line.
CC Biotechnology: Used for the production of the Human Diploid Cell Vaccine (HDCV) against Rabies (Trade name: Imovax Rabies).
CC Biotechnology: Used for the production of the Hepatitis A vaccines Havrix and Vaqta.
CC Biotechnology: Used for the production of the live zoster vaccine (Trade name: Zostavax).
CC Omics: Proteome analysis by 2D-DE.
CC Omics: Proteome analysis by 2D-DE/MS.
CC Omics: Transcriptome analysis.
CC Discontinued: CLS; 300395; true.
CC Discontinued: ECACC; 97112601; true.
ST Source(s): ATCC; JCRB; KCLB; PubMed=11416159; PubMed=25877200; RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9,11
ST D18S51: 15,21
ST D21S11: 31.2
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 21,23
ST Penta D: 12
ST Penta E: 12,16
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID MRC-5 CV1
AC CVCL_E260
SY MRC5-CV1; MRC5CV1
DR ChEMBL-Cells; CHEMBL3307319
DR ChEMBL-Targets; CHEMBL614182
RX PubMed=2903889;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Transformed cell line
//
ID MRC-5 pd13
AC CVCL_2621
DR ECACC; 05011802
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Finite cell line
//
ID MRC-5 pd19
AC CVCL_2622
DR ECACC; 05072101
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Finite cell line
//
ID MRC-5 pd25
AC CVCL_2623
DR ECACC; 05081101
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Finite cell line
//
ID MRC-5 pd30
AC CVCL_2624
DR ECACC; 05090501
DR ECACC; 84101801
CC Discontinued: ECACC; 84101801; true.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Finite cell line
//
ID MRC-5 PDL27
AC CVCL_H749
SY AG05965-C; AG05965C
DR CLO; CLO_0035205
DR Coriell; AG05965-C
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Finite cell line
//
ID MRC-5 PDL40
AC CVCL_H748
SY AG05965-D
DR CLO; CLO_0035211
DR Coriell; AG05965-D
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Finite cell line
//
ID MRC-5 PDL5.51
AC CVCL_8B13
SY AG05965-G
DR Coriell; AG05965-G
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Finite cell line
//
ID MRC-5 SV1 TG1
AC CVCL_2625
DR CLO; CLO_0007866
DR CLO; CLO_0050061
DR CLDB; cl3569
DR BioSample; SAMN03472345
DR ECACC; 85042501
DR RCB; RCB0207
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ECACC; RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,14
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Transformed cell line
//
ID MRC-5 SV1 TG2
AC CVCL_2626
DR CLO; CLO_0007867
DR CLDB; cl3570
DR ECACC; 85042502
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Transformed cell line
//
ID MRC-5-30
AC CVCL_3027
DR JCRB; JCRB0521
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Finite cell line
//
ID MRC-5-40
AC CVCL_3028
DR JCRB; JCRB0522
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Finite cell line
//
ID MRC-5-50
AC CVCL_3029
DR JCRB; JCRB0523
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Finite cell line
//
ID MRC-5V1
AC CVCL_D690
SY MRC5-V1; MRC5V1
DR BTO; BTO:0005066
RX PubMed=2821020;
RX PubMed=6313714;
RX PubMed=21528266;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Transformed cell line
//
ID MRC-5V2
AC CVCL_2627
SY MRC-5 V2; MRC5V2; MRC-5 SV2; MRC-5-SV2
DR CLO; CLO_0007868
DR CLDB; cl3571
DR ECACC; 84100401
RX PubMed=1965304;
RX PubMed=6313714;
RX PubMed=21528266;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Proteome analysis by 2D-DE.
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Transformed cell line
//
ID MRC-7
AC CVCL_2628
SY MRC7; Medical Research Council cell strain-7
DR CLO; CLO_0007869
DR CLDB; cl3572
DR ECACC; 85020203
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Finite cell line
//
ID MRC-9
AC CVCL_2629
SY MRC9; Medical Research Council cell strain-9
DR CLO; CLO_0007870
DR CLDB; cl3573
DR ATCC; CCL-212
DR BioSample; SAMN01821581
DR BioSample; SAMN01821703
DR BioSample; SAMN01821736
DR BioSample; SAMN03471472
DR ECACC; 85020202
DR IFO; IFO50072
DR JCRB; JCRB9060
DR KCLB; 10212
RX PubMed=113411;
RX PubMed=7065527;
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=69
CC Characteristics: Can undergo at least 40 PDL.
CC Discontinued: KCLB; 10212; probable.
ST Source(s): ATCC; ECACC; JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 6,8
ST TPOX: 11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID MRC-9-30
AC CVCL_3030
DR JCRB; JCRB0524
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2629 ! MRC-9
SX Female
CA Finite cell line
//
ID MRC-iPS-1
AC CVCL_D923
SY Bubba; MRC-iPS-01
DR SKIP; SKIP000414
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-10
AC CVCL_D924
SY Snip
DR SKIP; SKIP000423
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-100
AC CVCL_D925
SY Flip
DR SKIP; SKIP000512
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-101
AC CVCL_D926
SY Cue ball
DR SKIP; SKIP000513
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-11
AC CVCL_8343
SY Dotcom
DR JCRB; JCRB1327
DR JCRB; NIHS0598
DR SKIP; SKIP000009
DR SKIP; SKIP000351
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: JCRB; NIHS0598; true.
CC Discontinued: SKIP; SKIP000009; probable.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-12
AC CVCL_D927
SY Marbles
DR SKIP; SKIP000424
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-13
AC CVCL_D928
SY Sunspot
DR SKIP; SKIP000425
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-14
AC CVCL_D929
SY Nickels
DR SKIP; SKIP000426
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-15
AC CVCL_D930
SY Hotdog
DR SKIP; SKIP000427
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-16
AC CVCL_D931
SY Fetch
DR JCRB; NIHS0604
DR SKIP; SKIP000015
DR SKIP; SKIP000428
RX PubMed=21155951;
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000015; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-17
AC CVCL_D932
SY Cinders
DR SKIP; SKIP000429
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-18
AC CVCL_8367
SY Lollipop
DR JCRB; JCRB1336
DR JCRB; NIHS0605
DR SKIP; SKIP000012
DR SKIP; SKIP000430
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: JCRB; NIHS0605; true.
CC Discontinued: SKIP; SKIP000012; probable.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-19
AC CVCL_D933
SY Scout
DR SKIP; SKIP000168
DR SKIP; SKIP000431
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000168; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-2
AC CVCL_D934
SY Seargent; MRC-iPS-02
DR SKIP; SKIP000161
DR SKIP; SKIP000415
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000161; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-20
AC CVCL_D935
SY Domino
DR SKIP; SKIP000432
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-21
AC CVCL_D936
SY Gobstopper
DR SKIP; SKIP000433
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-22
AC CVCL_8426
SY Squeaky
DR JCRB; JCRB1329
DR JCRB; NIHS0599
DR SKIP; SKIP000010
DR SKIP; SKIP000434
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: JCRB; NIHS0599; true.
CC Discontinued: SKIP; SKIP000010; probable.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-23
AC CVCL_D937
SY Buttons
DR SKIP; SKIP000435
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-24
AC CVCL_D938
SY Cotton ball
DR SKIP; SKIP000436
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-25
AC CVCL_8433
SY Tic
DR JCRB; JCRB1331
DR JCRB; NIHS0606
DR SKIP; SKIP000008
DR SKIP; SKIP000437
RX PubMed=21155951;
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: JCRB; NIHS0606; true.
CC Discontinued: SKIP; SKIP000008; probable.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-26
AC CVCL_D939
SY Tac
DR SKIP; SKIP000438
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-27
AC CVCL_8434
SY Toe
DR JCRB; JCRB1338
DR JCRB; NIHS0607
DR SKIP; SKIP000011
DR SKIP; SKIP000439
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: JCRB; NIHS0607; true.
CC Discontinued: SKIP; SKIP000011; probable.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-28
AC CVCL_D940
SY Junior
DR SKIP; SKIP000440
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-29
AC CVCL_D941
SY Jake
DR SKIP; SKIP000441
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-3
AC CVCL_D942
SY Chew; MRC-iPS-03
DR SKIP; SKIP000416
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-30
AC CVCL_D943
SY Speckles
DR SKIP; SKIP000167
DR SKIP; SKIP000442
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000167; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-31
AC CVCL_D944
SY Ears
DR SKIP; SKIP000443
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-32
AC CVCL_D945
SY Bob
DR SKIP; SKIP000444
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-33
AC CVCL_D946
SY Alameda
DR SKIP; SKIP000445
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-34
AC CVCL_D947
SY Nipper
DR SKIP; SKIP000164
DR SKIP; SKIP000446
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000164; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-35
AC CVCL_D948
SY Oddball
DR SKIP; SKIP000447
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-36
AC CVCL_D949
SY Tippy
DR SKIP; SKIP000448
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-37
AC CVCL_D950
SY Jersey
DR SKIP; SKIP000449
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-38
AC CVCL_D951
SY Twister
DR SKIP; SKIP000450
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-39
AC CVCL_D952
SY Badger
DR SKIP; SKIP000451
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-4
AC CVCL_D953
SY Bones; MRC-iPS-04
DR SKIP; SKIP000417
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-40
AC CVCL_D954
SY Skipper
DR JCRB; NIHS0600
DR SKIP; SKIP000013
DR SKIP; SKIP000452
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000013; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-41
AC CVCL_D955
SY Snowball
DR SKIP; SKIP000453
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-42
AC CVCL_D956
SY Ellipses
DR SKIP; SKIP000454
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-43
AC CVCL_D957
SY Pepper
DR SKIP; SKIP000166
DR SKIP; SKIP000455
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000166; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-44
AC CVCL_D958
SY Pinwheel
DR SKIP; SKIP000456
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-45
AC CVCL_D959
SY Jimmies
DR SKIP; SKIP000457
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-46
AC CVCL_D960
SY Buddy
DR SKIP; SKIP000458
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-47
AC CVCL_D961
SY Stripes
DR SKIP; SKIP000459
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-48
AC CVCL_D962
SY Ralph
DR SKIP; SKIP000460
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-49
AC CVCL_D963
SY Nugget
DR SKIP; SKIP000461
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-5
AC CVCL_D964
SY Princess; MRC-iPS-05
DR SKIP; SKIP000418
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-50
AC CVCL_D965
SY Fang
DR SKIP; SKIP000462
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-51
AC CVCL_D966
SY Windy
DR SKIP; SKIP000162
DR SKIP; SKIP000463
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000162; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-52
AC CVCL_D967
SY Chester
DR SKIP; SKIP000464
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-53
AC CVCL_D968
SY Smoky
DR SKIP; SKIP000465
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-54
AC CVCL_D969
SY Chief
DR SKIP; SKIP000466
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-55
AC CVCL_D970
SY Soho
DR SKIP; SKIP000467
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-56
AC CVCL_D971
SY Drifter
DR SKIP; SKIP000163
DR SKIP; SKIP000468
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000163; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-57
AC CVCL_D972
SY Rufus
DR SKIP; SKIP000469
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-58
AC CVCL_D973
SY Peeve
DR SKIP; SKIP000470
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-59
AC CVCL_D974
SY Moose
DR SKIP; SKIP000471
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-6
AC CVCL_D975
SY Freckles; MRC-iPS-06
DR SKIP; SKIP000419
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-60
AC CVCL_D976
SY Cosmo
DR SKIP; SKIP000472
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-61
AC CVCL_D977
SY Grinder
DR SKIP; SKIP000473
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-62
AC CVCL_D978
SY Gideon
DR SKIP; SKIP000474
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-63
AC CVCL_D979
SY Snicker
DR SKIP; SKIP000475
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-64
AC CVCL_D980
SY Chance
DR SKIP; SKIP000476
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-65
AC CVCL_D981
SY Squirrel
DR SKIP; SKIP000165
DR SKIP; SKIP000477
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000165; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-66
AC CVCL_D982
SY Tug
DR SKIP; SKIP000478
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-67
AC CVCL_D983
SY Badges
DR SKIP; SKIP000479
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-68
AC CVCL_D984
SY Blunder
DR SKIP; SKIP000480
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-69
AC CVCL_D985
SY Little dipper
DR SKIP; SKIP000481
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-7
AC CVCL_D986
SY Eight ball; MRC-iPS-07
DR SKIP; SKIP000420
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-70
AC CVCL_D987
SY Zephyr
DR SKIP; SKIP000482
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-71
AC CVCL_D988
SY Chase
DR SKIP; SKIP000483
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-72
AC CVCL_D989
SY Bongo
DR SKIP; SKIP000484
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-73
AC CVCL_D990
SY Soccer
DR SKIP; SKIP000485
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-74
AC CVCL_D991
SY Sparky
DR SKIP; SKIP000486
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-75
AC CVCL_D992
SY Wags
DR JCRB; NIHS0601
DR SKIP; SKIP000014
DR SKIP; SKIP000487
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000014; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-76
AC CVCL_D993
SY Smudge
DR SKIP; SKIP000488
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-77
AC CVCL_D994
SY Bootsie
DR SKIP; SKIP000160
DR SKIP; SKIP000489
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000160; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-78
AC CVCL_D995
SY Bogey
DR SKIP; SKIP000490
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-79
AC CVCL_D996
SY Otto
DR SKIP; SKIP000491
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-8
AC CVCL_D997
SY Orion; MRC-iPS-08
DR SKIP; SKIP000421
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-80
AC CVCL_D998
SY Hydrant
DR SKIP; SKIP000492
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-81
AC CVCL_D999
SY Ashes
DR SKIP; SKIP000493
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-82
AC CVCL_E000
SY Typhoon
DR SKIP; SKIP000496
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-83
AC CVCL_E001
SY Snake eyes
DR SKIP; SKIP000494
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-84
AC CVCL_E002
SY Whirlwind
DR SKIP; SKIP000495
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-85
AC CVCL_E003
SY Bluster
DR SKIP; SKIP000157
DR SKIP; SKIP000497
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000157; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-86
AC CVCL_E004
SY Diggity
DR SKIP; SKIP000498
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-87
AC CVCL_E005
SY Scamper
DR SKIP; SKIP000499
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-88
AC CVCL_E006
SY Toffee
DR SKIP; SKIP000158
DR SKIP; SKIP000500
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000158; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-89
AC CVCL_E007
SY Gumball
DR SKIP; SKIP000159
DR SKIP; SKIP000501
RX PubMed=21155951;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000159; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-9
AC CVCL_E008
SY Full stop; MRC-iPS-09
DR SKIP; SKIP000422
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-90
AC CVCL_E009
SY Big dipper
DR SKIP; SKIP000502
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-91
AC CVCL_E010
SY Polka
DR JCRB; NIHS0608
DR SKIP; SKIP000016
DR SKIP; SKIP000503
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC Discontinued: SKIP; SKIP000016; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-92
AC CVCL_E011
SY Chocolate chip
DR SKIP; SKIP000504
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-93
AC CVCL_E012
SY Patches
DR SKIP; SKIP000505
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-94
AC CVCL_E013
SY Dab
DR SKIP; SKIP000506
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-95
AC CVCL_E014
SY Inky
DR SKIP; SKIP000511
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-96
AC CVCL_E015
SY Rorschach
DR SKIP; SKIP000507
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-97
AC CVCL_E016
SY Splatter
DR SKIP; SKIP000508
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-98
AC CVCL_E017
SY Fisher
DR SKIP; SKIP000509
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC-iPS-99
AC CVCL_E018
SY Spindle
DR SKIP; SKIP000510
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC5-iPS12
AC CVCL_C975
SY MRC5-IPS12
DR ISCR; 32
RX PubMed=18157115;
CC From: Children's Hospital Boston; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC5-iPS17
AC CVCL_C974
DR ISCR; 31
RX PubMed=18157115;
CC From: Children's Hospital Boston; Boston; USA.
CC Misspelling: 'MRC5-IPS7' in ISCR 31.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC5-iPS2
AC CVCL_V234
SY MRC5_iPS2
DR GEO; GSM248211
DR GEO; GSM248212
DR GEO; GSM579896
DR GEO; GSM579897
RX PubMed=18157115;
CC From: Children's Hospital Boston; Boston; USA.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC5-RiPS-1.11
AC CVCL_C976
SY MRC5_RiPS_1.11
DR GEO; GSM579915
DR ISCR; 1768
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC5-RiPS-1.2
AC CVCL_C977
DR ISCR; 1769
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC5-RiPS-1.3
AC CVCL_C978
DR ISCR; 1770
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC5-RiPS-1.8
AC CVCL_C979
SY MRC5_RiPS_1.8
DR GEO; GSM579913
DR ISCR; 1771
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRC5-RiPS-1.9
AC CVCL_C980
SY MRC5_RiPS_1.9
DR GEO; GSM579914
DR ISCR; 1772
RX PubMed=20888316;
CC From: Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0440 ! MRC-5
SX Male
CA Induced pluripotent stem cell
//
ID MRCC
AC CVCL_U325
SY HiMet-ccRC
RX Patent=CN101508972A;
RX PubMed=23442546;
RX PubMed=27993170;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C200909.
CC Doubling time: 55.2 hours (PubMed=23442546).
CC Derived from metastatic site: Spine.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID mRG1
AC CVCL_HC53
SY mRG1-1
RX PubMed=9040006;
WW https://www.kerafast.com/product/2816/fcri-cd64-expressing-cho-cell-line-mrg1
CC Transfected with: MGI; MGI:95498; Fcgr1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID MRHF
AC CVCL_H691
DR ChEMBL-Cells; CHEMBL3308589
DR ChEMBL-Targets; CHEMBL614496
CC From: Biowhittaker (Walkersville, MD) which is now part of Lonza.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID MRK-90
AC CVCL_W334
RX PubMed=8641715;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9548; ! Macaca radiata
CA Spontaneously immortalized cell line
//
ID MRK-nu-1
AC CVCL_1428
SY MRK-NU-1
DR BTO; BTO:0003679
DR BioSample; SAMN03471641
DR ChEMBL-Cells; CHEMBL3308550
DR ChEMBL-Targets; CHEMBL2366325
DR Cosmic; 908151
DR Cosmic-CLP; 908151
DR GDSC; 908151
DR GEO; GSM827236
DR GEO; GSM1670133
DR JCRB; JCRB0628
RX CelloPub=CLPUB00083;
RX PubMed=9290701;
RX PubMed=27397505;
CC Doubling time: ~47 hours (JCRB).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 9,10
ST D13S317: 8
ST D16S539: 10
ST D5S818: 13
ST D7S820: 8,10
ST TH01: 6,9
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MRL104.8a
AC CVCL_6781
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MRL104.8a
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID MRMT-1
AC CVCL_5156
DR CLO; CLO_0051603
DR RCB; RCB2860
DR TKG; TKG 0132
RX PubMed=1247997;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID MRN-1
AC CVCL_5626
SY MRN1
DR BTO; BTO:0002945
RX PubMed=1701342;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MRO
AC CVCL_6310
SY MRO-87-1; MRO 87-1; MRO-87; MRO87-1; MRO87; RO 87-M-1
DR BioSample; SAMN03151794
DR Cosmic; 886553
RX PubMed=18713817;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817, PubMed=20143388).
ST Source(s): PubMed=18713817
ST Amelogenin: X
ST D13S317: 11
ST D18S51: 12,13
ST D21S11: 30
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 10,16
ST FGA: 20,22
ST vWA: 17,19
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID mRPE
AC CVCL_GQ00
SY mouse Retinal Pigmented Epithelium cell line
RX PubMed=27554602;
CC Breed/subspecies: NMRI.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID MRRL-CH1
AC CVCL_Z389
SY MRRL-CH-1; MRRL-CH 1; MRRL-CH; CH; CH I; CM-1
DR ChEMBL-Cells; CHEMBL3307320
DR ChEMBL-Targets; CHEMBL614183
RX PubMed=1201855;
RX PubMed=1367489;
RX PubMed=16346059;
RX PubMed=16593348;
CC Group: Insect cell line.
OX NCBI_TaxID=7130; ! Manduca sexta
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID MRRL-CH2
AC CVCL_Z390
SY CH'; CH II
RX PubMed=1201855;
CC Group: Insect cell line.
OX NCBI_TaxID=7130; ! Manduca sexta
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID MRSS-1
AC CVCL_2630
SY D2D4
DR CLO; CLO_0007871
DR CLO; CLO_0007872
DR CLDB; cl5234
DR ATCC; HB-69
DR IZSLER; BS Hy 11
RX PubMed=6157395;
CC Monoclonal antibody target: ChEBI; CHEBI:9160; Single-stranded DNA.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MRSV2-1
AC CVCL_8647
SY MRSV-2.1
RX PubMed=1708884;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MRSV2-4
AC CVCL_8646
SY MRSV-2.4
RX PubMed=1708884;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MRT-1
AC CVCL_W491
RX PubMed=7669747;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MS
AC CVCL_4243
SY Monkey Stable
DR CLO; CLO_0007874
DR CLDB; cl3589
DR CLDB; cl3590
DR BioSample; SAMN03151745
DR ECACC; 91070510
DR IZSLER; BS CL 98
RX PubMed=14505435;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of Chlorocebus aethiops origin but found to be a human HeLa derivative (PubMed=14505435, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID MS-1 [Human lung carcinoma]
AC CVCL_1429
AS CVCL_3031
SY MS-1-L; MS1; Ms1
DR CLO; CLO_0050048
DR EFO; EFO_0002836
DR BioSample; SAMN03470995
DR ChEMBL-Cells; CHEMBL3308892
DR ChEMBL-Targets; CHEMBL2366125
DR Cosmic; 753594
DR Cosmic; 1212198
DR Cosmic; 1571744
DR Cosmic; 1656910
DR Cosmic-CLP; 753594
DR GDSC; 753594
DR GEO; GSM17311
DR GEO; GSM827217
DR GEO; GSM1670134
DR JCRB; JCRB1081
DR JCRB; NIHS0320
DR JCRB; NIHS0353
DR RCB; RCB0725
RX CelloPub=CLPUB00084;
RX PubMed=15016488;
RX PubMed=22313637;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: JCRB; NIHS0320; true.
CC Discontinued: JCRB; NIHS0353; true.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 9,12
ST D16S539: 9,11
ST D18S51: 13,17
ST D19S433: 14
ST D21S11: 29,30
ST D2S1338: 23,25
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 11
ST D8S1179: 15
ST FGA: 22,25
ST Penta D: 10
ST Penta E: 17,18
ST TH01: 8,9.3
ST TPOX: 8
ST vWA: 14,19
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MS-1 [Human Merkel cell carcinoma]
AC CVCL_E995
DR ECACC; 09111802
DR NIH-ARP; 11714-321
RX PubMed=20444890;
RX PubMed=23085629;
CC Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.
CC Derived from metastatic site: Adrenal gland.
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,14
ST D16S539: 9
ST D5S818: 11
ST D7S820: 8,9
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C9231; Merkel cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MS-1 [Human mesothelioma]
AC CVCL_E993
DR Cosmic; 1995513
RX PubMed=2457437;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MS-1 [Mouse]
AC CVCL_D134
RX PubMed=2783573;
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: C3H/HeNSlc.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID Ms-1
AC CVCL_IQ55
RX PubMed=9393586;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ms-11
AC CVCL_IQ49
RX PubMed=9393586;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ms-13
AC CVCL_IQ50
RX PubMed=9393586;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ms-16
AC CVCL_IQ51
RX PubMed=9393586;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MS-2
AC CVCL_E992
RX PubMed=2457437;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ms-2
AC CVCL_IQ54
RX PubMed=9393586;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ms-3
AC CVCL_IQ53
RX PubMed=9393586;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MS-5
AC CVCL_2128
DR CLO; CLO_0007877
DR DSMZ; ACC-441
RX PubMed=2783573;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MS-5
CC Doubling time: ~50 hours (DSMZ).
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: C3H/HeNSlc.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID MS-653-A
AC CVCL_5558
DR JCRB; JCRB1001.1
CC Breed/subspecies: Donryu.
DI NCIt; C60403; Rat fibrosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID MS-653-G
AC CVCL_5559
DR JCRB; JCRB1001.2
CC Breed/subspecies: Donryu.
DI NCIt; C60403; Rat fibrosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5558 ! MS-653-A
CA Cancer cell line
//
ID Ms-8
AC CVCL_IQ52
RX PubMed=9393586;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MS-BR
AC CVCL_X030
SY Monk Seal BRain
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X031 ! MS-EY
OI CVCL_X032 ! MS-HT
OI CVCL_X033 ! MS-KD
OI CVCL_X034 ! MS-LG
OI CVCL_X035 ! MS-LV
OI CVCL_X036 ! MS-SK
OI CVCL_X037 ! MS-SN
OI CVCL_X038 ! MS-SP
OI CVCL_X039 ! MS-TY
OI CVCL_X040 ! MS-UB
CA Finite cell line
//
ID MS-EY
AC CVCL_X031
SY Monk Seal EYe-around soft tissue
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X030 ! MS-BR
OI CVCL_X032 ! MS-HT
OI CVCL_X033 ! MS-KD
OI CVCL_X034 ! MS-LG
OI CVCL_X035 ! MS-LV
OI CVCL_X036 ! MS-SK
OI CVCL_X037 ! MS-SN
OI CVCL_X038 ! MS-SP
OI CVCL_X039 ! MS-TY
OI CVCL_X040 ! MS-UB
CA Finite cell line
//
ID MS-HT
AC CVCL_X032
SY Monk Seal HearT
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X030 ! MS-BR
OI CVCL_X031 ! MS-EY
OI CVCL_X033 ! MS-KD
OI CVCL_X034 ! MS-LG
OI CVCL_X035 ! MS-LV
OI CVCL_X036 ! MS-SK
OI CVCL_X037 ! MS-SN
OI CVCL_X038 ! MS-SP
OI CVCL_X039 ! MS-TY
OI CVCL_X040 ! MS-UB
CA Finite cell line
//
ID MS-KD
AC CVCL_X033
SY Monk Seal KiDney
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X030 ! MS-BR
OI CVCL_X031 ! MS-EY
OI CVCL_X032 ! MS-HT
OI CVCL_X034 ! MS-LG
OI CVCL_X035 ! MS-LV
OI CVCL_X036 ! MS-SK
OI CVCL_X037 ! MS-SN
OI CVCL_X038 ! MS-SP
OI CVCL_X039 ! MS-TY
OI CVCL_X040 ! MS-UB
CA Finite cell line
//
ID MS-LG
AC CVCL_X034
SY Monk Seal LunG
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X030 ! MS-BR
OI CVCL_X031 ! MS-EY
OI CVCL_X032 ! MS-HT
OI CVCL_X033 ! MS-KD
OI CVCL_X035 ! MS-LV
OI CVCL_X036 ! MS-SK
OI CVCL_X037 ! MS-SN
OI CVCL_X038 ! MS-SP
OI CVCL_X039 ! MS-TY
OI CVCL_X040 ! MS-UB
CA Finite cell line
//
ID MS-LV
AC CVCL_X035
SY Monk Seal LiVer
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X030 ! MS-BR
OI CVCL_X031 ! MS-EY
OI CVCL_X032 ! MS-HT
OI CVCL_X033 ! MS-KD
OI CVCL_X034 ! MS-LG
OI CVCL_X036 ! MS-SK
OI CVCL_X037 ! MS-SN
OI CVCL_X038 ! MS-SP
OI CVCL_X039 ! MS-TY
OI CVCL_X040 ! MS-UB
CA Finite cell line
//
ID MS-SK
AC CVCL_X036
SY Monk Seal SKin
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X030 ! MS-BR
OI CVCL_X031 ! MS-EY
OI CVCL_X032 ! MS-HT
OI CVCL_X033 ! MS-KD
OI CVCL_X034 ! MS-LG
OI CVCL_X035 ! MS-LV
OI CVCL_X037 ! MS-SN
OI CVCL_X038 ! MS-SP
OI CVCL_X039 ! MS-TY
OI CVCL_X040 ! MS-UB
CA Finite cell line
//
ID MS-SN
AC CVCL_X037
SY Monk Seal SNout
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X030 ! MS-BR
OI CVCL_X031 ! MS-EY
OI CVCL_X032 ! MS-HT
OI CVCL_X033 ! MS-KD
OI CVCL_X034 ! MS-LG
OI CVCL_X035 ! MS-LV
OI CVCL_X036 ! MS-SK
OI CVCL_X038 ! MS-SP
OI CVCL_X039 ! MS-TY
OI CVCL_X040 ! MS-UB
CA Finite cell line
//
ID MS-SP
AC CVCL_X038
SY Monk Seal SPleen
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X030 ! MS-BR
OI CVCL_X031 ! MS-EY
OI CVCL_X032 ! MS-HT
OI CVCL_X033 ! MS-KD
OI CVCL_X034 ! MS-LG
OI CVCL_X035 ! MS-LV
OI CVCL_X036 ! MS-SK
OI CVCL_X037 ! MS-SN
OI CVCL_X039 ! MS-TY
OI CVCL_X040 ! MS-UB
CA Finite cell line
//
ID MS-TY
AC CVCL_X039
SY Monk Seal ThYroid
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X030 ! MS-BR
OI CVCL_X031 ! MS-EY
OI CVCL_X032 ! MS-HT
OI CVCL_X033 ! MS-KD
OI CVCL_X034 ! MS-LG
OI CVCL_X035 ! MS-LV
OI CVCL_X036 ! MS-SK
OI CVCL_X037 ! MS-SN
OI CVCL_X038 ! MS-SP
OI CVCL_X040 ! MS-UB
CA Finite cell line
//
ID MS-UB
AC CVCL_X040
SY Monk Seal Urinary Bladder
RX PubMed=11264961;
OX NCBI_TaxID=29088; ! Monachus schauinslandi
OI CVCL_X030 ! MS-BR
OI CVCL_X031 ! MS-EY
OI CVCL_X032 ! MS-HT
OI CVCL_X033 ! MS-KD
OI CVCL_X034 ! MS-LG
OI CVCL_X035 ! MS-LV
OI CVCL_X036 ! MS-SK
OI CVCL_X037 ! MS-SN
OI CVCL_X038 ! MS-SP
OI CVCL_X039 ! MS-TY
CA Finite cell line
//
ID MS0010
AC CVCL_8Y20
DR ECACC; 03080863
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MS0011
AC CVCL_8Y21
DR ECACC; 03080864
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MS0812
AC CVCL_IK99
RX PubMed=19724881;
CC Doubling time: ~24 hours (PubMed=19724881).
DI NCIt; C6476; Dedifferentiated chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MS1
AC CVCL_6502
SY MILE SVEN 1; Mile Sven 1; MILE SVEN1
DR CLO; CLO_0007875
DR ATCC; CRL-2279
DR BCRC; 60150
RX PubMed=9023347;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-126.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MS1 mAKT
AC CVCL_0F28
DR ATCC; CRL-2878
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-2878; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6502 ! MS1
CA Transformed cell line
//
ID MS1 VEGF
AC CVCL_6503
DR CLO; CLO_0007876
DR ATCC; CRL-2460
DR BCRC; 60369
DR JCRB; NIHS0321
RX PubMed=10751370;
CC Transfected with: HGNC; 12680; VEGFA.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: JCRB; NIHS0321; true.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6502 ! MS1
CA Transformed cell line
//
ID MS115
AC CVCL_N705
RX PubMed=6243721;
RX PubMed=6243722;
RX PubMed=6265077;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MS18
AC CVCL_9823
SY Ms18; MS-18
DR Cosmic; 801619
DR Cosmic; 844824
DR Cosmic; 876154
DR Cosmic; 918018
DR Cosmic; 1239932
DR Cosmic; 2125279
RX PubMed=11005564;
RX PubMed=19472407;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MS257
AC CVCL_9834
CC From: Fletcher J.A.; Department of Pathology; Brigham and Women's Hospital; Harvard Medical School; Boston; USA.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MS4
AC CVCL_IW02
RX PubMed=21272942;
CC Transformant: NCBI_TaxID; 11768; Feline leukemia virus.
CC Breed/subspecies: Abyssinian.
OX NCBI_TaxID=9685; ! Felis catus
SX Male
CA Cancer cell line
//
ID MS428
AC CVCL_9835
DR EFO; EFO_0002837
RX PubMed=15920167;
CC From: Fletcher J.A.; Department of Pathology; Brigham and Women's Hospital; Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C45655; Sarcomatoid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MS589
AC CVCL_9836
DR EFO; EFO_0002838
RX PubMed=15920167;
CC From: Fletcher J.A.; Department of Pathology; Brigham and Women's Hospital; Harvard Medical School; Boston; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MS751
AC CVCL_4996
SY MS-751; MS 751
DR CLO; CLO_0007878
DR EFO; EFO_0006456
DR ATCC; HTB-34
DR BioSample; SAMN03472742
DR BioSample; SAMN03473089
DR Cosmic; 928910
DR Cosmic; 1071904
DR Cosmic; 1131523
DR Cosmic; 1176606
DR Cosmic; 1193034
DR Cosmic; 1201772
DR Cosmic; 1995514
DR Cosmic-CLP; 1240179
DR GDSC; 1240179
DR GEO; GSM113865
DR GEO; GSM253301
DR GEO; GSM675737
DR GEO; GSM685439
DR GEO; GSM1670135
DR IGRhCellID; MS751
RX PubMed=327080;
RX PubMed=2990217;
RX PubMed=6935474;
RX PubMed=7459858;
RX PubMed=9049418;
RX PubMed=15531914;
RX PubMed=25485619;
RX PubMed=27397505;
CC Characteristics: Contains a partial HPV45 genome.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): ATCC; Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12 (ATCC; Cosmic-CLP)
ST CSF1PO: 11 (PubMed=25877200)
ST D13S317: 12
ST D16S539: 11
ST D18S51: 12
ST D19S433: 16
ST D21S11: 29,30
ST D2S1338: 22
ST D3S1358: 19
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 14
ST FGA: 20
ST Penta D: 9
ST Penta E: 12
ST TH01: 6
ST TPOX: 8
ST vWA: 16
DI NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MS924
AC CVCL_9833
CC From: Fletcher J.A.; Department of Pathology; Brigham and Women's Hospital; Harvard Medical School; Boston; USA.
DI NCIt; C7985; Epithelioid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MSC 80
AC CVCL_S187
SY MSC-80; MSC80; Mouse Schwann Cell line 80
DR PRIDE; PXD000589
RX Patent=US7001767;
RX PubMed=1629940;
RX PubMed=11836421;
RX PubMed=25894527;
CC Characteristics: Can be infected in vitro with mouse scapie prion (PrPSc) and will continue to produce PrPSc after 18 passages and is able to transmit the prion disease to mice.
CC Doubling time: 17 hours (PubMed=1629940).
CC Omics: Cell surface proteome.
CC Breed/subspecies: C57BL/6 x DBA/2.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID MSC-1
AC CVCL_U446
RX PubMed=1331774;
RX PubMed=7918865;
RX PubMed=15541572;
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID MSC-iPS(fetal)#1
AC CVCL_9U81
RX PubMed=27345797;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9U82 ! MSC-iPS(fetal)#2
SX Female
CA Induced pluripotent stem cell
//
ID MSC-iPS(fetal)#2
AC CVCL_9U82
RX PubMed=27345797;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9U81 ! MSC-iPS(fetal)#1
SX Female
CA Induced pluripotent stem cell
//
ID MSC-iPS1
AC CVCL_C961
SY MSC-IPS1
DR ISCR; 33
RX PubMed=18157115;
CC From: Children's Hospital Boston; Boston; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID MSC-iPSC 74
AC CVCL_9S78
RX PubMed=26987921;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID MSC-P5
AC CVCL_5843
SY MSCP 5; MSCP-5; MSCP5
DR CLS; 400294/p2677_MSC-P5
OX NCBI_TaxID=10090; ! Mus musculus
CA Undefined cell line type
//
ID MSCB9
AC CVCL_9T03
SY MSC B9; B9; Mesenchymal Stem Cells clone B9
RX PubMed=17062733;
WW http://discovery.lifemapsc.com/stem-cell-differentiation/in-vitro-cells/bone-mus-musculus-bone-marrow-derived-mesenchymal-stem-cell-line-mscb9-university-of-texas-southwestern-medical-center
CC Breed/subspecies: Rosa26-lacZ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID MSCB9-Pax3
AC CVCL_9T04
RX PubMed=19460366;
CC Transfected with: MGI; MGI:97487; Pax3.
CC Breed/subspecies: Rosa26-lacZ.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9T03 ! MSCB9
SX Male
CA Spontaneously immortalized cell line
//
ID MSCFSHR-1
AC CVCL_U447
RX PubMed=9705082;
RX PubMed=15541572;
CC Transfected with: RGD; 2632; Fshr.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_U446 ! MSC-1
SX Male
CA Transformed cell line
//
ID mSDU-hES1
AC CVCL_C818
SY mSDU-hES 1
DR ISCR; 1670
RX PubMed=19941346;
CC From: Provincial Hospital Affiliated to Shandong University; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID mSDU-hES2
AC CVCL_C819
SY mSDU-hES 2
DR ISCR; 1671
RX PubMed=19941346;
CC From: Provincial Hospital Affiliated to Shandong University; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID mSDU-hES3
AC CVCL_C820
SY mSDU-hES 3
DR ISCR; 1672
RX PubMed=19941346;
CC From: Provincial Hospital Affiliated to Shandong University; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID mSDU-hES4
AC CVCL_C821
SY mSDU-hES 4
DR ISCR; 1673
RX PubMed=19941346;
CC From: Provincial Hospital Affiliated to Shandong University; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID mSDU-hES5
AC CVCL_C822
SY mSDU-hES 5
DR ISCR; 1674
RX PubMed=19941346;
CC From: Provincial Hospital Affiliated to Shandong University; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID mSDU-hES6
AC CVCL_C823
SY mSDU-hES 6
DR ISCR; 1675
RX PubMed=19941346;
CC From: Provincial Hospital Affiliated to Shandong University; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID mSDU-hES7
AC CVCL_C824
SY mSDU-hES 7
DR ISCR; 1676
RX PubMed=19941346;
CC From: Provincial Hospital Affiliated to Shandong University; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID mSDU-hES8
AC CVCL_C825
SY mSDU-hES 8
DR ISCR; 1677
RX PubMed=19941346;
CC From: Provincial Hospital Affiliated to Shandong University; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID mSDU-hES9
AC CVCL_C826
SY mSDU-hES 9
DR ISCR; 1678
RX PubMed=19941346;
CC From: Provincial Hospital Affiliated to Shandong University; China.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID mSEC1
AC CVCL_IN75
RX PubMed=11121394;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID mSEC1-CF
AC CVCL_IN76
RX PubMed=11121394;
RX PubMed=15463957;
CC Characteristics: Homozygous for the Cftr p.Ser489Ter mutation.
CC Knockout cell: Method=KO mouse; MGI; MGI:88388; Cftr.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x (C57BL/6J x 129)Cftr-/-].
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MSF32
AC CVCL_6G26
RX PubMed=21729198;
CC Breed/subspecies: Inner Mongolian.
OX NCBI_TaxID=9940; ! Ovis aries
SX Female
CA Finite cell line
//
ID MSG1
AC CVCL_0G10
RX PubMed=20924730;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MSH6-1-[ClX3.16]DT40
AC CVCL_1R68
DR RCB; RCB1853
CC Group: Bird cell line.
CC Knockout cell: Method=Cre/loxP; MSH6.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID Mshi
AC CVCL_0A02
DR ECACC; 90070560
CC Group: Insect cell line.
CC Discontinued: ECACC; 90070560; probable.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID MSIE
AC CVCL_6E39
SY Mouse Small Intestine Epithelium
RX PubMed=7678459;
WW https://www.abmgood.com/Immortalized-(Conditionally)-Mouse-Small-Intestinal-Epithelial-Cells-(MSIE)-T0568.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MSK
AC CVCL_8369
DR JCRB; JCRB0259
RX DOI=10.11277/stomatology1952.38.870;
CC Breed/subspecies: Fischer 344.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID MSK-921
AC CVCL_6988
SY MSK921; MSK 921; HN 921
DR Cosmic; 2043899
RX PubMed=11389082;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MSK-922
AC CVCL_6989
SY MSK 922; MSK922
DR Cosmic; 2043885
DR Cosmic; 2439756
RX PubMed=11389082;
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 11
ST TH01: 8
ST TPOX: 8
ST vWA: 17
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MSK-C5.8G
AC CVCL_5336
SY C5.8G
DR CLO; CLO_0050829
DR RCB; RCB2806
WW https://kaken.nii.ac.jp/d/p/02670887/1991/6/en.en.html
CC Breed/subspecies: Fischer 344.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8369 ! MSK
SX Female
CA Cancer cell line
//
ID MSK-Leuk1
AC CVCL_D684
SY MSK Leuk1; MSKleuk1; Leuk1
DR BTO; BTO:0005241
RX PubMed=8842478;
RX PubMed=9525275;
RX PubMed=11389082;
RX PubMed=21868764;
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11,14
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C3187; Oral leukoplakia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MSK-Leuk1S
AC CVCL_AT81
SY MSK Leuk1S; MSKleuk1S
RX PubMed=20145189;
RX PubMed=21868764;
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11,14
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,10
ST vWA: 17,18
DI NCIt; C3187; Oral leukoplakia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D684 ! MSK-Leuk1
SX Female
CA Cancer cell line
//
ID MSK-QLL1
AC CVCL_6990
SY MSK QLL1; MSKQLL1
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MSK-QLL2
AC CVCL_6991
SY MSK QLL2; MSKQLL2
RX PubMed=11389082;
CC From: Memorial Sloan-Kettering Cancer Center; New York; USA.
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MSL-G2
AC CVCL_M446
RX PubMed=2877997;
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID MSL-G2-Tu6
AC CVCL_M460
SY Tu6; Tu-6
RX CelloPub=CLPUB00274;
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M446 ! MSL-G2
CA Cancer cell line
//
ID MSN
AC CVCL_9882
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7579408;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MSPF-PI 31
AC CVCL_9W00
DR NCBI_Iran; C441
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MSS16
AC CVCL_5560
RX PubMed=2804371;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID MSS31
AC CVCL_5561
SY MSS-31; MSS 31
DR BTO; BTO:0002863
DR IFO; IFO50375
DR Wikidata; Q27671707
RX PubMed=2032312;
RX PubMed=2804371;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID MSS57
AC CVCL_5562
RX PubMed=2804371;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID MSS62
AC CVCL_5563
DR IFO; IFO50376
RX PubMed=2804371;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID MSS72
AC CVCL_5564
RX PubMed=2804371;
CC Breed/subspecies: C57BL/6J.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID MST-1
AC CVCL_0J34
SY MST1
RX PubMed=8664053;
RX PubMed=12966428;
DI NCIt; C3745; Clear cell sarcoma of soft tissue
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MST-2
AC CVCL_0J35
SY MST2
RX PubMed=12966428;
RX PubMed=15150091;
DI NCIt; C3745; Clear cell sarcoma of soft tissue
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MST-3
AC CVCL_0J36
SY MST3
RX PubMed=12966428;
RX PubMed=15150091;
DI NCIt; C3745; Clear cell sarcoma of soft tissue
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MST1
AC CVCL_1M73
SY GM03161
DR CLO; CLO_0013517
DR Coriell; GM03161
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MSTO-211H
AC CVCL_1430
SY MSTO-211 H; MSTO211H; 211H
DR BTO; BTO:0002425
DR CLO; CLO_0007880
DR EFO; EFO_0002839
DR CLDB; cl7174
DR ATCC; CRL-2081
DR BioSample; SAMN03471440
DR CCLE; MSTO211H_PLEURA
DR ChEMBL-Cells; CHEMBL3308116
DR ChEMBL-Targets; CHEMBL1075509
DR CLS; 300450/p759_MSTO-211H
DR Cosmic; 688057
DR Cosmic; 877275
DR Cosmic; 908152
DR Cosmic; 1067228
DR Cosmic; 1175876
DR Cosmic; 1481542
DR Cosmic; 1522772
DR Cosmic; 1541211
DR Cosmic; 1749563
DR Cosmic; 1963324
DR Cosmic; 1995515
DR Cosmic-CLP; 908152
DR DSMZ; ACC-390
DR GDSC; 908152
DR GEO; GSM726279
DR GEO; GSM827586
DR GEO; GSM887342
DR GEO; GSM888418
DR GEO; GSM1670136
DR ICLC; HL01018
RX PubMed=2840315;
RX PubMed=15920167;
RX PubMed=21642991;
RX PubMed=22460905;
RX PubMed=24926545;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC Doubling time: ~30-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 13
ST D18S51: 16,18
ST D21S11: 28,31
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 8,12
ST D8S1179: 13
ST FGA: 21
ST Penta D: 11,12
ST Penta E: 7,13
ST TH01: 8,9.3
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C9351; Pleural mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MSU-1.0
AC CVCL_9S99
SY MSU 1.0; MSU1.0
DR TOKU-E; 4098
RX DOI=10.1007/978-1-4612-0411-4_35;
RX PubMed=1915659;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9S81 ! MSU-1.1
SX Male
CA Transformed cell line
//
ID MSU-1.1
AC CVCL_9S81
SY MSU1.1
RX DOI=10.1007/978-1-4612-0411-4_35;
RX PubMed=1915659;
RX PubMed=9419347;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9S99 ! MSU-1.0
SX Male
CA Transformed cell line
//
ID MSU-TnT4
AC CVCL_9U39
SY TnT4
DR ATCC; PTA-9384
RX Patent=US8383402;
RX PubMed=18622664;
RX PubMed=19911241;
WW http://msut.technologypublisher.com/technology/7017
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
OX NCBI_TaxID=7111; ! Trichoplusia ni
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID MSUH-001
AC CVCL_V155
WW http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud_Deposito_MSUH_001.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0347 ! IMR-90
SX Female
CA Induced pluripotent stem cell
//
ID MSUMFH
AC CVCL_M829
RX PubMed=21208094;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MSV.B
AC CVCL_4244
SY MSV cell line
DR CLO; CLO_0007881
DR CLDB; cl3592
DR ECACC; 90031901
RX PubMed=5466001;
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MSV512
AC CVCL_6E67
RX PubMed=4307755;
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6E65 ! C3H2K
CA Transformed cell line
//
ID MSVIF-TK+
AC CVCL_4245
SY MSV-IF+; MSV-Interferon
DR CLO; CLO_0007882
DR CLDB; cl3593
DR ECACC; 90031902
RX PubMed=5466001;
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4244 ! MSV.B
CA Transformed cell line
//
ID mSXL 104
AC CVCL_4246
SY mSXL104
DR CLO; CLO_0007883
DR ATCC; CRL-1953
CC Monoclonal antibody target: UniProtKB; P19339; Drosophila melanogaster Sxl.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID mSXL 114
AC CVCL_4247
SY mSXL114; mSxl114
DR CLO; CLO_0007884
DR ATCC; CRL-1954
CC Monoclonal antibody target: UniProtKB; P19339; Drosophila melanogaster Sxl.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID mSXL 18
AC CVCL_4248
SY mSXL18
DR CLO; CLO_0007885
DR ATCC; CRL-1952
CC Monoclonal antibody target: UniProtKB; P19339; Drosophila melanogaster Sxl.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID mSXL 5
AC CVCL_4249
SY mSXL5
DR CLO; CLO_0007886
DR ATCC; CRL-1951
CC Monoclonal antibody target: UniProtKB; P19339; Drosophila melanogaster Sxl.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MSY00349IN
AC CVCL_E179
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9546; ! Macaca sylvanus
SX Female
CA Transformed cell line
//
ID MSY00350IN
AC CVCL_E180
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9546; ! Macaca sylvanus
SX Female
CA Transformed cell line
//
ID MSY00351IN
AC CVCL_E181
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9546; ! Macaca sylvanus
SX Female
CA Transformed cell line
//
ID MSY00352IN
AC CVCL_E182
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9546; ! Macaca sylvanus
SX Male
CA Transformed cell line
//
ID MSY00353IN
AC CVCL_E183
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9546; ! Macaca sylvanus
SX Male
CA Transformed cell line
//
ID MSY00354IN
AC CVCL_E184
WW http://www.biologia.uniba.it/primates/cell_lines.html
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9546; ! Macaca sylvanus
SX Male
CA Transformed cell line
//
ID MT
AC CVCL_6F14
SY Indian Muntjac (MT)
DR CLDB; cl2891
DR CLDB; cl2892
DR CLDB; cl2893
DR CLDB; cl2894
RX PubMed=19140346;
RX PubMed=25509114;
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_9126 ! DM87
SX Male
CA Finite cell line
//
ID MT-1 [Human contaminated breast cancer]
AC CVCL_0441
DR MCCL; MCC:0000337
DR BioSample; SAMN03151746
RX PubMed=1446057;
RX PubMed=9150904;
RX PubMed=10508494;
RX PubMed=11044355;
RX PubMed=12661003;
RX PubMed=15677628;
RX PubMed=20143388;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/MT-1.html
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=10508494, PubMed=20143388).
CC Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=15677628).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID MT-1 [Human leukemia]
AC CVCL_M518
SY FCCH1043
DR BioSample; SAMN03472436
DR JCRB; JCRB1209
DR JCRB; NIHS0526
RX PubMed=6275274;
RX PubMed=6966589;
RX PubMed=7031654;
CC Characteristics: HTLV-1 producing cell line.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC Discontinued: JCRB; NIHS0526; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,13
ST D13S317: 8
ST D16S539: 9
ST D5S818: 10,12
ST D7S820: 11,13
ST TH01: 8,9
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MT-1 [Human mesothelioma]
AC CVCL_M519
RX PubMed=3597716;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MT-10
AC CVCL_M802
RX PubMed=1850724;
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M804 ! MT-P
SX Male
CA Cancer cell line
//
ID MT-100-TC
AC CVCL_Y666
RX PubMed=6662551;
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_Y667 ! MT-100M
SX Female
CA Cancer cell line
//
ID MT-100M
AC CVCL_Y667
RX PubMed=2096989;
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_Y666 ! MT-100-TC
SX Female
CA Cancer cell line
//
ID MT-10R
AC CVCL_M803
DR RCB; RCB2722
RX PubMed=17267196;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M802 ! MT-10
SX Male
CA Cancer cell line
//
ID MT-2
AC CVCL_2631
SY MT2; MT-2J
DR BTO; BTO:0005492
DR CLO; CLO_0007888
DR CLDB; cl3596
DR CLDB; cl3597
DR BioSample; SAMN03472437
DR ChEMBL-Cells; CHEMBL3307558
DR ChEMBL-Targets; CHEMBL614184
DR Cosmic; 919158
DR ECACC; 08081401
DR ECACC; 93121518
DR JCRB; JCRB1210
DR JCRB; NIHS0527
DR NIH-ARP; 237-339
RX PubMed=3003193;
RX PubMed=6275274;
RX PubMed=6281119;
RX PubMed=26940204;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-576.html
CC Characteristics: HTLV-1 producing cell line. Contains 11 integrated HTLV-1 proviruses: one complete proviral genome, six copies of a provirus with an internal deletion of 5.3 kb, one copy of a provirus with an internal deletion of 3.9 kb, one copy of a provirus with a 6.2 kB deletion from 5'LTR to position 6257, and two copies of a provirus composed of LTR only.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC Discontinued: ECACC; 93121518; probable.
CC Discontinued: JCRB; NIHS0527; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 9,13
ST D16S539: 9,11
ST D5S818: 13
ST D7S820: 8,13
ST TH01: 6,10
ST TPOX: 10,11
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID MT-213-VGH
AC CVCL_W812
DR BCRC; 60598
RX PubMed=11575644;
CC Doubling time: 24.29 +- 1.81 hours (PubMed=11575644).
DI NCIt; C42700; Uterine carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MT-3 [Human contaminated breast cancer]
AC CVCL_2129
SY MT3
DR CLO; CLO_0007890
DR EFO; EFO_0002241
DR BioSample; SAMN03472975
DR BioSample; SAMN03473582
DR DSMZ; ACC-403
DR GEO; GSM115102
DR GEO; GSM217592
DR GEO; GSM412073
DR GEO; GSM412084
DR GEO; GSM412093
DR GEO; GSM412098
DR GEO; GSM412106
DR GEO; GSM412110
DR GEO; GSM459700
DR GEO; GSM474280
DR GEO; GSM474281
DR GEO; GSM476484
DR GEO; GSM476485
DR GEO; GSM478311
DR GEO; GSM478312
DR GEO; GSM478314
DR GEO; GSM478315
DR GEO; GSM478320
DR GEO; GSM478321
DR GEO; GSM783977
DR GEO; GSM847419
DR GEO; GSM847498
DR GEO; GSM844610
DR IGRhCellID; MT3
DR LINCS; 50031
RX PubMed=1446057;
RX PubMed=9150904;
RX PubMed=11044355;
RX PubMed=12661003;
RX PubMed=12800145;
RX PubMed=15677628;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/MT-3.html
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
WW http://tcpaportal.org/mclp/
CC Problematic cell line: Contaminated. Shown to be a LS174T derivative.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Instable (MSI) (PubMed=12661003; PubMed=15677628).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 10,11
ST D16S539: 11,13
ST D18S51: 10,12
ST D21S11: 29,31
ST D3S1358: 15,16
ST D5S818: 12,17 (DSMZ)
ST D5S818: 12 (PubMed=25877200)
ST D7S820: 10.3,11,12
ST D8S1179: 12,15
ST FGA: 20,21
ST Penta D: 9,10
ST Penta E: 13,15
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 13,14,17 (DSMZ)
ST vWA: 14,17 (PubMed=25877200)
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1384 ! LS174T
SX Female
CA Cancer cell line
//
ID MT-3 [Human leukocytes]
AC CVCL_M517
DR BioSample; SAMN03472443
DR JCRB; JCRB1217
DR JCRB; NIHS0528
CC Discontinued: JCRB; NIHS0528; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 9,11
ST D5S818: 11
ST D7S820: 10.3,12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID MT-3 [Human mesothelioma]
AC CVCL_M520
SY MT3
DR Cosmic; 733819
CC From: Anderson T. and Saxton R.; UCLA School of Medicine; Los Angeles; USA.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MT-4
AC CVCL_2632
SY MT4
DR BTO; BTO:0003030
DR CLO; CLO_0007891
DR CLDB; cl3594
DR CLDB; cl3599
DR BioSample; SAMN03470803
DR BioSample; SAMN03472442
DR ChEMBL-Cells; CHEMBL3308375
DR ChEMBL-Targets; CHEMBL388
DR Cosmic; 1191697
DR ECACC; 08081402
DR JCRB; JCRB0135
DR JCRB; JCRB1216
DR JCRB; NIHS0145
DR JCRB; NIHS0529
DR KCB; KCB 200308YJ
DR NIH-ARP; 120-438
RX PubMed=8927062;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-117.html
CC Characteristics: HTLV-1 producing cell line.
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC Discontinued: JCRB; NIHS0145; true.
CC Discontinued: JCRB; NIHS0529; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 9,12
ST D5S818: 10,11
ST D7S820: 8,10 (JCRB_JCRB0135)
ST D7S820: 8,9.3,10 (JCRB_JCRB1216)
ST TH01: 7
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MT-428
AC CVCL_W492
SY MT428
RX PubMed=8025019;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MT-45-5-3
AC CVCL_J275
SY MT45-5-3
DR JCRB; JCRB1304
RX PubMed=1500065;
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID MT-450TC
AC CVCL_L173
DR KCLB; 60006
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_L170 ! MT-W9A
SX Female
CA Cancer cell line
//
ID MT-5
AC CVCL_U900
SY M14T5
DR RCB; RCB0432
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0184 ! BALB/3T3 clone A31
CA Spontaneously immortalized cell line
//
ID MT-6
AC CVCL_4978
SY MT-6 [Mutatect]
DR CLO; CLO_0007892
DR ATCC; CRL-2805
RX PubMed=11228549;
CC Discontinued: ATCC; CRL-2805; true.
CC Breed/subspecies: C57BL/10.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4982 ! MC-TGS17-51
SX Male
CA Cancer cell line
//
ID MT-7
AC CVCL_M801
RX PubMed=1850724;
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M804 ! MT-P
SX Male
CA Cancer cell line
//
ID MT-8
AC CVCL_5337
DR CLO; CLO_0050834
DR RCB; RCB0760
RX PubMed=1850724;
RX PubMed=7834074;
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M804 ! MT-P
SX Male
CA Cancer cell line
//
ID MT-8L
AC CVCL_1Q70
RX PubMed=8916004;
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5337 ! MT-8
SX Male
CA Cancer cell line
//
ID MT-9
AC CVCL_5338
DR CLO; CLO_0050835
DR RCB; RCB0762
RX PubMed=1850724;
RX PubMed=7834074;
RX PubMed=11437512;
RX PubMed=18036812;
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M804 ! MT-P
SX Male
CA Cancer cell line
//
ID MT-9L
AC CVCL_1Q71
RX PubMed=8916004;
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5338 ! MT-9
SX Male
CA Cancer cell line
//
ID MT-CHC01
AC CVCL_4Z41
RX PubMed=26486326;
CC Doubling time: ~40 hours (PubMed=26486326).
DI NCIt; C35417; Intrahepatic cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MT-P
AC CVCL_M804
RX PubMed=2558251;
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID MT-PR
AC CVCL_M805
DR RCB; RCB2723
RX PubMed=17267196;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M804 ! MT-P
SX Male
CA Cancer cell line
//
ID MT-R8
AC CVCL_1Q72
DR RCB; RCB2720
RX PubMed=8893224;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5337 ! MT-8
SX Male
CA Cancer cell line
//
ID MT-R9
AC CVCL_1Q73
DR RCB; RCB2721
RX PubMed=8893224;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Breed/subspecies: Fischer 344/DuCrj.
DI NCIt; C60442; Rat malignant fibrous histiocytoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5338 ! MT-9
SX Male
CA Cancer cell line
//
ID MT-W9A
AC CVCL_L170
SY MTW9A
DR ATCC; CRL-6597
RX PubMed=639042;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6597; true.
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_Y665 ! MT-W9B
SX Female
CA Cancer cell line
//
ID MT-W9B
AC CVCL_Y665
RX PubMed=2096989;
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_L170 ! MT-W9A
SX Female
CA Cancer cell line
//
ID MT-W9/PL
AC CVCL_L171
SY MTW9/PL
RX PubMed=639042;
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_L170 ! MT-W9A
SX Female
CA Cancer cell line
//
ID MT-W9/PL2
AC CVCL_L172
SY MTW9/PL2
DR KCLB; 60003
RX PubMed=3338970;
RX PubMed=11039493;
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_L171 ! MT-W9/PL
SX Female
CA Cancer cell line
//
ID MT1.K
AC CVCL_5844
SY MT1K
DR CLO; CLO_0007887
DR ATCC; CRL-6309
CC Group: Non-human primate cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6309; true.
OX NCBI_TaxID=36231; ! Miopithecus talapoin
SX Sex undetermined
CA Finite cell line
//
ID Mt1/Mt2 DKO SV40
AC CVCL_6E52
SY SV40-transformed MT-/-
RX PubMed=10201648;
CC Knockout cell: Method=KO mouse; MGI; MGI:97171; Mt1.
CC Knockout cell: Method=KO mouse; MGI; MGI:97172; Mt2.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MT14B
AC CVCL_E783
DR dbMHC; 48978
DR ECACC; 88052098
DR IHW; IHW9098
DR IMGT/HLA; 11642
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl98.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID MT3
AC CVCL_M516
DR CLO; CLO_0007889
DR CLDB; cl3598
RX PubMed=3114153;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MT3/B4
AC CVCL_L534
DR ECACC; 92030607
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID MT4/E4
AC CVCL_L535
DR ECACC; 92030608
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3411 ! P3X63Ag8
CA Hybridoma
//
ID MT58
AC CVCL_0442
SY MT-58; CHO-MT58; CHO MT58; Mutant 58; CHO strain 58; CHO-58
DR MCCL; MCC:0000338
DR TOKU-E; 4018
RX PubMed=6265447;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/c/cell-lines-detail-189.html
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID MTA
AC CVCL_3032
DR BioSample; SAMN03472801
DR IFO; IFO50513
RX PubMed=10222657;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,12
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MTC-1
AC CVCL_B366
DR BTO; BTO:0005138
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID MTC-F
AC CVCL_8895
SY MTC F
RX PubMed=1972348;
RX PubMed=22538498;
DI NCIt; C3879; Thyroid gland medullary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MTC-M
AC CVCL_3548
DR CLO; CLO_0007897
DR ATCC; CRL-1806
DR BCRC; 60413
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MTC-SK
AC CVCL_8896
SY MTC SK
DR CLO; CLO_0007896
DR CLDB; cl3602
DR ECACC; 92013101
RX PubMed=1972348;
RX PubMed=12089864;
RX PubMed=15126569;
RX PubMed=22538498;
CC Discontinued: ECACC; 92013101; probable.
CC Derived from metastatic site: Lymph node.
DI NCIt; C3879; Thyroid gland medullary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8895 ! MTC-F
SX Female
CA Cancer cell line
//
ID MTD
AC CVCL_6F15
SY MT(D)
RX PubMed=19140346;
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_6F14 ! MT
SX Male
CA Finite cell line
//
ID MTD-1
AC CVCL_EG10
SY MTD
RX DOI=10.1111/j.1440-169X.1984.00223.x;
CC Breed/subspecies: SHN.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MTD-1A
AC CVCL_EG11
RX PubMed=3320048;
RX PubMed=7738090;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-577.html
CC Breed/subspecies: SHN.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_EG10 ! MTD-1
SX Female
CA Cancer cell line
//
ID MTEC1
AC CVCL_0443
SY Murine Thymic Epithelial Cell line 1
DR MCCL; MCC:0000339
RX DOI=10.1038/cr.1992.17;
RX PubMed=1581557;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MTEC1
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID mTEC1
AC CVCL_IN77
RX PubMed=11121394;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID mTEC1-CF
AC CVCL_IN78
RX PubMed=11121394;
RX PubMed=15463957;
CC Characteristics: Homozygous for the Cftr p.Ser489Ter mutation.
CC Knockout cell: Method=KO mouse; MGI; MGI:88388; Cftr.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: [(CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse x (C57BL/6J x 129)Cftr-/-].
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID MTh
AC CVCL_9W67
RX PubMed=11933048;
RX PubMed=16646156;
CC Transformant: Unknown product of UCHT1 (CVCL_9W35) conditioned media.
CC Breed/subspecies: C57BL/6 x Rb(16.17)32Lub/Rb(11.16)2H.
DI NCIt; C125660; Mouse trisomy 16
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MTHC-1
AC CVCL_8733
DR CLO; CLO_0050827
DR RCB; RCB0738
RX PubMed=1644664;
CC Breed/subspecies: Buffalo/Mna.
DI NCIt; C60470; Rat malignant thymoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID MTHC-2
AC CVCL_8734
DR CLO; CLO_0050161
DR RCB; RCB0739
RX PubMed=1644664;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybrid cell line
//
ID MTHC-3
AC CVCL_8735
DR CLO; CLO_0050162
DR RCB; RCB0740
RX PubMed=1644664;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybrid cell line
//
ID MTKP 97-12
AC CVCL_6504
SY TKMp97-12
DR CLO; CLO_0007898
DR ATCC; CRL-8985
DR CCRID; 3142C0001000000412
RX Patent=US5141742;
CC Transfected with: HGNC; 7037; MFI2.
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID MTLn2
AC CVCL_8133
RX PubMed=6950180;
RX PubMed=9397155;
RX PubMed=21104427;
CC Breed/subspecies: Fischer 344.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_8136 ! MTLn3
SX Female
CA Cancer cell line
//
ID MTLn2-Tf10
AC CVCL_8134
RX PubMed=9397155;
CC Breed/subspecies: Fischer 344.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8133 ! MTLn2
SX Female
CA Cancer cell line
//
ID MTLn2-Tf20
AC CVCL_8135
RX PubMed=9397155;
CC Breed/subspecies: Fischer 344.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_8133 ! MTLn2
SX Female
CA Cancer cell line
//
ID MTLn3
AC CVCL_8136
DR Lonza; 1113
RX PubMed=6950180;
RX PubMed=21104427;
RX PubMed=21414324;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-603.html
CC Breed/subspecies: Fischer 344.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_8133 ! MTLn2
SX Female
CA Cancer cell line
//
ID MTO-94
AC CVCL_W534
RX PubMed=9284971;
DI NCIt; C3247; Myelodysplastic syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID mTOP2beta-4
AC CVCL_D632
DR BTO; BTO:0005309
RX PubMed=10570059;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mtop2beta-5
AC CVCL_D633
DR BTO; BTO:0005310
RX PubMed=10570059;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:98791; Top2b.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID mtop2beta-6
AC CVCL_D634
RX PubMed=10570059;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:98791; Top2b.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID MTP-GFP
AC CVCL_3406
SY GFPneu
DR CLDB; cl7180
DR ICLC; ATL07002
RX PubMed=17109643;
CC Transfected with: RGD; 2561; Erbb2 (with E-661).
CC Transfected with: UniProtKB; P42212; GFP.
CC Transformant: Activated Erbb2/neu.
CC Breed/subspecies: CD-1 transgenic MMTV-neu x CMV-GFP.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MTS-RC
AC CVCL_X540
DR Cosmic; 849374
RX PubMed=11146448;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MTSV1-7
AC CVCL_8645
SY MTSV-1.7; MTSV 1.7
RX PubMed=1708884;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-107.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MTSV1-7 ce1
AC CVCL_3033
SY MTSV1-7 CE1
DR ECACC; 10081202
DR Ximbio; 151503
CC Transfected with: HGNC; 3430; ERBB2.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ECACC
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 8,13
ST D5S818: 10,13
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8645 ! MTSV1-7
SX Female
CA Transformed cell line
//
ID MTT-95
AC CVCL_B432
DR Cosmic; 1012101
DR Cosmic; 2306223
RX PubMed=10358725;
RX PubMed=16408098;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MtT/E
AC CVCL_H712
DR CLO; CLO_0050941
DR RCB; RCB1278
RX PubMed=2184014;
RX PubMed=15541569;
CC Breed/subspecies: Fischer 344.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_IV56 ! F4C1
OI CVCL_H713 ! MtT/S
OI CVCL_H714 ! MtT/Se
OI CVCL_H715 ! MtT/SM
SX Female
CA Cancer cell line
//
ID MtT/E-2
AC CVCL_U371
RX PubMed=10503991;
CC Breed/subspecies: Fischer 344.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_H712 ! MtT/E
SX Female
CA Cancer cell line
//
ID MtT/S
AC CVCL_H713
DR CLO; CLO_0050943
DR RCB; RCB0528
RX PubMed=2184014;
RX PubMed=15541569;
CC Breed/subspecies: Fischer 344.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_IV56 ! F4C1
OI CVCL_H712 ! MtT/E
OI CVCL_H714 ! MtT/Se
OI CVCL_H715 ! MtT/SM
SX Female
CA Cancer cell line
//
ID MtT/Se
AC CVCL_H714
DR CLO; CLO_0050944
DR RCB; RCB0529
RX PubMed=2184014;
RX PubMed=15541569;
CC Breed/subspecies: Fischer 344.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_IV56 ! F4C1
OI CVCL_H712 ! MtT/E
OI CVCL_H713 ! MtT/S
OI CVCL_H715 ! MtT/SM
SX Female
CA Cancer cell line
//
ID MtT/SM
AC CVCL_H715
DR CLO; CLO_0050942
DR RCB; RCB0530
RX PubMed=2184014;
RX PubMed=15541569;
CC Breed/subspecies: Fischer 344.
DI NCIt; C132194; Rat pituitary gland neoplasm
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_IV56 ! F4C1
OI CVCL_H712 ! MtT/E
OI CVCL_H713 ! MtT/S
OI CVCL_H714 ! MtT/Se
SX Female
CA Cancer cell line
//
ID MTV-L/BALB
AC CVCL_M057
RX PubMed=192465;
CC Breed/subspecies: BALB/c.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MTV-L/BALB CL2
AC CVCL_M058
SY MTV-L/CL2
DR KCLB; 60056
RX PubMed=192465;
CC Discontinued: KCLB; 60056; probable.
CC Breed/subspecies: BALB/c.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_M057 ! MTV-L/BALB
SX Female
CA Cancer cell line
//
ID MTV/TM-011
AC CVCL_M059
DR KCLB; 60057
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_M058 ! MTV-L/BALB CL2
CA Hybrid cell line
//
ID Mu Islet (E6/E7)
AC CVCL_B062
DR ATCC; CRL-2999
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID MU011.A-hiPS
AC CVCL_9S79
RX PubMed=26432158;
DI NCIt; C34368; Alpha thalassemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID mU1
AC CVCL_9T81
SY mouse Uterus 1
RX PubMed=11850199;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 x C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID MU1
AC CVCL_N681
DR ATCC; CRL-6477
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6477; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
SX Sex undetermined
CA Finite cell line
//
ID MU10
AC CVCL_N677
DR ATCC; CRL-6481
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6481; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
SX Male
CA Cancer cell line
//
ID MU11
AC CVCL_N676
DR ATCC; CRL-6482
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6482; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
SX Female
CA Undefined cell line type
//
ID MU12.T
AC CVCL_N675
DR ATCC; CRL-6483
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6483; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
SX Male
CA Cancer cell line
//
ID MU13.T
AC CVCL_N674
SY MU13T
DR ATCC; CRL-6484
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6484; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
SX Male
CA Cancer cell line
//
ID MU14.K
AC CVCL_5434
SY MU14K
DR CLO; CLO_0007899
DR ATCC; CRL-6485
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6485; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
SX Sex undetermined
CA Undefined cell line type
//
ID MU26
AC CVCL_N672
DR ATCC; CRL-6486
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6486; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
SX Female
CA Cancer cell line
//
ID MU27
AC CVCL_N673
DR ATCC; CRL-6487
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6487; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
SX Male
CA Cancer cell line
//
ID MU3
AC CVCL_N680
DR ATCC; CRL-6478
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6478; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
SX Sex undetermined
CA Finite cell line
//
ID MU8
AC CVCL_N679
DR ATCC; CRL-6479
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6479; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
SX Male
CA Cancer cell line
//
ID MU9
AC CVCL_N678
DR ATCC; CRL-6480
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6480; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
OI CVCL_N682 ! MU9.Sp
SX Female
CA Undefined cell line type
//
ID MU9.Sp
AC CVCL_N682
DR ATCC; CRL-6592
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6592; true.
OX NCBI_TaxID=13146; ! Melopsittacus undulatus
OI CVCL_N678 ! MU9
SX Female
CA Undefined cell line type
//
ID MUCC
AC CVCL_6C56
SY Murine Uterine Cervix Cancer
RX PubMed=3568983;
RX PubMed=3680100;
CC Breed/subspecies: Kunming.
DI NCIt; C24068; Mouse cervical carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID MUG-CC1
AC CVCL_AV05
RX PubMed=27072875;
WW https://www.chordomafoundation.org/reagents-data/cell-line-repository/mug-cc1-2/
CC Omics: CNV analysis.
ST Source(s): PubMed=27072875
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 9,14
ST D18S51: 12
ST D21S11: 28
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 13,15
ST FGA: 23
ST Penta D: 13
ST Penta E: 10
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C5412; Clivus chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DE11 ! MUG-CC1-LCL
SX Male
CA Cancer cell line
//
ID MUG-CC1-LCL
AC CVCL_DE11
RX PubMed=27072875;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): PubMed=27072875
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12,13
ST D16S539: 9,14
ST D18S51: 12
ST D21S11: 28,30
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 13,15
ST FGA: 23
ST Penta D: 10,13
ST Penta E: 10,13
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AV05 ! MUG-CC1
SX Male
CA Transformed cell line
//
ID MUG-Chor1
AC CVCL_9277
SY MUG-CHOR1
DR ATCC; CRL-3219
DR DSMZ; ACC-755
DR GEO; GSM631722
DR GEO; GSM631723
RX PubMed=22002331;
RX PubMed=27102572;
WW https://www.chordomafoundation.org/reagents-data/cell-line-repository/mug-chor1/
CC Doubling time: ~75-100 hours (DSMZ).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced.
ST Source(s): ATCC; DSMZ; PubMed=22002331; PubMed=27102572
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11,14
ST D18S51: 17,23
ST D19S433: 13,14
ST D21S11: 29,33.2
ST D2S1338: 18
ST D3S1358: 14,17
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 11,12
ST FGA: 21,26
ST Penta D: 13
ST Penta E: 5,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 15
DI NCIt; C129927; Sacral chordoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MUG-Myx1
AC CVCL_T030
RX PubMed=24289252;
ST Source(s): PubMed=24289252
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 9,12
ST D16S539: 12,13
ST D18S51: 17,24
ST D21S11: 26,31
ST D3S1358: 17,18
ST D5S818: 13
ST D7S820: 10,11
ST D8S1179: 13
ST FGA: 18,20
ST Penta D: 9,12
ST Penta E: 12,17
ST TH01: 6,8
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C6496; Myxofibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Muk-BL
AC CVCL_W775
SY MUK-BL; MUK; Muk
RX PubMed=2824665;
RX PubMed=2943927;
RX PubMed=2985508;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MUL
AC CVCL_E784
SY TER110; TER251; TER350; TER435; Terasaki B-cell 251
DR IMGT/HLA; 11112
WW http://www.hla.ucla.edu/pdf/Cell_summary/348cx.pdf
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID MuM-2B
AC CVCL_3447
SY MUM-2B; MUM2B; Mum2B
DR BTO; BTO:0005298
DR CCRID; 3111C0001CCC000231
DR GEO; GSM1082690
RX PubMed=12067204;
RX PubMed=15299072;
RX PubMed=18689700;
ST Source(s): PubMed=18689700;
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 8,12
ST D18S51: 15
ST D21S11: 30
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 12
ST D8S1179: 13
ST FGA: 20,21
ST TH01: 8,9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8471 ! C918
OI CVCL_8472 ! M619
SX Female
CA Cancer cell line
//
ID MuM-2C
AC CVCL_3448
SY MUM-2C; MUM2C; Mum2C
DR BTO; BTO:0005299
DR CCRID; 3111C0001CCC000232
DR Cosmic; 1628412
RX PubMed=12067204;
RX PubMed=15299072;
RX PubMed=18689700;
RX PubMed=22236444;
CC Derived from metastatic site: Liver.
ST Source(s): PubMed=18689700;
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 9
ST D18S51: 13,18
ST D21S11: 30
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 21
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6934 ! OCM-1
SX Female
CA Cancer cell line
//
ID MUM24
AC CVCL_M521
RX PubMed=23686003;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MUNIi001-A
AC CVCL_9S28
SY DMD02
DR hPSCreg; MUNIi001-A
CC From: Masaryk University; Brno; Czech Republic.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID MUNIi002-A
AC CVCL_9S29
SY MDMD02
DR hPSCreg; MUNIi002-A
CC From: Masaryk University; Brno; Czech Republic.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID MUNIi003-A
AC CVCL_9S30
SY DMD03
DR hPSCreg; MUNIi003-A
CC From: Masaryk University; Brno; Czech Republic.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID Muraoka
AC CVCL_E042
RX PubMed=1357816;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Murphy
AC CVCL_3549
DR CLO; CLO_0007900
DR ATCC; CRL-7722
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-7722; true.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Muriungi
AC CVCL_IU23
RX PubMed=4122458;
RX PubMed=4364259;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MuSS
AC CVCL_8736
SY MUSS; Murine Sarcoma Sendai
DR CLO; CLO_0050870
DR CLO; CLO_0050184
DR RCB; RCB1378
DR RCB; RCB2642
DR TKG; TKG 0497
RX PubMed=9591335;
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID MUTJ
AC CVCL_EI98
SY MutJ; MUT-J; Mut-J
DR Cosmic; 2434091
RX PubMed=25167228;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Arizona Cancer Center; USA.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mutu-1
AC CVCL_7202
SY MUTU-1; Mutu 1; Mutu1; MUTU1; MUTU-BL group I; Mutu I; Mutu-I; MUTU BL; Mutu.BL; Mutu
DR Cosmic; 931129
DR Cosmic; 1517666
DR GEO; GSM1604059
DR GEO; GSM1604060
DR GEO; GSM1604061
DR Lonza; 1378
RX PubMed=1356511;
RX PubMed=2165133;
RX PubMed=2898508;
RX PubMed=9473234;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-4.html
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mutu-3
AC CVCL_7203
SY Mutu 3; Mutu3; MUTU-BL group III; Mutu III; Mutu-III; Mutu III-BL; MutuIII
RX PubMed=2165133;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-482.html
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Misspelling: Occasionally 'MUTU 111'.
CC Misspelling: Occasionally 'MUTU-111'.
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7202 ! Mutu-1
CA Cancer cell line
//
ID MUTZ-1
AC CVCL_1431
SY Mutz-1; MUTZ1
DR CLO; CLO_0007901
DR CLDB; cl3603
DR BioSample; SAMN03151853
DR Cosmic; 908155
DR Cosmic; 1995516
DR Cosmic; 2491098
DR DSMZ; ACC-13
RX PubMed=9067587;
RX PubMed=9168445;
RX PubMed=19344951;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Namalwa derivative (PubMed=19344951).
CC Characteristics: Contains 2 integrated copies of EBV genome on chromosome 1.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: DSMZ; ACC-13; true.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 6,11
ST vWA: 14
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0067 ! Namalwa
SX Female
CA Cancer cell line
//
ID MUTZ-11
AC CVCL_8288
SY MUTZ11
DR Cosmic; 787415
DR Cosmic; 975283
DR Cosmic; 1012103
DR Cosmic; 1281341
DR Cosmic; 1465961
RX DOI=10.1007/978-3-642-59358-1_22;
RX PubMed=15068904;
RX PubMed=16408098;
CC Doubling time: 64-98 hours (PubMed=15068904).
DI NCIt; C7463; Acute myelomonocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MUTZ-2
AC CVCL_1432
SY MUTZ2; Mutz2
DR CLO; CLO_0007902
DR BioSample; SAMN03473338
DR Cosmic; 787461
DR Cosmic; 975280
DR Cosmic; 1281337
DR DSMZ; ACC-271
DR Lonza; 1245
RX PubMed=8667638;
CC Doubling time: ~47 hours (DSMZ); 48 hours, in presence of supernatant of 5637 (CVCL_0126) cells (PubMed=8667638).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C7961; Adult acute myeloid leukemia with maturation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MUTZ-3
AC CVCL_1433
SY Mutz-3; MUTZ3; Mutz3
DR CLO; CLO_0007903
DR EFO; EFO_0005395
DR BioSample; SAMN03473344
DR CCLE; MUTZ3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 787462
DR Cosmic; 975281
DR Cosmic; 1012102
DR Cosmic; 1281338
DR Cosmic; 2306224
DR Cosmic; 2378088
DR DSMZ; ACC-295
DR GEO; GSM1374693
DR Lonza; 53
RX Patent=US8455253;
RX PubMed=8667638;
RX PubMed=12091369;
RX PubMed=16408098;
RX PubMed=17533051;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Characteristics: Contains both CD34+ stem cell and CD14+ monocyte/macrophage cell populations and can thus be considered as a hematopoietic progenitor/stem cell line.
CC Doubling time: ~110 hours (DSMZ); 90-110 hours, in presence of supernatant of 5637 (CVCL_0126) cells (PubMed=8667638).
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 8,12
ST D16S539: 12
ST D5S818: 12,13
ST D7S820: 10,12
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 14,16
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MUTZ-5
AC CVCL_1873
SY Mutz-5; MUTZ5
DR BioSample; SAMN03473564
DR CCLE; MUTZ5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1130257
DR Cosmic; 1278371
DR Cosmic; 1519165
DR Cosmic; 1524809
DR DSMZ; ACC-490
DR GEO; GSM887343
DR GEO; GSM888419
RX PubMed=11516110;
RX PubMed=15843827;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~70-100 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 8,9
ST D13S317: 10,12
ST D16S539: 10
ST D5S818: 11
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L068 ! MUTZ-6
OI CVCL_L069 ! MUTZ-7
SX Male
CA Cancer cell line
//
ID MUTZ-6
AC CVCL_L068
RX PubMed=11516110;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1873 ! MUTZ-5
OI CVCL_L069 ! MUTZ-7
SX Male
CA Cancer cell line
//
ID MUTZ-7
AC CVCL_L069
RX PubMed=11516110;
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1873 ! MUTZ-5
OI CVCL_L068 ! MUTZ-6
SX Male
CA Cancer cell line
//
ID MUTZ-8
AC CVCL_2130
DR BTO; BTO:0004768
DR Cosmic; 975282
DR Cosmic; 1012053
DR Cosmic; 1281339
DR Cosmic; 1465960
DR Cosmic; 2306225
DR DSMZ; ACC-689
RX DOI=10.1007/978-3-642-59358-1_22;
RX PubMed=12145698;
RX PubMed=16408098;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=MUTZ-8
CC Doubling time: ~3-5 days (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9,11
ST D16S539: 12
ST D5S818: 12
ST D7S820: 11
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 18
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MV-3D9
AC CVCL_5339
SY Mv-3D9; MV3D9; Mv3D9
OX NCBI_TaxID=452646; ! Neovison vison
CA Factor-dependent cell line
//
ID MV-522
AC CVCL_7204
SY MV522; Metastatic Variant-522; Metastatic Variant 522; Line 522
DR BTO; BTO:0004952
DR ATCC; CRL-2519
DR BioSample; SAMN03151795
DR Cosmic; 1173992
DR Cosmic; 1945858
RX PubMed=3596831;
WW http://www.atcc.org/support/faqs/0ebeb/MV522%20ATCC%20CRL2519-1075.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HT-29 derivative. Originally thought to originate from a lung carcinoma.
CC Misspelling: 'MU522' in Cosmic 1945858.
CC Discontinued: ATCC; CRL-2519; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6,9
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0320 ! HT-29
SX Female
CA Cancer cell line
//
ID Mv1Lu
AC CVCL_0593
SY Mv 1 Lu (NBL-7); NBL-7; Mv 1 Lu; MV 1 LU; Mv1.Lu; Mv.1.Lu; MV-1-Lu; Mink; Mink Lung
DR BTO; BTO:0005493
DR CLO; CLO_0007904
DR CLO; CLO_0007905
DR CLO; CLO_0051612
DR MCCL; MCC:0000342
DR CLDB; cl3604
DR CLDB; cl3605
DR CLDB; cl3606
DR CLDB; cl3607
DR CLDB; cl3608
DR CLDB; cl3609
DR ATCC; CCL-64
DR ATCC; CRL-6584
DR ATCC; PTA-3450
DR BCRC; 60321
DR CCRID; 3111C0001CCC000195
DR CCRID; 3131C0001000400008
DR CCRID; 3153C0001000000034
DR ECACC; 88050503
DR ICLC; AL97002
DR IZSLER; BS CL 69
DR JCRB; JCRB9128
DR KCB; KCB 93005YJ
DR NCBI_Iran; C647
DR RCB; RCB0996
DR RCB; RCB1833
RX PubMed=4366800;
RX PubMed=7065527;
RX PubMed=8895552;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=CCL-64
WW http://en.vircell.com/products/mink-lung-cell-line/
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-6.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6584; true.
OX NCBI_TaxID=452646; ! Neovison vison
SX Mixed sex
CA Spontaneously immortalized cell line
//
ID MV3
AC CVCL_W280
SY MV-3; MV 3
DR BTO; BTO:0005033
DR BCRJ; 0284
DR Cosmic; 1181740
RX PubMed=1918136;
RX PubMed=2019461;
RX PubMed=2060184;
RX PubMed=18235964;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MV4-11
AC CVCL_0064
SY MV-4-11; MV-4:11; MV4:11; MV 4;11; MV4;11; MV411; MV4II
DR BTO; BTO:0004479
DR CLO; CLO_0007906
DR EFO; EFO_0002242
DR CLDB; cl3610
DR CLDB; cl3611
DR ATCC; CRL-9591
DR ATCC; HTB-189
DR BioSample; SAMN01821582
DR BioSample; SAMN01821649
DR BioSample; SAMN03473104
DR CCLE; MV411_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308063
DR ChEMBL-Targets; CHEMBL613835
DR CLS; 300295/p637_MV4-11
DR Cosmic; 787416
DR Cosmic; 798673
DR Cosmic; 908156
DR Cosmic; 975284
DR Cosmic; 994182
DR Cosmic; 996315
DR Cosmic; 1012104
DR Cosmic; 1037736
DR Cosmic; 1078732
DR Cosmic; 1089516
DR Cosmic; 1127256
DR Cosmic; 1150899
DR Cosmic; 1152712
DR Cosmic; 1181603
DR Cosmic; 1278781
DR Cosmic; 1281340
DR Cosmic; 1308221
DR Cosmic; 1319550
DR Cosmic; 1451846
DR Cosmic; 1476424
DR Cosmic; 1516631
DR Cosmic; 1524837
DR Cosmic; 1623635
DR Cosmic; 1696137
DR Cosmic; 1779133
DR Cosmic; 2131568
DR Cosmic; 2306226
DR Cosmic; 2392908
DR Cosmic; 2393011
DR Cosmic; 2542841
DR Cosmic-CLP; 908156
DR DSMZ; ACC-102
DR GDSC; 908156
DR GEO; GSM236796
DR GEO; GSM236832
DR GEO; GSM482560
DR GEO; GSM887344
DR GEO; GSM888420
DR GEO; GSM1374694
DR GEO; GSM1670137
DR IGRhCellID; MV4II
DR TOKU-E; 2536
RX PubMed=2656885;
RX PubMed=3496132;
RX PubMed=8353274;
RX PubMed=8358709;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=19608861;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 32 hours (PubMed=25984343); ~50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Acetylation analysis by proteomics.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; HTB-189; true.
ST Source(s): ATCC; CLS; COG; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11,12
ST D18S51: 11,17
ST D19S433: 15
ST D21S11: 32,32.2
ST D2S1338: 24,25
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 8,9
ST D8S1179: 13
ST FGA: 19,21
ST Penta D: 9,10
ST Penta E: 7,18
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C9163; Childhood acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MV522/MDR1
AC CVCL_0E37
DR ATCC; CRL-2520
CC Problematic cell line: Contaminated. Parent cell line (MV-522) has been shown to be a HT-29 derivative.
CC Discontinued: ATCC; CRL-2520; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7204 ! MV-522
SX Female
CA Cancer cell line
//
ID MV522/MRP
AC CVCL_0E38
DR ATCC; CRL-2521
DR BioSample; SAMN03471605
CC Problematic cell line: Contaminated. Parent cell line (MV-522) has been shown to be a HT-29 derivative.
CC Discontinued: ATCC; CRL-2521; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6
ST TPOX: 8,9
ST vWA: 17,19
DI NCIt; C43584; Rectosigmoid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7204 ! MV-522
SX Female
CA Cancer cell line
//
ID MVA28C
AC CVCL_8Y22
DR ECACC; 06011807
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID MVh-Venns GS
AC CVCL_1T55
DR RCB; AES0196
CC Characteristics: Germ stem cell line.
CC Breed/subspecies: C57BL/6J x DBA2.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID Mvi/It
AC CVCL_3550
SY MVI-it
DR CLO; CLO_0007908
DR ATCC; CRL-6012
DR GEO; GSM2037235
RX PubMed=27303702;
CC Group: Bat cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Characteristics: From a skin tumor found in a bat from Frio Cave, Texas.
CC Characteristics: Infected by bat gammaherpesvirus 8 (BGHV8).
CC Discontinued: ATCC; CRL-6012; true.
OX NCBI_TaxID=9435; ! Myotis velifer
OI CVCL_S455 ! Mvi/Mu
SX Female
CA Cancer cell line
//
ID Mvi/Mu
AC CVCL_S455
DR ATCC; CRL-6011
CC Group: Bat cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6011; true.
OX NCBI_TaxID=9435; ! Myotis velifer
OI CVCL_3550 ! Mvi/It
SX Female
CA Finite cell line
//
ID MVL
AC CVCL_F658
SY GM06826
DR CLO; CLO_0036524
DR Coriell; GM06826
DR IMGT/HLA; 11116
RX PubMed=6417008;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID MVLN
AC CVCL_4Y56
SY MVLN 15-C7
DR ChEMBL-Cells; CHEMBL3307321
DR ChEMBL-Targets; CHEMBL614185
RX PubMed=9831484;
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0031 ! MCF-7
SX Female
CA Cancer cell line
//
ID MVP1
AC CVCL_U130
DR CLO; CLO_0050318
DR RCB; RCB1837
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID MVP25
AC CVCL_U131
DR CLO; CLO_0050319
DR RCB; RCB1838
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID MVP47
AC CVCL_U132
DR CLO; CLO_0050333
DR RCB; RCB1839
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID MVP49
AC CVCL_U133
DR CLO; CLO_0050320
DR RCB; RCB1840
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID MVP51
AC CVCL_U134
DR CLO; CLO_0050321
DR RCB; RCB1841
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID MVPK-1
AC CVCL_4544
SY MVPK 1; Mengeling-Vaughn Porcine Kidney-1
DR CLO; CLO_0007909
DR CLDB; cl3612
DR IZSLER; BS CL 119
RX PubMed=185927;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID MVPK-1 clone 7
AC CVCL_U234
RX PubMed=192426;
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_4544 ! MVPK-1
CA Spontaneously immortalized cell line
//
ID MW
AC CVCL_U799
DR Cosmic; 848243
DR Cosmic; 928721
DR GEO; GSM226864
RX PubMed=9354451;
RX PubMed=17363583;
CC Omics: CNV analysis.
CC Omics: SNP array analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MW1
AC CVCL_M367
RX PubMed=17273757;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mw1Ht
AC CVCL_S347
SY MW1H
DR ATCC; CRL-6013
CC Group: Bat cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6013; true.
OX NCBI_TaxID=124750; ! Macrotus waterhousii
SX Sex undetermined
CA Finite cell line
//
ID Mw2Lu
AC CVCL_S348
SY MW2.Lu
DR ATCC; CRL-6014
CC Group: Bat cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6014; true.
OX NCBI_TaxID=124750; ! Macrotus waterhousii
SX Sex undetermined
CA Finite cell line
//
ID MWCL-1
AC CVCL_M086
SY MWCL1; MWCL.1
DR Cosmic; 1762457
DR LINCS; 51098
RX PubMed=21415268;
RX PubMed=22950966;
RX PubMed=24189269;
RX PubMed=25853860;
CC Characteristics: Hemizygous for the TP53 p.Val143Ala mutation.
DI NCIt; C80307; Waldenstrom macroglobulinemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MWF
AC CVCL_1M74
SY GM03162; GM 3162
DR CLO; CLO_0013519
DR Coriell; GM03162
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Mwika
AC CVCL_7205
SY MWIKA; Mwi-BL; MWI-BL; MWI; Mwi
RX PubMed=2824665;
RX PubMed=2943927;
RX PubMed=3035497;
RX PubMed=9882297;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MX-1
AC CVCL_4774
SY MX1; MXI
DR BTO; BTO:0004179
DR EFO; EFO_0006457
DR BioSample; SAMN03472921
DR ChEMBL-Cells; CHEMBL3307479
DR ChEMBL-Cells; CHEMBL3308046
DR ChEMBL-Targets; CHEMBL613704
DR ChEMBL-Targets; CHEMBL614186
DR CLS; 300296/p541_MX-1
DR GEO; GSM845398
DR GEO; GSM844612
DR GEO; GSM844611
DR GEO; GSM844613
DR LINCS; 51090
RX PubMed=25485619;
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): CLS; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12 (CLS)
ST D13S317: 11 (PubMed=25877200)
ST D16S539: 12
ST D18S51: 12,16
ST D21S11: 29,30,32 (CLS)
ST D21S11: 29,32 (PubMed=25877200)
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 11,12 (CLS)
ST D7S820: 11 (PubMed=25877200)
ST D8S1179: 11,12,13 (CLS)
ST D8S1179: 11 (PubMed=25877200)
ST FGA: 20
ST Penta D: 9,11 (CLS)
ST Penta D: 6,9,11 (PubMed=25877200)
ST Penta E: 14
ST TH01: 7,9
ST TPOX: 8
ST vWA: 17,18 (CLS)
ST vWA: 17 (PubMed=25877200)
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MY
AC CVCL_3034
DR CLO; CLO_0050475
DR BioSample; SAMN03472122
DR GEO; GSM827267
DR JCRB; JCRB0158.0
DR JCRB; NIHS0246
DR RCB; RCB1701
RX PubMed=9790503;
CC Discontinued: JCRB; NIHS0246; true.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 9
ST D5S818: 11,13
ST D7S820: 10,13
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4673; Acute biphenotypic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID My 43.51
AC CVCL_L539
SY My 43
DR CLO; CLO_0007910
DR ATCC; HB-12128
RX Patent=US5610057;
CC Discontinued: ATCC; HB-12128; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID MY-EBV-LCL
AC CVCL_J500
DR CLO; CLO_0050986
DR BioSample; SAMN03472145
DR RCB; RCB1487
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12,14
ST D5S818: 10,11
ST D7S820: 8,10
ST TH01: 7
ST TPOX: 8
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID My-La CD4+
AC CVCL_2633
SY My-La, marker chromosome
DR ECACC; 95051032
RX PubMed=1582990;
CC Characteristics: IL2 and IL4 dependent.
CC Doubling time: 20-24 hours (ECACC).
ST Source(s): ECACC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 8,11
ST D5S818: 9,12
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2634 ! My-La CD8+
SX Male
CA Cancer cell line
//
ID My-La CD8+
AC CVCL_2634
SY My-La 46,XY-18+i(18q)
DR ECACC; 95051033
RX PubMed=1582990;
CC Characteristics: IL2 dependent.
DI NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2633 ! My-La CD4+
SX Male
CA Cancer cell line
//
ID MY-M12
AC CVCL_3035
SY MY clone M12
DR Cosmic; 2131569
DR Cosmic-CLP; 1330960
DR GDSC; 1330960
DR GEO; GSM1670138
DR JCRB; JCRB0158.1
DR JCRB; NIHS0246.1
RX PubMed=9790503;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: JCRB; NIHS0246.1; true.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 9
ST D5S818: 11,13
ST D7S820: 10,13
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4673; Acute biphenotypic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3034 ! MY
SX Female
CA Cancer cell line
//
ID MY-M13
AC CVCL_3036
SY MY clone M13
DR JCRB; JCRB0158.2
DR JCRB; NIHS0246.2
RX PubMed=9790503;
CC Discontinued: JCRB; NIHS0246.2; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 9
ST D5S818: 11,13
ST D7S820: 10,13
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C4673; Acute biphenotypic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3034 ! MY
SX Female
CA Cancer cell line
//
ID My.Sp
AC CVCL_S317
DR ATCC; CRL-6000
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6000; true.
OX NCBI_TaxID=181542; ! Myoprocta acouchy
SX Male
CA Finite cell line
//
ID MY904
AC CVCL_C556
SY MY-904; 904
DR CLO; CLO_0007911
DR ATCC; HB-9510
DR CCRID; 3142C0001000000427
RX Patent=US4840793;
CC Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID MYA-1
AC CVCL_3753
DR CLO; CLO_0007912
DR ATCC; CRL-2417
RX PubMed=1313703;
RX PubMed=2480760;
CC Characteristics: IL2 dependent.
OX NCBI_TaxID=9685; ! Felis catus
CA Factor-dependent cell line
//
ID MYB 2-3.76
AC CVCL_B433
SY MYB2-3.76; Myb2-3
DR CLO; CLO_0007913
DR ATCC; CRL-1728
RX PubMed=6084811;
CC Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-Myb (also reacts with chicken MYB).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MYB 2-32
AC CVCL_G337
SY Myb2-32
DR ECACC; 84101003
RX PubMed=6084811;
CC Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-Myb (also reacts with chicken MYB).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MYB 2-37.63
AC CVCL_B434
SY MYB2-37.63; Myb2-37
DR CLO; CLO_0007914
DR ATCC; CRL-1726
DR ECACC; 84110802
RX PubMed=6084811;
CC Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-Myb (also reacts with chicken MYB).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MYB 2-7.77
AC CVCL_B435
SY MYB2-7.77; Myb2-7
DR ATCC; CRL-1724
DR ECACC; 84110801
RX PubMed=6084811;
CC Monoclonal antibody target: UniProtKB; P01104; Avian myeloblastosis virus v-Myb (also reacts with chicken MYB).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MYC 1-9E10.2
AC CVCL_G671
SY MYC1-9E10.2; 9E10
DR CLO; CLO_0007915
DR ATCC; CRL-1729
CC Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L708 ! Myc1-9E10
CA Hybridoma
//
ID MYC CT 14-G4.3
AC CVCL_G672
SY MYCCT 14-G4.3; CT14-G4
DR CLO; CLO_0007916
DR ATCC; CRL-1727
RX PubMed=3915782;
CC Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MYC CT 9-B7.3
AC CVCL_G673
SY MYCCT9-B7.3; CT9-B7
DR CLO; CLO_0007917
DR ATCC; CRL-1725
RX PubMed=3915782;
CC Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Myc-CaP
AC CVCL_J703
DR BTO; BTO:0005126
DR ATCC; CRL-3255
RX PubMed=16357166;
WW https://www.researchgate.net/post/I_am_having_difficulty_growing_the_Myc-CaP_mouse_prostate_cancer_cell_line_Does_anyone_have_a_suggestion_on_how_to_care_for_this_cell_line
CC Breed/subspecies: FVB Hi-Myc.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID Myc1-3C7
AC CVCL_L706
SY Mycl-3C7
DR ECACC; 85102203
RX PubMed=3915782;
CC Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Myc1-6E10
AC CVCL_U066
RX PubMed=3915782;
CC Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Myc1-8F9
AC CVCL_L707
SY Mycl-8F9
DR ECACC; 85102204
DR NCBI_Iran; H120
RX PubMed=3915782;
CC Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Myc1-9E10
AC CVCL_L708
SY Mycl-9E10
DR ECACC; 83133297
DR ECACC; 85102202
RX PubMed=3915782;
CC Monoclonal antibody target: UniProtKB; P01106; Human MYC.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID MYE 2001
AC CVCL_E785
DR dbMHC; 48979
DR IHW; IHW9417
DR IMGT/HLA; 26021
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID MYE 2002
AC CVCL_E786
DR dbMHC; 48980
DR IHW; IHW9418
DR IMGT/HLA; 26022
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID MYE 2003
AC CVCL_E787
DR dbMHC; 48981
DR IHW; IHW9419
DR IMGT/HLA; 26023
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID MYE 2004
AC CVCL_E788
DR dbMHC; 48982
DR IHW; IHW9420
DR IMGT/HLA; 26024
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID MYE 2006
AC CVCL_E789
DR dbMHC; 48983
DR IHW; IHW9422
DR IMGT/HLA; 26025
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID MyEnd
AC CVCL_2131
SY MyEND; Myocardial Endothelial
RX PubMed=11850521;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID Myf5 Myod1 DKO MEF 2C5/7
AC CVCL_BS98
SY 2C5/7; dblKO; MyoD-null/Myf5-null dblKO
DR GEO; GSM73062
DR GEO; GSM73063
DR GEO; GSM73064
RX PubMed=16275751;
CC Knockout cell: Method=KO mouse; MGI; MGI:97252; Myf5.
CC Knockout cell: Method=KO mouse; MGI; MGI:97275; Myod1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID MYL
AC CVCL_D202
DR Cosmic; 1151880
RX PubMed=17432977;
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MYL-R
AC CVCL_D203
RX PubMed=17432977;
CC Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D202 ! MYL
SX Female
CA Cancer cell line
//
ID MyLa 1850
AC CVCL_M415
SY MyLa1850
RX PubMed=17179233;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID MyLa 1885
AC CVCL_8327
SY MyLa1885; MF1885
RX PubMed=16932349;
RX PubMed=17179233;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M416 ! MyLa 1928
OI CVCL_8328 ! MyLa 2000
OI CVCL_8326 ! MyLa 3675
CA Finite cell line
//
ID MyLa 1928
AC CVCL_M416
SY MyLa1928; MF1928
RX PubMed=16932349;
RX PubMed=17179233;
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8327 ! MyLa 1885
OI CVCL_8328 ! MyLa 2000
OI CVCL_8326 ! MyLa 3675
CA Finite cell line
//
ID MyLa 1929
AC CVCL_5340
SY MyLa1929
RX PubMed=17179233;
DI NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5341 ! MyLa 2039
CA Cancer cell line
//
ID MyLa 2000
AC CVCL_8328
SY MyLa2000; MF2000
RX PubMed=16932349;
DI NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8327 ! MyLa 1885
OI CVCL_M416 ! MyLa 1928
OI CVCL_8326 ! MyLa 3675
CA Cancer cell line
//
ID MyLa 2039
AC CVCL_5341
SY MyLa2039
DR BTO; BTO:0004842
RX PubMed=17179233;
DI NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5340 ! MyLa 1929
CA Cancer cell line
//
ID MyLa 2059
AC CVCL_5342
SY MyLa2059
DR BTO; BTO:0004843
RX PubMed=17179233;
DI NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5341 ! MyLa 2039
CA Cancer cell line
//
ID MyLa 2355
AC CVCL_M417
SY MyLa2355
RX PubMed=17179233;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID MyLa 3241
AC CVCL_M418
SY MyLa3241
RX PubMed=17179233;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID MyLa 3675
AC CVCL_8326
SY MyLa3675; MF3675
RX PubMed=16932349;
DI NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8327 ! MyLa 1885
OI CVCL_M416 ! MyLa 1928
OI CVCL_8328 ! MyLa 2000
CA Cancer cell line
//
ID MYP30
AC CVCL_Z591
SY MYP-30
DR BTO; BTO:0005684
RX PubMed=7524206;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID MYP30-fDAF
AC CVCL_CZ86
RX PubMed=25671605;
CC Transfected with: UniProtKB; U6C7L4; Cat DAF.
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_Z591 ! MYP30
CA Spontaneously immortalized cell line
//
ID MZ-159
AC CVCL_M407
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-18
AC CVCL_M404
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-256
AC CVCL_M408
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-257
AC CVCL_M409
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-294
AC CVCL_M410
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-304
AC CVCL_M411
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-327
AC CVCL_M412
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-348
AC CVCL_M413
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-373
AC CVCL_M414
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-51
AC CVCL_M405
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-54
AC CVCL_M406
RX PubMed=17924059;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mz-ChA-1
AC CVCL_6932
SY MZ CHA-1; Mz-ChA1; MzChA-1; MzChA1
DR BTO; BTO:0003311
DR Cosmic; 924012
DR Cosmic; 927192
RX CelloPub=CLPUB00275;
RX PubMed=4056357;
RX PubMed=9824643;
RX PubMed=21533411;
CC Doubling time: 41 hours (PubMed=9824643).
CC Derived from metastatic site: Abdominal wall.
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mz-ChA-2
AC CVCL_6933
SY MZ CHA-2; Mz-ChA2; MzChA-2; MzChA2
DR Cosmic; 924013
DR Cosmic; 927193
RX CelloPub=CLPUB00275;
RX PubMed=4056357;
RX PubMed=9824643;
RX PubMed=21533411;
CC Doubling time: 34 hours (PubMed=9824643).
CC Derived from metastatic site: Liver.
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mz-ChA-3
AC CVCL_H708
SY MZ CHA-3; MZ-CHA-3
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-CO-1
AC CVCL_7685
SY MZ CO-1; MZ-Co 1
RX PubMed=7654439;
RX PubMed=8375931;
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-CRC-1
AC CVCL_A656
SY MZCRC1
DR Cosmic; 796732
DR Cosmic; 1239956
DR Cosmic; 2036698
DR Cosmic; 2050373
RX PubMed=7736432;
DI NCIt; C3879; Thyroid gland medullary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MZ-GC-1
AC CVCL_4U28
RX PubMed=7599790;
CC Derived from metastatic site: Liver.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MZ-GC-2
AC CVCL_4U29
SY MzGC2
RX PubMed=7599790;
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Mz-Hep-1
AC CVCL_5A02
SY MzHep1
RX PubMed=2415435;
RX PubMed=8738480;
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MZ-LC-1
AC CVCL_7686
RX PubMed=7654439;
RX PubMed=8375931;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-MEL-11
AC CVCL_7687
SY MZ-Mel-11
RX PubMed=7654439;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-MEL-13
AC CVCL_B286
SY MZ-Mel-13; Mz-Mel-13; MZ MEL 13; MZ Mel 13
DR Cosmic; 972268
DR Cosmic; 2163795
DR ESTDAB; ESTDAB-052
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D3S1358: 16,18
ST D5S818: 12
ST D7S820: 10,12
ST FGA: 21
ST TH01: 9
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MZ-MEL-18
AC CVCL_7688
SY MZ-Mel-18
RX PubMed=8375931;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-MEL-19
AC CVCL_8061
SY MZ-Mel-19; Mz-Mel-19; MZ Mel 19; Mz-19; MZ19
RX PubMed=10910072;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DE24 ! MZ-MEL-19/B-LCL
SX Female
CA Cancer cell line
//
ID MZ-MEL-19/B-LCL
AC CVCL_DE24
SY MZ-Mel-19/B-LCL
DR ESTDAB; ESTDAB-054
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D3S1358: 15,17
ST D5S818: 9,11
ST D7S820: 9
ST FGA: 20,23
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8061 ! MZ-MEL-19
SX Female
CA Transformed cell line
//
ID MZ-MEL-2
AC CVCL_1435
SY Mz-Mel-2; MZ Mel 2; MZ-2 Mel; MZ2-MEL; MZ2-Mel
DR ChEMBL-Cells; CHEMBL3308272
DR ChEMBL-Targets; CHEMBL2366226
DR Cosmic; 971777
DR Cosmic-CLP; 971777
DR GDSC; 971777
DR GEO; GSM1670140
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 12,13
ST D5S818: 9,11
ST D7S820: 10,12
ST TH01: 8,9.3
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-MEL-3.1
AC CVCL_7689
SY MZ-Mel-3.1; MZ-Mel-3; MzMel3
DR Cosmic; 2163796
DR ESTDAB; ESTDAB-055
RX PubMed=8375931;
ST Source(s): ESTDAB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D3S1358: 15,17
ST D5S818: 9,11
ST D7S820: 9
ST FGA: 20,23
ST TH01: 6,8
ST TPOX: 8,11
ST vWA: 14,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MZ-MEL-4
AC CVCL_B287
SY Mz-Mel-4; MZ Mel 4
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-MEL-5
AC CVCL_A468
SY MZ-Mel-5; Mz-Mel-5; MZ MEL 5
DR Cosmic; 972269
DR Cosmic; 2163797
DR ESTDAB; ESTDAB-056
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D3S1358: 16
ST D5S818: 11
ST D7S820: 8,13
ST FGA: 21,25
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MZ-MEL-6
AC CVCL_7690
SY MZ-Mel-6
RX PubMed=7654439;
RX PubMed=8375931;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-MEL-7
AC CVCL_1436
SY MZ-Mel-7; MZ7-MEL; MZ7-mel
DR ChEMBL-Cells; CHEMBL3308546
DR ChEMBL-Targets; CHEMBL2366138
DR Cosmic; 753596
DR Cosmic-CLP; 753596
DR GDSC; 753596
DR GEO; GSM1670141
DR LINCS; 51006
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 8,11
ST TH01: 6,8
ST TPOX: 9,11
ST vWA: 17
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MZ-MEL-9
AC CVCL_C619
SY MZ-Mel-9
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-PC-1
AC CVCL_1434
AS CVCL_A657
SY MZPC-1; MZ1-PC; MZ1PC
DR ChEMBL-Cells; CHEMBL3308242
DR ChEMBL-Targets; CHEMBL2366204
DR Cosmic; 753595
DR Cosmic; 948732
DR Cosmic-CLP; 753595
DR GDSC; 753595
DR GEO; GSM1670139
RX PubMed=7599790;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 11,12
ST D5S818: 10,11
ST D7S820: 9,10
ST TH01: 6,8
ST TPOX: 8
ST vWA: 18
DI NCIt; C9120; Pancreatic ductal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MZ-PC-2
AC CVCL_A658
SY MZPC-2
DR Cosmic; 948733
RX PubMed=8514455;
RX PubMed=9665481;
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-PC-3
AC CVCL_4U30
SY MZPC-3
RX PubMed=9665481;
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ-PC-4
AC CVCL_A659
SY MZPC-4
DR Cosmic; 948734
RX PubMed=9665481;
DI NCIt; C3850; Pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mz-Sto-1
AC CVCL_S859
SY MZ-Sto-1
RX PubMed=2820743;
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MZ070782
AC CVCL_E790
DR dbMHC; 48984
DR ECACC; 88052002
DR IHW; IHW9002
DR IMGT/HLA; 11120
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl2.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID MZ1257
AC CVCL_E044
SY MZ1257-RCC; MZ 1257 RC
RX PubMed=7989126;
RX PubMed=8864171;
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ1774
AC CVCL_X415
SY MZ1774-RCC; MZ 1774 RC
RX PubMed=7989126;
RX PubMed=8864171;
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ1790
AC CVCL_X409
SY MZ1790-RCC; MZ 1790 RC
RX PubMed=8864171;
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ1795
AC CVCL_X416
SY MZ 1795 RC
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mz18
AC CVCL_M401
RX PubMed=11688964;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MZ1846
AC CVCL_X417
SY MZ 1846 RC
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ1851
AC CVCL_E045
SY MZ1851-RCC; MZ 1851 RC
RX PubMed=7989126;
RX PubMed=8864171;
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_X418 ! MZ1851-LN
CA Cancer cell line
//
ID MZ1851-LN
AC CVCL_X418
SY MZ 1851 LN
RX PubMed=17200335;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_E045 ! MZ1851
CA Cancer cell line
//
ID MZ1879
AC CVCL_X406
SY MZ1879-RCC; MZ 1879 RC
RX PubMed=7989126;
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ1940
AC CVCL_X407
SY MZ1940-RCC; MZ 1940 RC
RX PubMed=7989126;
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ1973
AC CVCL_E046
SY MZ1973-RCC; MZ 1973 RC
RX PubMed=8864171;
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ1973/10-4
AC CVCL_7684
SY MZ1973-10-4; MZ1973-10-4-RCC
RX PubMed=8864171;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E046 ! MZ1973
CA Cancer cell line
//
ID MZ1979
AC CVCL_X408
SY MZ1979-RCC
RX PubMed=7989126;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mz21
AC CVCL_M402
RX PubMed=11688964;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID MZ2733
AC CVCL_X419
SY MZ 2733 RC
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ2858
AC CVCL_X420
SY MZ 2858 RC
RX PubMed=17200335;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ2861
AC CVCL_X421
SY MZ 2861 RC
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ2862
AC CVCL_X422
SY MZ 2862 RC
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ2865
AC CVCL_E047
SY MZ 2865 RC
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ2877
AC CVCL_X423
SY MZ 2877 RC
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ2885
AC CVCL_X424
SY MZ 2885 RC
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ2902
AC CVCL_X425
SY MZ 2902 RC
RX PubMed=17200335;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID MZ2905
AC CVCL_X426
SY MZ 2905 RC
RX PubMed=17200335;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Mz35
AC CVCL_M403
RX PubMed=11688964;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID MZ93
AC CVCL_F999
DR TKG; TKG 0712
RX PubMed=11792418;
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 13
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 9
ST vWA: 16,18
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID N-1A-103
AC CVCL_L428
SY N103
RX PubMed=4400294;
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4343 ! C-1300
SX Male
CA Cancer cell line
//
ID N-S.2.1
AC CVCL_G338
DR CLO; CLO_0008199
DR ATCC; TIB-108
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID N-S.4.1
AC CVCL_G339
DR CLO; CLO_0008200
DR ATCC; TIB-110
CC Monoclonal antibody target: Sheep red blood cells (SRBC).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID N-S.7
AC CVCL_G340
DR CLO; CLO_0008201
DR ATCC; TIB-114
CC Monoclonal antibody target: Sheep red blood cells (SRBC).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID N-S.8.1
AC CVCL_G341
DR CLO; CLO_0008202
DR ATCC; TIB-109
CC Monoclonal antibody target: Sheep red blood cells (SRBC).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID N/N1003A
AC CVCL_0450
SY N/N 1003A; NN 1003A; NN1003A
DR MCCL; MCC:0000347
DR CCRID; 3111C0001CCC000196
RX PubMed=3569698;
RX PubMed=9990330;
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
CA Spontaneously immortalized cell line
//
ID N/TERT-1
AC CVCL_CW92
RX PubMed=10648628;
DI NCIt; C129863; Oral dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L237 ! POE9n
CA Telomerase immortalized cell line
//
ID N_M5R1
AC CVCL_HG07
DR Ximbio; 152837
RX PubMed=27323823;
CC Selected for resistance to: ChEBI; CHEBI:134602; MI-63.
CC Derived from metastatic site: Lung.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2141 ! NGP
SX Male
CA Cancer cell line
//
ID N_N20R
AC CVCL_HG08
DR Ximbio; 152840
RX PubMed=27323823;
CC Selected for resistance to: ChEBI; CHEBI:46742; Nutlin-3.
CC Derived from metastatic site: Lung.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2141 ! NGP
SX Male
CA Cancer cell line
//
ID N1-S1
AC CVCL_3551
DR BTO; BTO:0000591
DR CLO; CLO_0007923
DR CLDB; cl3618
DR ATCC; CRL-1604
DR BCRC; 60267
DR ECACC; 90011902
RX PubMed=14297488;
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID N1-S1 Fudr
AC CVCL_3552
SY N1-S1/Fudr
DR CLO; CLO_0007924
DR ATCC; CRL-1603
RX PubMed=14297488;
CC Selected for resistance to: ChEBI; CHEBI:60761; 5-fluoro-2'-deoxyuridine (FUdR).
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3551 ! N1-S1
SX Male
CA Cancer cell line
//
ID N1.551
AC CVCL_J692
DR CLO; CLO_0007918
DR ATCC; CRL-2040
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID N1000
AC CVCL_F671
SY GM11534
DR CLO; CLO_0020999
DR Coriell; GM11534
RX PubMed=3004699;
RX PubMed=3390826;
RX PubMed=3461479;
DI NCIt; C7542; Askin tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID N1001
AC CVCL_F672
RX PubMed=3004699;
RX PubMed=3390826;
RX PubMed=3461479;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID N1002
AC CVCL_F673
RX PubMed=3004699;
RX PubMed=3390826;
RX PubMed=3461479;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID N1003
AC CVCL_X410
RX PubMed=3004699;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID N1007
AC CVCL_X411
RX PubMed=3004699;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID N1008
AC CVCL_F674
RX PubMed=3004699;
RX PubMed=3390826;
RX PubMed=3461479;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C7542; Askin tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID N1016
AC CVCL_F675
RX PubMed=3004699;
RX PubMed=3390826;
RX PubMed=3461479;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C7542; Askin tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID N1024
AC CVCL_X412
RX PubMed=3004699;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID N1043
AC CVCL_F676
RX PubMed=3390826;
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID N1046
AC CVCL_X413
RX PubMed=3390826;
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID N1050
AC CVCL_X414
RX PubMed=3390826;
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID N115-BU-1
AC CVCL_AR48
DR ECACC; 08062547
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0451 ! N1E-115
SX Male
CA Cancer cell line
//
ID N115-BU-10
AC CVCL_4250
DR ECACC; 08062559
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0451 ! N1E-115
SX Male
CA Cancer cell line
//
ID N115-BU-2
AC CVCL_4251
DR ECACC; 08062552
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0451 ! N1E-115
SX Male
CA Cancer cell line
//
ID N115-BU-7
AC CVCL_4252
DR ECACC; 08062554
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0451 ! N1E-115
SX Male
CA Cancer cell line
//
ID N115-BU-8
AC CVCL_4253
DR ECACC; 08062519
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0451 ! N1E-115
SX Male
CA Cancer cell line
//
ID N115-BU-9
AC CVCL_4254
DR ECACC; 08062558
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0451 ! N1E-115
SX Male
CA Cancer cell line
//
ID N13
AC CVCL_5G93
RX PubMed=2789141;
RX PubMed=7681038;
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID N14.5
AC CVCL_U465
DR CLO; CLO_0051389
DR RCB; RCB2863
RX PubMed=16616428;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID N14A
AC CVCL_4V86
RX PubMed=25929336;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3345; Pseudomyxoma peritonei
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID N1511
AC CVCL_A781
SY N-1511
DR BTO; BTO:0005494
RX PubMed=12369787;
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID N15A
AC CVCL_4V87
RX PubMed=25929336;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3345; Pseudomyxoma peritonei
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID N15C6
AC CVCL_4749
RX PubMed=15381370;
WW http://capcelllines.ca/details.asp?id=164
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID N18 [Mouse]
AC CVCL_4724
AS CVCL_8661
SY N-18; N18 (Hamprecht); C-1300N18
DR CLO; CLO_0007920
DR CLO; CLO_0050185
DR CLDB; cl3614
DR ECACC; 08062527
DR RCB; RCB2620
DR TKG; TKG 0307
RX PubMed=4400294;
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4343 ! C-1300
SX Male
CA Cancer cell line
//
ID N18 [Mouse/rat hybrid]
AC CVCL_4723
DR CLO; CLO_0007919
DR CLDB; cl3619
DR ECACC; 88112301
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4724 ! N18 [Mouse]
CA Hybrid cell line
//
ID N18-RE-105
AC CVCL_J375
SY N18-RE 105
DR IFO; IFO50221
DR TOKU-E; 4029
RX PubMed=6149215;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2132 ! N18TG2
CA Hybrid cell line
//
ID N18TG2
AC CVCL_2132
SY N18Tg2; N18 tg 2
DR BTO; BTO:0000933
DR CLO; CLO_0007921
DR CLDB; cl3620
DR DSMZ; ACC-103
DR ECACC; 08062523
DR TOKU-E; 4020
CC Doubling time: ~40 hours (DSMZ).
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4724 ! N18 [Mouse]
SX Male
CA Cancer cell line
//
ID N1E-115
AC CVCL_0451
SY NIE-115
DR BTO; BTO:0001909
DR CLO; CLO_0007922
DR MCCL; MCC:0000348
DR CLDB; cl3621
DR CLDB; cl4996
DR ATCC; CRL-2263
DR ChEMBL-Cells; CHEMBL3307973
DR ChEMBL-Targets; CHEMBL612553
DR ECACC; 88112303
RX PubMed=4400294;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-95.html
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4343 ! C-1300
SX Male
CA Cancer cell line
//
ID N1E-115-1
AC CVCL_4033
DR ECACC; 08062511
CC Doubling time: ~20 hours (ECACC).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0451 ! N1E-115
SX Male
CA Cancer cell line
//
ID N2.261
AC CVCL_2133
SY N2-261
DR CLO; CLO_0007925
DR ATCC; CRL-2047
DR DSMZ; ACC-322
CC Doubling time: ~20 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID N206
AC CVCL_C885
DR Cosmic; 930068
DR Cosmic; 1109114
DR Cosmic; 1153807
DR Cosmic; 1518069
DR Cosmic; 1526631
DR Cosmic; 1543775
DR Cosmic; 2239463
DR GEO; GSM692867
RX PubMed=7838528;
RX PubMed=22213050;
CC Omics: Transcriptome analysis.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID N2102Ep Clone 2/A6
AC CVCL_3037
DR Cosmic; 2439939
DR ECACC; 06011803
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_C522 ! 2102EP
SX Male
CA Cancer cell line
//
ID N211-1-8
AC CVCL_DD06
RX PubMed=1986234;
RX PubMed=6270122;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_7182 ! CHO-pro3-
SX Female
CA Spontaneously immortalized cell line
//
ID N22
AC CVCL_8965
DR CLO; CLO_0007926
DR ATCC; HB-225
RX PubMed=2185332;
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID N27
AC CVCL_D584
SY N-27; 1RB3AN27; 1RB3A-N27
DR BTO; BTO:0002393
DR Millipore; SCC048
RX PubMed=7820310;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID N2aEGFP
AC CVCL_D649
DR BTO; BTO:0002653
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0470 ! Neuro-2a
SX Male
CA Cancer cell line
//
ID N2aSW
AC CVCL_D650
SY Swe.24
DR BTO; BTO:0002663
RX PubMed=8621605;
CC Transfected with: HGNC; 620; APP (with N-670 and L-671).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0470 ! Neuro-2a
SX Male
CA Cancer cell line
//
ID N3.36
AC CVCL_2134
SY N3-36
DR CLO; CLO_0007927
DR CLO; CLO_0007928
DR ATCC; CRL-2042
DR DSMZ; ACC-318
CC Doubling time: ~24 hours (DSMZ).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID N418
AC CVCL_8966
DR CLO; CLO_0007929
DR ATCC; HB-224
RX PubMed=2185332;
OX NCBI_TaxID=10032; ! Cricetulus migratorius
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID N44SV.5
AC CVCL_AB85
RX PubMed=27345790;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID N4TG3
AC CVCL_2135
DR CLO; CLO_0007930
DR CLDB; cl3624
DR DSMZ; ACC-101
DR ECACC; 08062515
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4343 ! C-1300
SX Male
CA Cancer cell line
//
ID N52.E6
AC CVCL_IQ88
RX Patent=US6558948;
RX PubMed=11044912;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2416.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5 [E1A/E1B].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IQ89 ! N52.F4
CA Transformed cell line
//
ID N52.F4
AC CVCL_IQ89
RX Patent=US6558948;
RX PubMed=11044912;
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5 [E1A/E1B].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IQ88 ! N52.E6
CA Transformed cell line
//
ID N521J
AC CVCL_5343
RX PubMed=1693429;
RX PubMed=3262925;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=N521J
DI NCIt; C3992; AIDS-related Kaposi sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID N70-1.5e
AC CVCL_DC95
DR ATCC; CRL-10464
RX Patent=US6190871;
RX PubMed=1694449;
CC Monoclonal antibody target: HIV-1 gp120.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-10464; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DC96 ! N70-1.9b
OI CVCL_DC97 ! N70-2.1H
OI CVCL_DC98 ! N70-2.3a
CA Transformed cell line
//
ID N70-1.9b
AC CVCL_DC96
RX Patent=US6190871;
RX PubMed=1694449;
CC Monoclonal antibody target: HIV-1 gp120.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DC95 ! N70-1.5e
OI CVCL_DC97 ! N70-2.1H
OI CVCL_DC98 ! N70-2.3a
CA Transformed cell line
//
ID N70-2.1H
AC CVCL_DC97
DR ATCC; CRL-10758
RX Patent=US6190871;
CC Monoclonal antibody target: HIV-1 gp120.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ATCC; CRL-10758; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DC95 ! N70-1.5e
OI CVCL_DC96 ! N70-1.9b
OI CVCL_DC98 ! N70-2.3a
CA Transformed cell line
//
ID N70-2.3a
AC CVCL_DC98
RX Patent=US6190871;
RX PubMed=1694449;
CC Monoclonal antibody target: HIV-1 gp120.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DC95 ! N70-1.5e
OI CVCL_DC96 ! N70-1.9b
OI CVCL_DC97 ! N70-2.1H
CA Transformed cell line
//
ID N9
AC CVCL_0452
SY N-9
DR BTO; BTO:0003957
DR MCCL; MCC:0000349
RX PubMed=7681038;
RX PubMed=21961028;
RX PubMed=22651808;
CC Transformant: Recombinant retrovirus 3RV.
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID NA
AC CVCL_7082
DR BTO; BTO:0004003
DR CGH-DB; 356-2
DR Cosmic; 930336
DR Cosmic; 974314
DR Cosmic; 1046035
DR Cosmic; 1123037
DR Cosmic; 1317412
RX PubMed=17052259;
RX PubMed=17599052;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NA-112-S2
AC CVCL_2Z41
SY NA-112-S2.4; WC00008
DR CLO; CLO_0013438
DR BioSamples; SAME17781
DR Coriell; WC00008
CC Discontinued: Coriell; WC00008; probable.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID NA-NP15
AC CVCL_DG71
SY NP15
DR GEO; GSM157161
DR GEO; GSM157162
CC Characteristics: In vitro infected with EBV isolate Akata.
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6008 ! NPC-TW01
SX Male
CA Cancer cell line
//
ID NA-NR1
AC CVCL_DG72
SY NR1
DR GEO; GSM147666
DR GEO; GSM147667
CC Characteristics: In vitro infected with EBV isolate Akata.
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6008 ! NPC-TW01
SX Male
CA Cancer cell line
//
ID NA-NR15
AC CVCL_DG73
SY NR15
DR GEO; GSM147668
DR GEO; GSM147669
CC Characteristics: In vitro infected with EBV isolate Akata.
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_DG72 ! NA-NR1
SX Male
CA Cancer cell line
//
ID NA1/34.HLK
AC CVCL_G199
SY NA1-34.HLK; NA 1/34
DR ECACC; 85102243
RX PubMed=376318;
CC Monoclonal antibody target: UniProtKB; P06126; Human CD1A.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID NA101
AC CVCL_L979
DR CLO; CLO_0007933
DR CLDB; cl3627
RX PubMed=2553220;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
OX NCBI_TaxID=9031; ! Gallus gallus
CA Transformed cell line
//
ID NA8-MEL
AC CVCL_S599
SY Na-8-MEL; Na-8 MEL; NA 8-MEL; Na8Mel; Na-8; NA8; Na8
CC From: Jotereau F.; U211 INSERM; Nantes; France.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NAB
AC CVCL_9T72
SY North American Burkitt
DR Cosmic; 717424
DR Cosmic; 923825
RX PubMed=176407;
RX PubMed=1697668;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NAB-2
AC CVCL_E219
SY NAB2; Nab2; North American Burkitt-2
DR Cosmic; 2297023
DR GEO; GSM115811
RX PubMed=1697668;
RX PubMed=15241441;
RX PubMed=16960149;
CC Characteristics: The single copy EBV genome is integrated on chromosome 2p13 between REL and BCL11A.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9T72 ! NAB
SX Female
CA Cancer cell line
//
ID NAB9B
AC CVCL_IU55
RX PubMed=2052620;
RX PubMed=9359519;
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NABCA
AC CVCL_M368
RX PubMed=17257375;
CC Doubling time: ~66 hours (PubMed=17257375).
CC Derived from metastatic site: Lymph node.
DI NCIt; C7362; Scirrhous breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Nagai
AC CVCL_6E84
SY Nagai-cell
RX PubMed=233287;
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NAGL-1
AC CVCL_3038
DR BioSample; SAMN03472798
DR IFO; IFO50479
RX PubMed=10071461;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,9
ST D16S539: 9,12
ST D5S818: 9,11
ST D7S820: 12
ST TH01: 6,9
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Nagoya-78
AC CVCL_D116
RX DOI=10.1007/978-1-4757-1647-4_13;
RX PubMed=5100402;
DI NCIt; C40409; Salivary gland pleomorphic adenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NAI003
AC CVCL_E791
SY NAI 003
DR dbMHC; 48985
DR ECACC; 94082270
DR IHW; IHW9170
DR IMGT/HLA; 11713
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl170.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94082270; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID NAI006
AC CVCL_E792
SY NAI 006
DR dbMHC; 48986
DR ECACC; 94082272
DR IHW; IHW9172
DR IMGT/HLA; 11715
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl172.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID NAI026
AC CVCL_E793
SY NAI 026
DR dbMHC; 48987
DR ECACC; 94082271
DR IHW; IHW9171
DR IMGT/HLA; 11714
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl171.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID NAI031
AC CVCL_E794
SY NAI 031
DR dbMHC; 48988
DR ECACC; 94082273
DR IHW; IHW9173
DR IMGT/HLA; 11716
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl173.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID Nak-Pc2
AC CVCL_M587
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NAKT-15
AC CVCL_L910
SY NAKT15
RX PubMed=16186810;
RX PubMed=16211061;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NAL1A
AC CVCL_R787
SY Nal1A; NAL-1A; NAL 1A
RX PubMed=2152771;
RX PubMed=3001399;
RX PubMed=3409226;
RX PubMed=4067735;
RX PubMed=6522104;
RX PubMed=6713549;
RX PubMed=9347924;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID NAL1A clone B5
AC CVCL_5U87
RX PubMed=3001399;
RX PubMed=3409226;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_R787 ! NAL1A
CA Spontaneously immortalized cell line
//
ID NAL1A clone B5D3
AC CVCL_5U90
SY B5D3
RX PubMed=2152771;
RX PubMed=2177605;
RX PubMed=3409226;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5U87 ! NAL1A clone B5
CA Spontaneously immortalized cell line
//
ID NAL1A clone B5SF11
AC CVCL_5U91
SY B5SF11
RX PubMed=2152771;
RX PubMed=2177605;
RX PubMed=3409226;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5U87 ! NAL1A clone B5
CA Transformed cell line
//
ID NAL1A clone C1
AC CVCL_5U88
RX PubMed=3409226;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_R787 ! NAL1A
CA Spontaneously immortalized cell line
//
ID NAL1A clone C1C10
AC CVCL_5U92
SY Nal1a C1C10; C1C10; C-10; C10
DR BTO; BTO:0004532
RX PubMed=2152771;
RX PubMed=2177605;
RX PubMed=2548715;
RX PubMed=3409226;
RX PubMed=9149863;
RX PubMed=9347924;
RX PubMed=12727792;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5U88 ! NAL1A clone C1
CA Spontaneously immortalized cell line
//
ID NAL1A clone C1SA5
AC CVCL_5U93
SY Nal1A C1A5; C1SA5; A-5; A5
RX PubMed=2152771;
RX PubMed=2177605;
RX PubMed=3409226;
RX PubMed=9149863;
RX PubMed=9347924;
RX PubMed=12727792;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5U88 ! NAL1A clone C1
CA Transformed cell line
//
ID NAL1A clone C4
AC CVCL_5U89
RX PubMed=3001399;
RX PubMed=3409226;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_R787 ! NAL1A
CA Spontaneously immortalized cell line
//
ID NAL1A clone C4E10
AC CVCL_0251
SY C4E10; E10
DR MCCL; MCC:0000142
RX PubMed=2152771;
RX PubMed=2177605;
RX PubMed=3409226;
RX PubMed=9347924;
RX PubMed=12727792;
CC Omics: Proteome analysis by 2D-DE/MS.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5U89 ! NAL1A clone C4
CA Spontaneously immortalized cell line
//
ID NAL1A clone C4SE9
AC CVCL_5V04
SY C4SE9; E9
RX PubMed=2152771;
RX PubMed=2177605;
RX PubMed=3409226;
RX PubMed=9347924;
RX PubMed=12727792;
CC Omics: Proteome analysis by 2D-DE/MS.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5U89 ! NAL1A clone C4
CA Transformed cell line
//
ID NAL1AM
AC CVCL_5U85
RX PubMed=3001399;
RX PubMed=3409226;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_R787 ! NAL1A
CA Transformed cell line
//
ID NAL1AS
AC CVCL_5U86
RX PubMed=2152771;
RX PubMed=3409226;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_R787 ! NAL1A
CA Spontaneously immortalized cell line
//
ID Naliaka
AC CVCL_8266
SY NALIAKA
DR Cosmic; 931106
RX PubMed=170370;
RX PubMed=4122458;
RX PubMed=4364259;
RX PubMed=9473234;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NALL-1
AC CVCL_3039
DR BTO; BTO:0004951
DR ChEMBL-Cells; CHEMBL3307425
DR ChEMBL-Targets; CHEMBL614769
DR Cosmic; 801717
DR Cosmic; 932760
DR Cosmic; 998694
DR Cosmic; 1037720
DR JCRB; JCRB1332
RX PubMed=155647;
RX PubMed=200333;
RX PubMed=6097530;
RX PubMed=9738977;
RX PubMed=11986953;
ST Source(s): COG; JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 16,19
ST D19S433: 13,14.2
ST D21S11: 30,32.2
ST D2S1338: 17,19
ST D3S1358: 16
ST D5S818: 10,12
ST D7S820: 12,13
ST D8S1179: 12,13
ST FGA: 19,23
ST TH01: 6,7
ST TPOX: 8
ST vWA: 17
DI NCIt; C3168; Childhood acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NALM-1
AC CVCL_0091
SY Nalm-1; NALM 1; NALM1; Nalm1
DR CLO; CLO_0007937
DR EFO; EFO_0002244
DR CLDB; cl3630
DR ATCC; CRL-1567
DR BioSample; SAMN01821583
DR BioSample; SAMN01821650
DR BioSample; SAMN03471397
DR CCLE; NALM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CGH-DB; 9216-4
DR Cosmic; 787506
DR Cosmic; 801721
DR Cosmic; 908157
DR Cosmic; 999775
DR Cosmic; 1012105
DR Cosmic; 1026573
DR Cosmic; 1498418
DR Cosmic; 2491099
DR DSMZ; ACC-131
DR GEO; GSM887346
DR GEO; GSM888422
DR IGRhCellID; NALM1
RX PubMed=301573;
RX PubMed=302341;
RX PubMed=3332852;
RX PubMed=6582512;
RX PubMed=9067587;
RX PubMed=12506034;
RX PubMed=15588857;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~48 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11,15
ST D5S818: 11
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 15,17
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NALM-10
AC CVCL_L059
SY NALM10
RX CelloPub=CLPUB00085;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0092 ! NALM-6
OI CVCL_5677 ! NALM-7
OI CVCL_L057 ! NALM-8
OI CVCL_L058 ! NALM-9
OI CVCL_L060 ! NALM-11
OI CVCL_5660 ! NALM-12
OI CVCL_L061 ! NALM-13
SX Male
CA Cancer cell line
//
ID NALM-11
AC CVCL_L060
SY NALM11
RX CelloPub=CLPUB00085;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0092 ! NALM-6
OI CVCL_5677 ! NALM-7
OI CVCL_L057 ! NALM-8
OI CVCL_L058 ! NALM-9
OI CVCL_L059 ! NALM-10
OI CVCL_5660 ! NALM-12
OI CVCL_L061 ! NALM-13
SX Male
CA Cancer cell line
//
ID NALM-12
AC CVCL_5660
SY NALM12; Nalm 12
RX CelloPub=CLPUB00085;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0092 ! NALM-6
OI CVCL_5677 ! NALM-7
OI CVCL_L057 ! NALM-8
OI CVCL_L058 ! NALM-9
OI CVCL_L059 ! NALM-10
OI CVCL_L060 ! NALM-11
OI CVCL_L061 ! NALM-13
SX Male
CA Cancer cell line
//
ID NALM-13
AC CVCL_L061
SY NALM13
RX CelloPub=CLPUB00085;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0092 ! NALM-6
OI CVCL_5677 ! NALM-7
OI CVCL_L057 ! NALM-8
OI CVCL_L058 ! NALM-9
OI CVCL_L059 ! NALM-10
OI CVCL_L060 ! NALM-11
OI CVCL_5660 ! NALM-12
SX Male
CA Cancer cell line
//
ID NALM-16
AC CVCL_1834
SY NALM16; Nalm-16
DR BioSample; SAMN03473434
DR Cosmic; 998707
DR Cosmic; 999758
DR Cosmic; 1037712
DR DSMZ; ACC-680
RX PubMed=155647;
RX PubMed=6582512;
RX PubMed=8847894;
CC Doubling time: ~36 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 13
ST D5S818: 11
ST D7S820: 10
ST TH01: 8
ST TPOX: 11
ST vWA: 17
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NALM-17
AC CVCL_3887
SY NALM17
DR BTO; BTO:0004933
DR Cosmic; 919146
DR Cosmic; 991552
DR Cosmic; 996285
DR Cosmic; 998699
DR Cosmic; 999749
DR Cosmic; 1037713
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5661 ! NALM-18
CA Cancer cell line
//
ID NALM-18
AC CVCL_5661
SY NALM18
RX PubMed=9738977;
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3887 ! NALM-17
CA Cancer cell line
//
ID NALM-19
AC CVCL_1835
SY NALM19; Nalm19
DR BioSample; SAMN03473520
DR CCLE; NALM19_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 999733
DR DSMZ; ACC-522
DR GEO; GSM887345
DR GEO; GSM888421
RX PubMed=1664237;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50-70 hours (DSMZ).
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 9,10
ST D13S317: 8,12
ST D16S539: 11,13
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17,20
DI NCIt; C8644; B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L055 ! B239
OI CVCL_L056 ! B240
SX Male
CA Cancer cell line
//
ID NALM-20
AC CVCL_1836
SY NALM20
DR BTO; BTO:0004934
DR BioSample; SAMN03473435
DR Cosmic; 996290
DR Cosmic; 998700
DR Cosmic; 999766
DR Cosmic; 1037714
DR DSMZ; ACC-681
RX PubMed=1817649;
CC Doubling time: ~60-80 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 9,10
ST D5S818: 11,13
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L054 ! B250
OI CVCL_1837 ! NALM-21
OI CVCL_5662 ! NALM-22
OI CVCL_5663 ! NALM-23
SX Male
CA Cancer cell line
//
ID NALM-21
AC CVCL_1837
SY NALM21
DR Cosmic; 999738
DR DSMZ; ACC-682
RX PubMed=1817649;
CC Doubling time: ~50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 9,10
ST D5S818: 11,13
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L054 ! B250
OI CVCL_1836 ! NALM-20
OI CVCL_5662 ! NALM-22
OI CVCL_5663 ! NALM-23
SX Male
CA Cancer cell line
//
ID NALM-22
AC CVCL_5662
SY NALM22
RX PubMed=1817649;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L054 ! B250
OI CVCL_1836 ! NALM-20
OI CVCL_1837 ! NALM-21
OI CVCL_5663 ! NALM-23
SX Male
CA Cancer cell line
//
ID NALM-23
AC CVCL_5663
SY NALM23
RX PubMed=1817649;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L054 ! B250
OI CVCL_1836 ! NALM-20
OI CVCL_1837 ! NALM-21
OI CVCL_5662 ! NALM-22
SX Male
CA Cancer cell line
//
ID NALM-24
AC CVCL_3888
SY NALM24
DR BTO; BTO:0004935
DR Cosmic; 996291
DR Cosmic; 998701
DR Cosmic; 999745
DR Cosmic; 1037715
RX PubMed=1667895;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5664 ! NALM-25
SX Female
CA Cancer cell line
//
ID NALM-25
AC CVCL_5664
SY NALM25
RX PubMed=1667895;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3888 ! NALM-24
SX Female
CA Cancer cell line
//
ID NALM-26
AC CVCL_3889
SY NALM26
DR BTO; BTO:0004936
DR Cosmic; 996284
DR Cosmic; 998698
DR Cosmic; 999734
DR Cosmic; 1037716
DR Cosmic; 2491083
RX PubMed=7599111;
RX PubMed=9067587;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NALM-27
AC CVCL_5665
SY NALM27
DR Cosmic; 999736
DR Cosmic; 1130247
DR Cosmic; 2491084
RX PubMed=9067587;
RX PubMed=9710720;
DI NCIt; C4673; Acute biphenotypic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5666 ! NALM-28
OI CVCL_5668 ! NALM-30
OI CVCL_5669 ! NALM-31
OI CVCL_5670 ! NALM-32
SX Male
CA Cancer cell line
//
ID NALM-28
AC CVCL_5666
SY NALM28
DR Cosmic; 999737
DR Cosmic; 2491085
RX PubMed=9067587;
RX PubMed=9710720;
DI NCIt; C4673; Acute biphenotypic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5665 ! NALM-27
OI CVCL_5668 ! NALM-30
OI CVCL_5669 ! NALM-31
OI CVCL_5670 ! NALM-32
SX Male
CA Cancer cell line
//
ID NALM-29
AC CVCL_5667
SY NALM29
DR Cosmic; 999744
DR Cosmic; 1037717
RX PubMed=10456671;
CC Doubling time: 46 hours (PubMed=10456671).
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NALM-30
AC CVCL_5668
SY NALM30
DR Cosmic; 999735
DR Cosmic; 2491086
RX PubMed=9067587;
RX PubMed=10363160;
DI NCIt; C4673; Acute biphenotypic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5665 ! NALM-27
OI CVCL_5666 ! NALM-28
OI CVCL_5669 ! NALM-31
OI CVCL_5670 ! NALM-32
SX Male
CA Cancer cell line
//
ID NALM-31
AC CVCL_5669
SY NALM31
DR Cosmic; 999739
DR Cosmic; 2491087
RX PubMed=9067587;
RX PubMed=10363160;
DI NCIt; C4673; Acute biphenotypic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5665 ! NALM-27
OI CVCL_5666 ! NALM-28
OI CVCL_5668 ! NALM-30
OI CVCL_5670 ! NALM-32
SX Male
CA Cancer cell line
//
ID NALM-32
AC CVCL_5670
SY NALM32
DR Cosmic; 999740
DR Cosmic; 2491088
RX PubMed=9067587;
RX PubMed=10363160;
DI NCIt; C4673; Acute biphenotypic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5665 ! NALM-27
OI CVCL_5666 ! NALM-28
OI CVCL_5668 ! NALM-30
OI CVCL_5669 ! NALM-31
SX Male
CA Cancer cell line
//
ID NALM-33
AC CVCL_5671
SY NALM33
DR Cosmic; 999746
DR DSMZ; ACC-782
RX PubMed=10609789;
CC Doubling time: ~48 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 10,12
ST D5S818: 9,12
ST D7S820: 11,12
ST TH01: 7
ST TPOX: 8
ST vWA: 17
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5672 ! NALM-34
SX Male
CA Cancer cell line
//
ID NALM-34
AC CVCL_5672
SY NALM34
RX PubMed=10609789;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5671 ! NALM-33
SX Male
CA Cancer cell line
//
ID NALM-35
AC CVCL_5673
SY NALM35
RX PubMed=12889857;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NALM-36
AC CVCL_5674
SY NALM36
RX PubMed=11734297;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5676 ! NALM-37
SX Female
CA Cancer cell line
//
ID NALM-36KL
AC CVCL_5675
SY NALM36KL
RX PubMed=11734297;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5674 ! NALM-36
SX Female
CA Cancer cell line
//
ID NALM-37
AC CVCL_5676
SY NALM37
RX PubMed=11734297;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5674 ! NALM-36
SX Female
CA Cancer cell line
//
ID NALM-6
AC CVCL_0092
SY Nalm-6; NALM 6; Nalm 6; NALM6; Nalm6; NALM-6-M1
DR BTO; BTO:0003288
DR CLO; CLO_0007938
DR CLO; CLO_0050970
DR EFO; EFO_0002245
DR CLDB; cl3631
DR CLDB; cl3632
DR BioSample; SAMN03472035
DR BioSample; SAMN03473163
DR BioSample; SAMN03473413
DR CCLE; NALM6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3307559
DR ChEMBL-Targets; CHEMBL614187
DR CLS; 300297/NA
DR Cosmic; 801722
DR Cosmic; 889112
DR Cosmic; 908158
DR Cosmic; 919147
DR Cosmic; 991553
DR Cosmic; 998708
DR Cosmic; 999748
DR Cosmic; 1012106
DR Cosmic; 1037711
DR Cosmic; 1070706
DR Cosmic; 1130246
DR Cosmic; 1191699
DR Cosmic; 1483361
DR Cosmic; 1509198
DR Cosmic; 1524810
DR Cosmic; 2491082
DR Cosmic-CLP; 908158
DR DSMZ; ACC-128
DR GDSC; 908158
DR GEO; GSM236797
DR GEO; GSM236833
DR GEO; GSM887347
DR GEO; GSM888423
DR GEO; GSM1670142
DR IGRhCellID; NALM6
DR NCBI_Iran; C212
DR RCB; RCB1933
DR TKG; TKG 0413
RX CelloPub=CLPUB00085;
RX PubMed=83966;
RX PubMed=155647;
RX PubMed=2415623;
RX PubMed=2783384;
RX PubMed=8847894;
RX PubMed=9067587;
RX PubMed=9738977;
RX PubMed=10490826;
RX PubMed=10695022;
RX PubMed=11021758;
RX PubMed=11986953;
RX PubMed=15843827;
RX PubMed=16405397;
RX PubMed=16408098;
RX PubMed=20103924;
RX PubMed=22460905;
RX PubMed=23596518;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-607.html
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Doubling time: 25 hours (PubMed=25984343); ~36 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: CLS; 300297; true.
ST Source(s): COG; Cosmic-CLP; DSMZ; PubMed=11416159; PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 12 (COG; Cosmic-CLP; DSMZ; PubMed=25877200)
ST CSF1PO: 13 (RCB; TKG)
ST D13S317: 8,9,12 (COG; DSMZ)
ST D13S317: 9,12 (Cosmic-CLP; PubMed=25877200)
ST D13S317: 9,13 (RCB; TKG)
ST D16S539: 9,10,11 (COG; DSMZ)
ST D16S539: 10,11 (Cosmic-CLP; PubMed=25877200; RCB; TKG)
ST D18S51: 12,15
ST D19S433: 13,15
ST D21S11: 28,29
ST D2S1338: 17,24
ST D3S1358: 16,17
ST D5S818: 10,11,12 (COG; DSMZ; PubMed=25877200)
ST D5S818: 11,12 (Cosmic-CLP; RCB; TKG)
ST D7S820: 10 (COG)
ST D7S820: 8,9,10 (Cosmic-CLP; DSMZ; PubMed=25877200)
ST D7S820: 8,11 (RCB; TKG)
ST D8S1179: 11,13,14
ST FGA: 21,22 (COG)
ST FGA: 22 (PubMed=11416159; PubMed=25877200)
ST Penta D: 8,14
ST Penta E: 11
ST TH01: 8,9 (COG; Cosmic-CLP; DSMZ; RCB; TKG)
ST TH01: 8 (PubMed=11416159; PubMed=25877200)
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5677 ! NALM-7
OI CVCL_L057 ! NALM-8
OI CVCL_L058 ! NALM-9
OI CVCL_L059 ! NALM-10
OI CVCL_L060 ! NALM-11
OI CVCL_5660 ! NALM-12
OI CVCL_L061 ! NALM-13
SX Male
CA Cancer cell line
//
ID NALM-6 DCLRE1C(-/-)
AC CVCL_HE04
SY DCLRE1C (-/-) NALM-6; ARTEMIS-/- cells
RX PubMed=17941805;
WW https://www.horizondiscovery.com/human-dclre1c-nalm-6-cell-line-hd-115-045
CC Knockout cell: Method=Homologous recombination; HGNC; 17642; DCLRE1C.
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-6 LIG4(-/-)
AC CVCL_HE05
SY LIG4 (-/-) NALM-6; LIG4-/- Nalm-6
RX PubMed=18835848;
WW https://www.horizondiscovery.com/human-lig4-nalm-6-cell-line-hd-115-041
CC Knockout cell: Method=Homologous recombination; HGNC; 6601; LIG4.
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-6 MUS81(-/-)
AC CVCL_HE06
SY MUS81 (-/-) NALM-6
RX PubMed=17903171;
WW https://www.horizondiscovery.com/human-mus81-nalm-6-cell-line-hd-115-055
CC Knockout cell: Method=Homologous recombination; HGNC; 29814; MUS81.
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-6 PRKDC(+/-)
AC CVCL_HE07
SY PRKDC (+/-) NALM-6
RX PubMed=18710952;
WW https://www.horizondiscovery.com/human-prkdc-nalm-6-cell-line-hd-r08-001
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 9413; PRKDC.
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-6 RAD54L(-/-)
AC CVCL_HE08
SY RAD54L (-/-) NALM-6
RX PubMed=18835848;
WW https://www.horizondiscovery.com/human-rad54l-nalm-6-cell-line-hd-115-043
CC Knockout cell: Method=Homologous recombination; HGNC; 9826; RAD54L.
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-6 TOP1(+/-)
AC CVCL_HE09
SY TOP1 (+/-) NALM-6; TOP1 +/- Nalm-6
RX PubMed=19336913;
WW https://www.horizondiscovery.com/human-top1-nalm-6-cell-line-hd-115-072
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 11986; TOP1.
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-6 TOP2B(-/-)
AC CVCL_HE10
SY TOP2B (-/-) NALM-6
RX PubMed=18596031;
WW https://www.horizondiscovery.com/human-top2b-nalm-6-cell-line-hd-115-061
CC Knockout cell: Method=Homologous recombination; HGNC; 11990; TOP2B.
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-6 TP53(+/-)
AC CVCL_HE11
SY TP53 (+/-) NALM-6
RX PubMed=16405397;
WW https://www.horizondiscovery.com/human-tp53-nalm-6-cell-line-hd-115-048
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 11998; TP53.
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-6 TP53(-/-)
AC CVCL_HE12
SY TP53 (-/-) NALM-6
RX PubMed=16405397;
WW https://www.horizondiscovery.com/tp53-nalm-6-cell-line-hd-115-049
CC Knockout cell: Method=Homologous recombination; HGNC; 11998; TP53.
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-6 XRCC5(+/-)
AC CVCL_HE13
SY XRCC5 (+/-) NALM-6; Ku86+/- NALM-6
RX PubMed=18387344;
RX PubMed=18562296;
WW https://www.horizondiscovery.com/human-xrcc5-nalm-6-cell-line-hd-115-102
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 12833; XRCC5.
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID Nalm-6-MSH+
AC CVCL_J365
DR JCRB; JCRB1475
RX PubMed=23596518;
CC Characteristics: NALM-6 has a partial C-terminal deletion of the MSH2 gene, Nalm-6-MSH+ repairs the gene by transfection of the missing exons.
CC Transfected with: HGNC; 7235; MSH2 (exons 9 to 16).
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 14
ST D13S317: 9,13
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 8,12
ST TH01: 8,9
ST TPOX: 8,10
ST vWA: 15,16
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-6/SP-B
AC CVCL_0U51
RX PubMed=22684370;
CC Selected for resistance to: ChEBI; CHEBI:90235; Spiruchostatin B (SP-B).
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID NALM-7
AC CVCL_5677
SY NALM7
RX CelloPub=CLPUB00085;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0092 ! NALM-6
OI CVCL_L057 ! NALM-8
OI CVCL_L058 ! NALM-9
OI CVCL_L059 ! NALM-10
OI CVCL_L060 ! NALM-11
OI CVCL_5660 ! NALM-12
OI CVCL_L061 ! NALM-13
SX Male
CA Cancer cell line
//
ID NALM-8
AC CVCL_L057
SY NALM8
RX CelloPub=CLPUB00085;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0092 ! NALM-6
OI CVCL_5677 ! NALM-7
OI CVCL_L058 ! NALM-9
OI CVCL_L059 ! NALM-10
OI CVCL_L060 ! NALM-11
OI CVCL_5660 ! NALM-12
OI CVCL_L061 ! NALM-13
SX Male
CA Cancer cell line
//
ID NALM-9
AC CVCL_L058
SY NALM9
RX CelloPub=CLPUB00085;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0092 ! NALM-6
OI CVCL_5677 ! NALM-7
OI CVCL_L057 ! NALM-8
OI CVCL_L059 ! NALM-10
OI CVCL_L060 ! NALM-11
OI CVCL_5660 ! NALM-12
OI CVCL_L061 ! NALM-13
SX Male
CA Cancer cell line
//
ID NALM6/Clo
AC CVCL_4V57
RX PubMed=25461250;
CC Selected for resistance to: ChEBI; CHEBI:681569; Clofarabine (CAFdA).
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0092 ! NALM-6
SX Male
CA Cancer cell line
//
ID Namalwa
AC CVCL_0067
SY NAMALWA; Namalva; NAMALVA; NWA; NK62a
DR BTO; BTO:0003289
DR CLO; CLO_0007939
DR EFO; EFO_0002246
DR CLDB; cl3633
DR CLDB; cl3634
DR CLDB; cl3635
DR CLDB; cl3636
DR CLDB; cl3637
DR ATCC; CRL-1432
DR BCRC; 60553
DR BCRJ; 0181
DR BioSample; SAMN01821584
DR BioSample; SAMN01821651
DR BioSample; SAMN03473179
DR CCLE; NAMALWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CCRID; 3131C0001000700075
DR CGH-DB; 9201-4
DR ChEMBL-Cells; CHEMBL3307288
DR ChEMBL-Targets; CHEMBL614049
DR CLS; 300439/p2697_Namalwa
DR Cosmic; 929814
DR Cosmic; 931107
DR Cosmic; 998717
DR Cosmic; 1037702
DR Cosmic; 1086329
DR Cosmic; 1818345
DR Cosmic-CLP; 908159
DR DSMZ; ACC-24
DR ECACC; 87060801
DR ENCODE; ENCBS105ISO
DR ENCODE; ENCBS499IUK
DR GDSC; 908159
DR GEO; GSM119534
DR GEO; GSM499728
DR GEO; GSM499734
DR GEO; GSM888424
DR GEO; GSM907523
DR GEO; GSM1374695
DR GEO; GSM1670143
DR IFO; IFO50040
DR IGRhCellID; NAMALWA
DR IZSLER; BS TCL 47
DR NCBI_Iran; C126
DR RCB; RCB0445
DR TOKU-E; 2556
RX PubMed=170370;
RX PubMed=464569;
RX PubMed=1325212;
RX PubMed=1915267;
RX PubMed=2052620;
RX PubMed=2415623;
RX PubMed=2830981;
RX PubMed=3080238;
RX PubMed=4122458;
RX PubMed=4364259;
RX PubMed=6286763;
RX PubMed=7316467;
RX PubMed=7849311;
RX PubMed=8344493;
RX PubMed=8515068;
RX PubMed=9473234;
RX PubMed=9973220;
RX PubMed=16960149;
RX PubMed=21269460;
RX PubMed=22460905;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=Namalwa
WW http://www.addexbio.com/productdetail?pid=4670
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Characteristics: Contains 2 integrated copies of EBV genome on chromosome 1.
CC Doubling time: ~20-30 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Deep proteome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
CC Misspelling: 'NAMALLA' in Cosmic 998717.
CC Discontinued: RCB; RCB0445; true.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 15
ST D21S11: 27,28
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 11
ST D8S1179: 13,15
ST FGA: 22
ST Penta D: 8,13
ST Penta E: 5,15
ST TH01: 7,9.3
ST TPOX: 6,11
ST vWA: 14
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Namalwa KJM-1
AC CVCL_4Y60
SY Namalva KJM-1
DR TOKU-E; 3616
RX PubMed=1366592;
RX PubMed=1369278;
RX PubMed=22358567;
CC Characteristics: Contains 2 integrated copies of EBV genome on chromosome 1.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0067 ! Namalwa
SX Female
CA Cancer cell line
//
ID Namalwa.CSN/70
AC CVCL_1838
SY NAMALWA.CSN/70; NAMALWACSN70; CSN/70
DR CLO; CLO_0007940
DR CLDB; cl3638
DR DSMZ; ACC-70
RX PubMed=2298494;
RX PubMed=28196595;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=CSN%2f70
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Characteristics: Contains 2 integrated copies of EBV genome on chromosome 1.
CC Doubling time: ~40 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 6,11
ST vWA: 16
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0067 ! Namalwa
SX Female
CA Cancer cell line
//
ID Namalwa.IPN/45
AC CVCL_1839
SY NAMALWA.IPN/45; NAMALWA-IPN.45; Namalwa IPN/45; IPN/45
DR CLO; CLO_0007941
DR CLDB; cl3639
DR BioSample; SAMN03473394
DR DSMZ; ACC-71
RX PubMed=2298494;
RX PubMed=7849311;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=IPN%2f45
CC Characteristics: Contains 2 integrated copies of EBV genome on chromosome 1.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 6,11
ST vWA: 14,16
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0067 ! Namalwa
SX Female
CA Cancer cell line
//
ID Namalwa.KN2
AC CVCL_1840
SY NAMALWA.KN2; KN2
DR CLO; CLO_0007942
DR CLDB; cl3640
DR BioSample; SAMN03473433
DR DSMZ; ACC-68
RX PubMed=2298494;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=KN2
CC Characteristics: Contains 2 integrated copies of EBV genome on chromosome 1.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 6,11
ST vWA: 14
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0067 ! Namalwa
SX Female
CA Cancer cell line
//
ID Namalwa.PNT
AC CVCL_1841
SY NAMALWA.PNT; PNT
DR CLO; CLO_0007943
DR CLDB; cl3641
DR DSMZ; ACC-69
RX PubMed=2298494;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=PNT
CC Characteristics: Contains 2 integrated copies of EBV genome on chromosome 1.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 11
ST TH01: 7,9.3
ST TPOX: 6,11
ST vWA: 16
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0067 ! Namalwa
SX Female
CA Cancer cell line
//
ID NAMO-2
AC CVCL_R913
RX PubMed=17118759;
DI NCIt; C7463; Acute myelomonocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NAMRU2-CQ-01
AC CVCL_1B68
RX PubMed=5501238;
CC Group: Insect cell line.
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the institution (Naval Medical Research Unit 2) and the species.
OX NCBI_TaxID=7176; ! Culex quinquefasciatus
SX Female
CA Spontaneously immortalized cell line
//
ID NAMRU2-CT-01
AC CVCL_1B73
RX PubMed=5019214;
CC Group: Insect cell line.
CC Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the institution (Naval Medical Research Unit 2) and the species.
OX NCBI_TaxID=7178; ! Culex tritaeniorhynchus
SX Female
CA Spontaneously immortalized cell line
//
ID NAN-1
AC CVCL_A775
SY NAN1
RX PubMed=16638930;
RX PubMed=16956823;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NAN-2
AC CVCL_HX08
SY NAN2
RX PubMed=16956823;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NAN-3
AC CVCL_B318
SY NAN3
RX PubMed=16638930;
RX PubMed=16956823;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NAN-4
AC CVCL_B319
SY NAN4
RX PubMed=16638930;
RX PubMed=16956823;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NAN-5
AC CVCL_B324
SY NAN5
RX PubMed=16638930;
RX PubMed=16956823;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NAN-6
AC CVCL_HX09
SY NAN6
RX PubMed=16956823;
RX PubMed=21173094;
CC Characteristics: IL6 dependent.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NAN2
AC CVCL_B317
SY NAN-2
DR Cosmic; 932157
RX PubMed=11410884;
CC From: Tachikawa T.; Department of Oral Pathology; Showa University; Tokyo; Japan.
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Nanog^(Beta geo/+)ES
AC CVCL_T795
SY Nanog Beta geo/+ ES
DR RCB; AES0121
DR RCB; RCB2662
RX PubMed=12787504;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); MGI; MGI:1919200; Nanog.
CC Discontinued: RCB; RCB2662; true.
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_T793 ! RF8
SX Male
CA Embryonic stem cell
//
ID Nanog^(Beta geo/Hyg)
AC CVCL_T796
SY Nanog Beta geo/Hyg
DR RCB; AES0126
DR RCB; RCB2697
RX PubMed=12787504;
CC From: Center for iPS Cell Research and Application; Kyoto University; Kyoto; Japan.
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1919200; Nanog.
CC Discontinued: RCB; RCB2697; true.
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_T793 ! RF8
SX Male
CA Embryonic stem cell
//
ID NAP
AC CVCL_HF46
RX DOI=10.1007/0-306-46872-7_2;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Nara-F
AC CVCL_W997
RX PubMed=11408058;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W998 ! Nara-H
SX Female
CA Cancer cell line
//
ID Nara-H
AC CVCL_W998
RX PubMed=11408058;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W997 ! Nara-F
SX Female
CA Cancer cell line
//
ID NAT-30
AC CVCL_U821
SY NAT 30
RX PubMed=3902783;
CC Group: Hybridoma fusion partner cell line.
CC Characteristics: Contains 2 integrated copies of EBV genome on chromosome 1.
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0067 ! Namalwa
SX Female
CA Cancer cell line
//
ID NAT1(+/-)ES(A7)
AC CVCL_0J06
DR RCB; AES0190
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Embryonic stem cell
//
ID NAT1(+/-)ES(B4)
AC CVCL_0J08
DR RCB; AES0191
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Embryonic stem cell
//
ID NAT1(+/-)ES(C1)
AC CVCL_0J09
DR RCB; AES0192
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Embryonic stem cell
//
ID NAT1(-/-)ES(B12)
AC CVCL_0J11
DR RCB; AES0194
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Embryonic stem cell
//
ID NAT1(-/-)ES(B2)
AC CVCL_0J10
DR RCB; AES0193
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Embryonic stem cell
//
ID NAT1(-/-)ES(C3)
AC CVCL_0J12
DR RCB; AES0195
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
SX Sex undetermined
CA Embryonic stem cell
//
ID NATO
AC CVCL_M830
RX PubMed=7599108;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NaUCC-1
AC CVCL_M680
RX PubMed=1786199;
RX PubMed=3171272;
RX PubMed=3819510;
CC Doubling time: 17.3 hours (in vivo); 20 hours (in vitro) (PubMed=3171272).
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NaUCC-2
AC CVCL_M681
RX PubMed=3171272;
RX PubMed=3819510;
RX PubMed=8397359;
CC Doubling time: 20.6 hours (in vivo) (PubMed=3171272).
CC Derived from metastatic site: Brain.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NaUCC-3
AC CVCL_M682
RX PubMed=1786199;
RX PubMed=3171272;
RX PubMed=3819510;
RX PubMed=8397359;
CC Doubling time: 14.9 hours (in vivo) (PubMed=3171272).
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NaUCC-4
AC CVCL_M683
RX PubMed=1786199;
RX PubMed=8397359;
CC Derived from metastatic site: Lung.
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NaV 1.3 KIR 2.1
AC CVCL_5I44
DR ATCC; CRL-3269
RX PubMed=24391999;
CC Transfected with: RGD; 3635; Scn3a.
CC Transfected with: MGI; MGI:104744; Kcnj2.
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12,14
ST D16S539: 9,13
ST D5S818: 8
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5I43 ! HEK293-Nav 1.3
SX Female
CA Transformed cell line
//
ID NB-1
AC CVCL_GZ01
RX DOI=10.3353/omp.9.133;
CC Doubling time: 25.2 hours (DOI=10.3353/omp.9.133).
DI NCIt; C4040; Buccal mucosa squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NB-1643
AC CVCL_5627
SY NB1643; NB 1643
DR BTO; BTO:0002833
DR Cosmic; 1161994
DR Cosmic; 1890114
RX PubMed=20922763;
RX PubMed=23202128;
WW http://www.cogcell.org/dl/NB_Data_Sheets/NB-1643_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID NB-1691
AC CVCL_5628
SY NB1691; NB 1691
DR BTO; BTO:0002834
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Cancer cell line
//
ID NB-1771
AC CVCL_E216
SY NB1771
DR Cosmic; 1161995
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NB-39-nu
AC CVCL_B229
SY NB-39; NB39; NB39-nu; NB39nu
DR BTO; BTO:0004871
DR Cosmic; 920247
RX DOI=10.11418/jtca1981.8.2_6;
RX PubMed=19320641;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NB-EbC1
AC CVCL_E218
SY NB-EBC1; NBEbC1; NBEBC1; EbC1; EBC1
DR Cosmic; 1161996
RX PubMed=20922763;
WW http://www.cogcell.org/dl/NB_Data_Sheets/NB-EBc1_Cell_Line_Data_Sheet_COGcell_org.pdf
WW http://www.cogcell.org/cellreqs-ncipptp.php
WW http://www.pptpinvitro.org/cell_lines_panel.php
CC Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC Misspelling: Occasionally 'NB-EBcl'.
CC Misspelling: Occasionally 'NB-Ebcl-1'.
ST Source(s): COG
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 15,20
ST D19S433: 14,15
ST D21S11: 27,32.2
ST D2S1338: 19,20
ST D3S1358: 17
ST D5S818: 10,12
ST D7S820: 12,14
ST D8S1179: 11,13
ST FGA: 24,25
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NB-YK
AC CVCL_M806
RX PubMed=8720061;
CC Breed/subspecies: Fischer 344.
DI NCIt; C60478; Rat nephroblastoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID NB(TU)1
AC CVCL_3041
SY NBTU1; NB(TU)1-10; NB (TU) 1-10
DR BioSample; SAMN03470814
DR BioSample; SAMN03470968
DR Cosmic; 1037354
DR Cosmic; 2131596
DR Cosmic-CLP; 1240181
DR GDSC; 1240181
DR GEO; GSM827250
DR GEO; GSM1670144
DR JCRB; JCRB0154
DR JCRB; NIHS0179
RX PubMed=9378542;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: JCRB; NIHS0179; true.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 9,11,12 (Cosmic-CLP)
ST D16S539: 9,12 (JCRB)
ST D16S539: 9,11 (PubMed=25877200)
ST D18S51: 13,15
ST D19S433: 13.2,14
ST D21S11: 30
ST D2S1338: 17,19
ST D3S1358: 15
ST D5S818: 10
ST D7S820: 12
ST D8S1179: 13,16
ST FGA: 22,24
ST Penta D: 12,14
ST Penta E: 14,19
ST TH01: 9
ST TPOX: 11
ST vWA: 14
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NB0001
AC CVCL_8Y23
DR ECACC; 01082320
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85068; Russell-Silver syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NB1
AC CVCL_1440
SY NB-1; NB-I; NB 1
DR BTO; BTO:0005103
DR CLO; CLO_0051419
DR BioSample; SAMN03470966
DR BioSample; SAMN03472043
DR CCLE; NB1_AUTONOMIC_GANGLIA
DR CGH-DB; 74-1
DR CGH-DB; 9097-4
DR Cosmic; 801736
DR Cosmic; 920243
DR Cosmic; 947696
DR Cosmic; 949179
DR Cosmic; 1037339
DR Cosmic; 1099136
DR Cosmic; 1153784
DR Cosmic; 1526632
DR Cosmic; 2131573
DR Cosmic-CLP; 949179
DR GDSC; 949179
DR GEO; GSM333816
DR GEO; GSM333825
DR GEO; GSM887348
DR GEO; GSM888425
DR GEO; GSM1670145
DR IFO; IFO50295
DR JCRB; JCRB0621
DR RCB; RCB1953
DR TKG; TKG 0486
RX CelloPub=CLPUB00086;
RX PubMed=174024;
RX PubMed=590688;
RX PubMed=4144593;
RX PubMed=9290701;
RX PubMed=11129446;
RX PubMed=12702577;
RX PubMed=18923524;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Neck lymph node.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,13
ST D16S539: 9 (Cosmic-CLP; JCRB; PubMed=25877200; TKG)
ST D16S539: 9,12 (RCB)
ST D18S51: 16
ST D19S433: 13.2,15.2
ST D21S11: 30,31.2
ST D2S1338: 17,27
ST D3S1358: 15,17
ST D5S818: 9,11
ST D7S820: 8,12 (Cosmic-CLP; JCRB; PubMed=25877200; RCB)
ST D7S820: 12 (TKG)
ST D8S1179: 12,16
ST FGA: 19,23
ST Penta D: 8,9
ST Penta E: 17,18
ST TH01: 7
ST TPOX: 11
ST vWA: 16,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NB1-G
AC CVCL_W493
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2437946;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NB16
AC CVCL_B323
SY NB-16; NB_16; NB 16; NB16-RIKEN
DR CLO; CLO_0051539
DR Cosmic; 688074
DR Cosmic; 801737
DR Cosmic; 910929
DR Cosmic; 920245
DR Cosmic; 947708
DR Cosmic; 1019945
DR Cosmic; 1037340
DR Cosmic; 1099137
DR Cosmic; 1153785
DR Cosmic; 1890118
DR Cosmic; 2131575
DR GEO; GSM333800
DR RCB; RCB0478
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=18923524;
RX PubMed=23202128;
CC Omics: SNP array analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 15,17
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NB1RGB
AC CVCL_J377
SY NB1-RGB
DR CLO; CLO_0050717
DR BioSample; SAMN03472347
DR RCB; RCB0222
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,11
ST D16S539: 9,11
ST D5S818: 7,10
ST D7S820: 12,13
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Nb2
AC CVCL_G705
SY Nb 2; NB-2
DR BTO; BTO:0003056
RX PubMed=1988090;
RX PubMed=6992985;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=Nb2
CC Breed/subspecies: Nb.
DI NCIt; C60448; Rat malignant lymphoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID Nb2-11
AC CVCL_3860
DR CLO; CLO_0007945
DR CLDB; cl5086
DR ECACC; 97041101
DR NCBI_Iran; C606
RX PubMed=7895694;
RX PubMed=9890649;
CC Doubling time: 12 hours (ECACC).
CC Breed/subspecies: Nb.
DI NCIt; C60448; Rat malignant lymphoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_G705 ! Nb2
SX Male
CA Cancer cell line
//
ID Nb2-SFJCD1
AC CVCL_6E51
RX PubMed=1988090;
RX PubMed=7895694;
RX PubMed=9890649;
CC Breed/subspecies: Nb.
DI NCIt; C60448; Rat malignant lymphoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_G705 ! Nb2
SX Male
CA Cancer cell line
//
ID Nb2-SP
AC CVCL_G706
SY Nb2-Sp; NB2-Sp
DR BTO; BTO:0003057
RX PubMed=3087389;
CC Breed/subspecies: Nb.
DI NCIt; C60448; Rat malignant lymphoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_G705 ! Nb2
SX Male
CA Cancer cell line
//
ID NB2a/d1
AC CVCL_B436
DR BTO; BTO:0003058
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0470 ! Neuro-2a
SX Male
CA Cancer cell line
//
ID NB3
AC CVCL_J050
SY NB-3
DR CLO; CLO_0007946
DR ATCC; HB-10205
RX Patent=US5604107;
CC Monoclonal antibody target: UniProtKB; P04626; Human ERBB2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID NB324K
AC CVCL_U409
SY 324K
RX PubMed=6602222;
RX PubMed=9015283;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-556.html
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NB4
AC CVCL_0005
SY NB-4; NB.4
DR BTO; BTO:0002136
DR CLO; CLO_0007947
DR EFO; EFO_0002798
DR MCCL; MCC:0000350
DR CLDB; cl3643
DR BioSample; SAMN03470835
DR CCLE; NB4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308423
DR ChEMBL-Targets; CHEMBL614188
DR CLS; 300299/p638_NB-4
DR CLS; 300299-SF/p11500_NB-4
DR Cosmic; 787463
DR Cosmic; 922661
DR Cosmic; 924050
DR Cosmic; 975285
DR Cosmic; 981582
DR Cosmic; 996313
DR Cosmic; 1012107
DR Cosmic; 1037664
DR Cosmic; 1070692
DR Cosmic; 1078721
DR Cosmic; 1089522
DR Cosmic; 1127257
DR Cosmic; 1181601
DR Cosmic; 1523826
DR Cosmic; 1524838
DR Cosmic; 1601063
DR Cosmic; 1779130
DR Cosmic; 2036677
DR Cosmic; 2089653
DR Cosmic; 2131548
DR Cosmic; 2306227
DR Cosmic; 2579202
DR Cosmic-CLP; 1323913
DR DSMZ; ACC-207
DR ENCODE; ENCBS032SIL
DR ENCODE; ENCBS259AAA
DR ENCODE; ENCBS390ENC
DR GDSC; 1323913
DR GEO; GSM236798
DR GEO; GSM236834
DR GEO; GSM472929
DR GEO; GSM510512
DR GEO; GSM510513
DR GEO; GSM887349
DR GEO; GSM888426
DR GEO; GSM945252
DR GEO; GSM945275
DR GEO; GSM1374696
DR GEO; GSM1374697
DR GEO; GSM1670151
DR NCBI_Iran; C515
DR PRIDE; PXD000589
DR PRIDE; PXD001610
RX Patent=US5589345;
RX PubMed=1453773;
RX PubMed=1995093;
RX PubMed=7630193;
RX PubMed=9737686;
RX PubMed=11704857;
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=23325432;
RX PubMed=23955599;
RX PubMed=25894527;
RX PubMed=25984343;
RX PubMed=27397505;
WW http://www.proteinatlas.org/learn/cellines
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/NB4_protocol.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2030.
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1045.
CC Doubling time: 36-40 hours (PubMed=1995093); 30 hours (PubMed=25984343); ~35-45 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Cell surface proteome.
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): CLS; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 12,14
ST D21S11: 28,33.2
ST D3S1358: 15,17
ST D5S818: 13
ST D7S820: 10,13
ST D8S1179: 10,14
ST FGA: 21,22
ST Penta D: 10,13
ST Penta E: 7,13
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 16,19
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NB4-AsR
AC CVCL_U080
SY NB4-dT-AsR1
RX PubMed=9596679;
RX PubMed=11704857;
CC Selected for resistance to: ChEBI; CHEBI:30621; Diarsenic trioxide (ATO; As2O3).
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0005 ! NB4
SX Female
CA Cancer cell line
//
ID NB4-DR1
AC CVCL_U085
SY NB4-R1
RX PubMed=9342843;
RX PubMed=9716606;
RX PubMed=11704857;
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0005 ! NB4
SX Female
CA Cancer cell line
//
ID NB4-DR2
AC CVCL_U087
SY NB4-R2
RX PubMed=9342843;
RX PubMed=11704857;
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U086 ! NB4-S1
SX Female
CA Cancer cell line
//
ID NB4-DR3
AC CVCL_U088
SY NB4-R3
RX PubMed=9342843;
RX PubMed=11704857;
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U086 ! NB4-S1
SX Female
CA Cancer cell line
//
ID NB4-LR1
AC CVCL_8811
SY NB4-RAr; NB4-R1
RX PubMed=1453773;
RX PubMed=7630193;
RX PubMed=7915840;
RX PubMed=11704857;
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0005 ! NB4
SX Female
CA Cancer cell line
//
ID NB4-LR2
AC CVCL_U081
SY NB4-R2
RX PubMed=7915840;
RX PubMed=10673742;
RX PubMed=11704857;
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8811 ! NB4-LR1
SX Female
CA Cancer cell line
//
ID NB4-S1
AC CVCL_U086
DR TOKU-E; 4157
RX PubMed=9342843;
RX PubMed=9716606;
CC Selected for resistance to: ChEBI; CHEBI:15367; All-trans-retinoic acid (ATRA; Tretinoin).
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0005 ! NB4
SX Female
CA Cancer cell line
//
ID NB4/As
AC CVCL_U082
SY NB4-N-AsR1
RX PubMed=11021749;
RX PubMed=11704857;
CC Selected for resistance to: ChEBI; CHEBI:30621; Diarsenic trioxide (ATO; As2O3).
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0005 ! NB4
SX Female
CA Cancer cell line
//
ID NB4.007/6
AC CVCL_U083
SY NB4-007/6; NB4-GR007/6
RX PubMed=7719237;
RX PubMed=11704857;
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0005 ! NB4
SX Female
CA Cancer cell line
//
ID NB4.306
AC CVCL_U084
SY NB4-306; NB4-GR306
RX PubMed=8395911;
RX PubMed=11704857;
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0005 ! NB4
SX Female
CA Cancer cell line
//
ID NB4.437r
AC CVCL_U112
SY NB4-437r; NB4-G-437R
RX PubMed=10753850;
RX PubMed=11704857;
CC Selected for resistance to: ChEBI; CHEBI:88334; AHPN (6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalenecarboxylic acid; CD437).
DI NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0005 ! NB4
SX Female
CA Cancer cell line
//
ID NB41A3
AC CVCL_3553
SY NB4 1A3
DR CLO; CLO_0007948
DR CLDB; cl3644
DR CLDB; cl3645
DR ATCC; CCL-147
DR BCRC; 60295
DR ECACC; 89121405
DR IZSLER; BS TCL 209
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NB5-B2
AC CVCL_Y276
RX PubMed=1847391;
DI NCIt; C4827; Adrenal gland neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NB56
AC CVCL_L112
RX DOI=10.1007/0-306-46872-7_2;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NB69
AC CVCL_1448
SY NB-69; NB_69; NB 69; NB69-RIKEN
DR BTO; BTO:0005426
DR CLO; CLO_0050263
DR BioSample; SAMN03470996
DR ChEMBL-Cells; CHEMBL3308799
DR ChEMBL-Targets; CHEMBL1075510
DR Cosmic; 688081
DR Cosmic; 801739
DR Cosmic; 908440
DR Cosmic; 920248
DR Cosmic; 930069
DR Cosmic; 947709
DR Cosmic; 1019930
DR Cosmic; 1037342
DR Cosmic; 1099139
DR Cosmic; 1109123
DR Cosmic; 1153787
DR Cosmic; 1890119
DR Cosmic; 2058110
DR Cosmic; 2131577
DR Cosmic-CLP; 908440
DR ECACC; 99072802
DR GDSC; 908440
DR GEO; GSM313807
DR GEO; GSM563353
DR GEO; GSM827391
DR GEO; GSM1670154
DR RCB; RCB0480
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=18923524;
RX PubMed=23202128;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200; RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 9,11
ST D18S51: 15,16
ST D19S433: 14,15
ST D21S11: 30.2,31.2,32
ST D2S1338: 17,23
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10
ST D8S1179: 13.2,14,15
ST FGA: 21,25
ST Penta D: 7,12
ST Penta E: 10,13
ST TH01: 8
ST TPOX: 8,11 (Cosmic-CLP; PubMed=25877200; RCB)
ST TPOX: 11 (ECACC)
ST vWA: 17,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NB76
AC CVCL_L111
RX DOI=10.1007/0-306-46872-7_2;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NB9
AC CVCL_A797
SY NB-9
DR CLO; CLO_0050261
DR BioSample; SAMN03472322
DR Cosmic; 920244
DR Cosmic; 2131574
DR RCB; RCB0477
RX DOI=10.1007/0-306-46872-7_2;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 13
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NBE-3
AC CVCL_S104
SY Normal Beagle Embryo-3
DR ATCC; CRL-6254
RX PubMed=700899;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6254; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Finite cell line
//
ID NBE-5
AC CVCL_Y443
SY Normal Beagle Embryo-5
DR ATCC; CRL-6255
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6255; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Sex undetermined
CA Finite cell line
//
ID NBFL
AC CVCL_F013
RX PubMed=8093644;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=NBFL
DI NCIt; C4827; Adrenal gland neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y276 ! NB5-B2
CA Cancer cell line
//
ID NBL-3-11
AC CVCL_0490
RX PubMed=8768552;
RX PubMed=10591122;
RX PubMed=14989177;
RX PubMed=14989178;
RX PubMed=17582998;
OX NCBI_TaxID=9310; ! Potorous tridactylus
HI CVCL_0489 ! Pt K1
SX Female
CA Finite cell line
//
ID NBL-3-17
AC CVCL_0491
RX PubMed=8768552;
RX PubMed=14989177;
RX PubMed=14989178;
RX PubMed=17582998;
OX NCBI_TaxID=9310; ! Potorous tridactylus
HI CVCL_0489 ! Pt K1
SX Female
CA Finite cell line
//
ID NBL-S
AC CVCL_2136
SY NBL_S; NBLS
DR BioSample; SAMN03473469
DR Cosmic; 848930
DR Cosmic; 923829
DR Cosmic; 930070
DR Cosmic; 1019947
DR Cosmic; 1109367
DR Cosmic; 1161997
DR Cosmic; 1167414
DR Cosmic; 1526636
DR DSMZ; ACC-656
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=11550280;
RX PubMed=23202128;
CC Doubling time: ~36 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,13
ST D16S539: 10,13
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,12
ST vWA: 18,19
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NBL-W
AC CVCL_9899
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=1933896;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NBL-W N
AC CVCL_9900
SY N (W-N)
RX PubMed=1933896;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9899 ! NBL-W
SX Male
CA Cancer cell line
//
ID NBL-W S
AC CVCL_9901
SY N (W-S)
RX PubMed=1933896;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9899 ! NBL-W
SX Male
CA Cancer cell line
//
ID NBR4-RJK835
AC CVCL_0F80
SY NBR4; GM08011
DR CLO; CLO_0010045
DR Coriell; GM08011
RX PubMed=6947270;
RX PubMed=7027497;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0058 ! HeLa S3
CA Hybrid cell line
//
ID NBsusSR
AC CVCL_1450
SY NBSUSSR
DR CLO; CLO_0050117
DR BioSample; SAMN03472240
DR ChEMBL-Cells; CHEMBL3308847
DR ChEMBL-Targets; CHEMBL2366150
DR Cosmic; 925342
DR Cosmic-CLP; 925342
DR GDSC; 925342
DR GEO; GSM1670156
DR RCB; RCB0803
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 8,10
ST D16S539: 10,12
ST D5S818: 10,12
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 15,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NBT-2
AC CVCL_6545
SY NBT2
RX PubMed=439532;
RX PubMed=7185004;
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NBT-II
AC CVCL_0453
SY Nara Bladder Tumor No. 2; Nara Bladder Tumor II; NBTII
DR BTO; BTO:0004316
DR CLO; CLO_0007950
DR MCCL; MCC:0000351
DR CLDB; cl3646
DR ATCC; CRL-1655
DR ECACC; 93012901
DR KCLB; 21655
RX PubMed=3567912;
RX PubMed=4941696;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-146.html
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: Wistar.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID NBT-L1
AC CVCL_4671
DR CLO; CLO_0050839
DR RCB; RCB1371
RX PubMed=9369930;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: Wistar.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0453 ! NBT-II
SX Male
CA Cancer cell line
//
ID NBT-L2a
AC CVCL_4672
DR CLO; CLO_0050840
DR RCB; RCB1372
RX PubMed=9369930;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: Wistar.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0453 ! NBT-II
SX Male
CA Cancer cell line
//
ID NBT-L2b
AC CVCL_4673
DR CLO; CLO_0050841
DR RCB; RCB1373
RX PubMed=9369930;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: Wistar.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0453 ! NBT-II
SX Male
CA Cancer cell line
//
ID NBT-T1
AC CVCL_4674
DR CLO; CLO_0050837
DR RCB; RCB1369
RX PubMed=9369930;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: Wistar.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0453 ! NBT-II
SX Male
CA Cancer cell line
//
ID NBT-T2
AC CVCL_4675
DR CLO; CLO_0050838
DR RCB; RCB1370
RX PubMed=9369930;
CC Transformant: ChEBI; CHEBI:91275; N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN).
CC Breed/subspecies: Wistar.
DI NCIt; C60691; Rat urinary system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0453 ! NBT-II
SX Male
CA Cancer cell line
//
ID NC 14.3.36
AC CVCL_B437
RX PubMed=1716303;
CC Transformant: N-Myc+c-Myc.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NC 14.3.3G
AC CVCL_B438
RX PubMed=1716303;
CC Transformant: N-Myc+c-Myc.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NC 14.4.6E
AC CVCL_B439
SY NC14.4.6E
DR BTO; BTO:0002903
RX PubMed=1716303;
CC Transformant: N-Myc+c-Myc.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NC 14.4.8
AC CVCL_B440
RX PubMed=1716303;
CC Transformant: N-Myc+c-Myc.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NC 14.4.9D
AC CVCL_B441
RX PubMed=1716303;
CC Transformant: N-Myc+c-Myc.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NC 14.9.1
AC CVCL_B442
SY NC14.9.1
DR BTO; BTO:0002902
RX PubMed=1716303;
CC Transformant: N-Myc+c-Myc.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NC 14.9.10
AC CVCL_B443
RX PubMed=1716303;
CC Transformant: N-Myc+c-Myc.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NC 14.9.8
AC CVCL_B444
RX PubMed=1716303;
CC Transformant: N-Myc+c-Myc.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NC 15.2.10H
AC CVCL_B445
RX PubMed=1716303;
CC Transformant: N-Myc+c-Myc.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NC 15.2.56
AC CVCL_B446
RX PubMed=1716303;
CC Transformant: N-Myc+c-Myc.
CC Breed/subspecies: CBA.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NC 65-R
AC CVCL_T312
RX PubMed=291478;
RX PubMed=711402;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T311 ! NC 65-Sp
SX Male
CA Cancer cell line
//
ID NC 65-Sp
AC CVCL_T311
RX PubMed=291478;
RX PubMed=711402;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_T312 ! NC 65-R
SX Male
CA Cancer cell line
//
ID NC-15
AC CVCL_Z284
RX DOI=10.2183/pjab.60.198;
CC Group: Insect cell line.
OX NCBI_TaxID=94400; ! Nephotettix cincticeps
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NC-19
AC CVCL_Z285
RX DOI=10.2183/pjab.60.198;
CC Group: Insect cell line.
OX NCBI_TaxID=94400; ! Nephotettix cincticeps
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NC-20
AC CVCL_Z286
RX DOI=10.2183/pjab.60.198;
CC Group: Insect cell line.
OX NCBI_TaxID=94400; ! Nephotettix cincticeps
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NC-21
AC CVCL_Z287
RX DOI=10.2183/pjab.60.198;
CC Group: Insect cell line.
OX NCBI_TaxID=94400; ! Nephotettix cincticeps
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NC-24
AC CVCL_Z288
RX CelloPub=CLPUB00181;
RX DOI=10.2183/pjab.60.198;
CC Group: Insect cell line.
OX NCBI_TaxID=94400; ! Nephotettix cincticeps
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NC-25
AC CVCL_Z289
DR NISES; SK0033
RX DOI=10.2183/pjab.60.198;
CC Group: Insect cell line.
OX NCBI_TaxID=94400; ! Nephotettix cincticeps
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NC-37
AC CVCL_3042
SY NC 37; NC37; Nc37
DR BTO; BTO:0005495
DR CLO; CLO_0007952
DR EFO; EFO_0002247
DR CLDB; cl3648
DR CLDB; cl3649
DR ATCC; CCL-214
DR BioSample; SAMN03151899
DR BioSample; SAMN03471475
DR ChEMBL-Cells; CHEMBL3307322
DR ChEMBL-Targets; CHEMBL614189
DR Cosmic; 687848
DR ECACC; 89111414
DR IFO; IFO50039
DR IGRhCellID; NC37
DR KCLB; 10214
DR NCBI_Iran; C501
DR NIH-ARP; 9936-272
DR RCB; RCB3008
DR TKG; TKG 0232
RX PubMed=165156;
RX PubMed=170370;
RX PubMed=6500159;
RX PubMed=20143388;
WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Raji derivative (PubMed=20143388).
CC Doubling time: ~20 hours (NIH-ARP).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 89111414; true.
CC Discontinued: KCLB; 10214; probable.
ST Source(s): ATCC; JCRB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13,14 (ATCC)
ST D13S317: 13 (JCRB; TKG)
ST D16S539: 8,11
ST D5S818: 10,13
ST D7S820: 10
ST TH01: 6,7
ST TPOX: 8,13
ST vWA: 16 (ATCC)
ST vWA: 16,19 (JCRB; TKG)
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0511 ! Raji
SX Male
CA Cancer cell line
//
ID NC-37/DC-SIGN
AC CVCL_S547
DR NIH-ARP; 9937-50
RX PubMed=14972530;
CC Problematic cell line: Contaminated. Parent cell line (NC-37) has been shown to be a Raji derivative.
CC Transfected with: HGNC; 1641; CD209.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3042 ! NC-37
SX Male
CA Cancer cell line
//
ID NC-HIMT
AC CVCL_W389
RX PubMed=15369138;
DI NCIt; C8111; Immature ovarian teratoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
- 公告/新闻
